Section 55

EurekaMag Full Text Articles Chapter 54,954


Fortier, L.-C.; Moineau, S. 2009: Phage production and maintenance of stocks, including expected stock lifetimes. Methods in Molecular Biology 501: 203-219
Petrenko, V.A.; Jayanna, P.K. 2014: Phage protein-targeted cancer nanomedicines. Febs Letters 588(2): 341-349
Lavigne, R.; Ceyssens, P.-J.; Robben, J. 2009: Phage proteomics: applications of mass spectrometry. Methods in Molecular Biology 502: 239-251
Poshtiban, S.; Javed, M.A.; Arutyunov, D.; Singh, A.; Banting, G.; Szymanski, C.M.; Evoy, S. 2013: Phage receptor binding protein-based magnetic enrichment method as an aid for real time PCR detection of foodborne bacteria. Analyst 138(19): 5619-5626
Murphy, K.C. 2012: Phage recombinases and their applications. Advances in Virus Research 83: 367-414
Potera, C. 2013: Phage renaissance: new hope against antibiotic resistance. Environmental Health Perspectives 121(2): A48-A53
McNerney, R. 2001: Phage replication technology for diagnosis and drug susceptibility testing. Methods in Molecular Medicine 54: 145-154
Hu, Y.; Li, T.; Yang, Z.; Zhang, B.; Li, Y. 2008: Phage resistance of Corynebacterium crenatum conferred by the restriction and modification system cgli. Sheng Wu Gong Cheng Xue Bao 24(5): 760-765
Huang, C.; Zhang, Y.; Jiao, N. 2010: Phage resistance of a marine bacterium, Roseobacter denitrificans OCh114, as revealed by comparative proteomics. Current Microbiology 61(2): 141-147
Rentero Rebollo, I.; Heinis, C. 2013: Phage selection of bicyclic peptides. Methods 60(1): 46-54
Fujiwara, D.; Fujii, I. 2013: Phage selection of peptide "microantibodies". Current Protocols in Chemical Biology 5(3): 171-194
Bellotto, S.; Chen, S.; Rentero Rebollo, I.; Wegner, H.A.; Heinis, C. 2014: Phage selection of photoswitchable peptide ligands. Journal of the American Chemical Society 136(16): 5880-5883
Flores-Kim, Jé.; Darwin, A.J. 2012: Phage shock protein C (PspC) of Yersinia enterocolitica is a polytopic membrane protein with implications for regulation of the Psp stress response. Journal of Bacteriology 194(23): 6548-6559
Sharma, R.S.; Mishra, V.; Mohmmed, A.; Babu, C.R. 2008: Phage specificity and lipopolysaccarides of stem- and root-nodulating bacteria (Azorhizobium caulinodans, Sinorhizobium spp., and Rhizobium spp.) of Sesbania spp. Archives of Microbiology 189(4): 411-418
Laanto, E.; Sundberg, L.-R.; Bamford, J.K.H. 2011: Phage specificity of the freshwater fish pathogen Flavobacterium columnare. Applied and Environmental Microbiology 77(21): 7868-7872
Sangster, W.; Hegarty, J.P.; Stewart, D.B. 2015: Phage tail-like particles kill Clostridium difficile and represent an alternative to conventional antibiotics. Surgery 157(1): 96-103
Barbirz, S.; Becker, M.; Freiberg, A.; Seckler, R. 2009: Phage tailspike proteins with beta-solenoid fold as thermostable carbohydrate binding materials. Macromolecular Bioscience 9(2): 169-173
Gross, M. 2014: Phage therapies for plants and people. Current Biology: Cb 24(12): R541-R544
Housby, J.N.; Mann, N.H. 2009: Phage therapy. Drug Discovery Today 14(11-12): 536-540
Almeida, A.; Cunha, A.; Gomes, N.C.M.; Alves, E.; Costa, L.; Faustino, M.A.F. 2009: Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants. Marine Drugs 7(3): 268-313
Kutateladze, M.; Adamia, R. 2008: Phage therapy experience at the Eliava Institute. Medecine et Maladies Infectieuses 38(8): 426-430
Balogh, B.; Jones, J.B.; Iriarte, F.B.; Momol, M.T. 2010: Phage therapy for plant disease control. Current Pharmaceutical Biotechnology 11(1): 48-57
Völkel, I.; Czerny, C-Peter. 2011: Phage therapy in the fields of veterinary medicine: an overview. Berliner und Munchener Tierarztliche Wochenschrift 124(7-8): 303-312
Endersen, L.; O'Mahony, J.; Hill, C.; Ross, R.P.; McAuliffe, O.; Coffey, A. 2014: Phage therapy in the food industry. Annual Review of Food Science and Technology 5: 327-349
Trigo, G.; Martins, T.G.; Fraga, A.G.; Longatto-Filho, A.; Castro, Aónio.G.; Azeredo, J.; Pedrosa, J. 2013: Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model. Plos Neglected Tropical Diseases 7(4): E2183
Tóthová, L.ír.; Celec, P.; Bábíčková, J.; Gajdošová, J.; Al-Alami, H.; Kamodyova, N.ál.; Drahovská, H.; Liptáková, A.; Turňa, J.án.; Hodosy, J.úl. 2011: Phage therapy of Cronobacter-induced urinary tract infection in mice. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 17(7): Br173-Br178
Miedzybrodzki, R.; Fortuna, W.; Weber-Dabrowska, B.; Górski, A. 2007: Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment. Postepy Higieny i Medycyny Doswiadczalnej 61: 461-465
Zabezhinsky, L.M.; Gorstkina-Shevandronova, L.A. 1946: Phage therapy of typhoid. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 25-27
Abedon, S.T.; Thomas-Abedon, C. 2010: Phage therapy pharmacology. Current Pharmaceutical Biotechnology 11(1): 28-47
Chan, B.K.; Abedon, S.T. 2012: Phage therapy pharmacology phage cocktails. Advances in Applied Microbiology 78: 1-23
Abedon, S. 2011: Phage therapy pharmacology: calculating phage dosing. Advances in Applied Microbiology 77: 1-40
Cohen, Y.; Joseph Pollock, F.; Rosenberg, E.; Bourne, D.G. 2013: Phage therapy treatment of the coral pathogen Vibrio coralliilyticus. Microbiologyopen 2(1): 64-74
Nilsson, A.S. 2014: Phage therapy--constraints and possibilities. Upsala Journal of Medical Sciences 119(2): 192-198
Chanishvili, N. 2012: Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches. Advances in Virus Research 83: 3-40
Ormälä, A.-M.; Jalasvuori, M. 2013: Phage therapy: Should bacterial resistance to phages be a concern, even in the long run?. Bacteriophage 3(1): E24219
Keen, E.C. 2012: Phage therapy: concept to cure. Frontiers in Microbiology 3: 238
Harper, D.R.; Anderson, J.; Enright, M.C. 2011: Phage therapy: delivering on the promise. Therapeutic Delivery 2(7): 935-947
Abedon, S.T. 2014: Phage therapy: eco-physiological pharmacology. Scientifica 2014: 581639
Van Bergen, M.; Wagenaar, J. 2008: Phage therapy: harmless viruses help destroy bacterial infections. Tijdschrift Voor Diergeneeskunde 133(14-15): 618-621
Brüssow, H. 2014: Phage therapy: quo vadis?. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 58(4): 535-536
Siegrist, M.Sloan.; Rubin, E.J. 2009: Phage transposon mutagenesis. Methods in Molecular Biology 465: 311-323
Abedon, S.T.; Kuhl, S.J.; Blasdel, B.G.; Kutter, E.M. 2011: Phage treatment of human infections. Bacteriophage 1(2): 66-85
Asai, T.; Harada, K.; Kojima, A.; Sameshima, T.; Takahashi, T.; Akiba, M.; Nakazawa, M.; Izumiya, H.; Terajima, J.; Watanbe, H. 2008: Phage type and antimicrobial susceptibility of Salmonella enterica serovar Enteritidis from food-producing animals in Japan between 1976 and 2004. New Microbiologica 31(4): 555-559
Wiśniewska, K.; Piechowicz, L.; Dabrowska-Szponar, M.; Haras, K. 2007: Phage types of Staphylococcus aureus strains and their antibiotic resistance in carriers of medical students population. Medycyna Doswiadczalna i Mikrobiologia 59(4): 287-292
Sarkar, B.L.; Bhowmick, T.S.; Das, M.; Rajendran, K.; Nair, G.B. 2011: Phage types of Vibrio cholerae O1 and O139 in the past decade in India. Japanese Journal of Infectious Diseases 64(4): 312-315
Dera-Tomaszewska, B.; Tokarska-Pietrzak, E. 2012: Phage types recognized within Salmonella Enteritidis strains isolated in Poland in 1996-2007. Przeglad epidemiologiczny 66(4): 611-616
Chirakadze, I.; Perets, A.; Ahmed, R. 2009: Phage typing. Methods in Molecular Biology 502: 293-305
Barton, E.L.; Edge, G.E.A.; Hardman, R.P. 1948: Phage typing in the investigation of an outbreak of food poisoning of staphylococcus etiology. Canadian Journal of Public Health 39(2): 76
Baggesen, D.L.; Sørensen, G.; Nielsen, E.M.; Wegener, H.C. 2010: Phage typing of Salmonella Typhimurium - is it still a useful tool for surveillance and outbreak investigation?. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 15(4): 19471
Al-Khulaifi Manal, M.; Amin Aref Nagwa, M.; Al Salamah, A.A. 2009: Phage typing, PCR amplification for mecA gene, and antibiotic resistance patterns as epidemiologic markers in nosocomial outbreaks of methicillin resistant Staphylococcus aureus. Saudi Journal of Biological Sciences 16(1): 37-49
Sen, B.; Dutta, S.; Sur, D.; Manna, B.; Deb, A.K.; Bhattacharya, S.K.; Niyogi, S.K. 2007: Phage typing, biotyping and antimicrobial resistance profile of Salmonella enterica serotype Typhi from Kolkata. Indian Journal of Medical Research 125(5): 685-688
Lamboy, J.A.; Arter, J.A.; Knopp, K.A.; Der, D.; Overstreet, C.M.; Palermo, E.F.; Urakami, H.; Yu, T.-B.; Tezgel, O.; Tew, G.N.; Guan, Z.; Kuroda, K.; Weiss, G.A. 2009: Phage wrapping with cationic polymers eliminates nonspecific binding between M13 phage and high pi target proteins. Journal of the American Chemical Society 131(45): 16454-16460
Węgrzyn, G.; Licznerska, K.; Węgrzyn, A. 2012: Phage λ--new insights into regulatory circuits. Advances in Virus Research 82: 155-178
Goh, S.; Hussain, H.; Chang, B.J.; Emmett, W.; Riley, T.V.; Mullany, P. 2013: Phage ϕC2 mediates transduction of Tn6215, encoding erythromycin resistance, between Clostridium difficile strains. Mbio 4(6): E00840
Comeau, A.é M.; Tétart, F.ço.; Trojet, S.N.; Prère, M.-F.ço.; Krisch, H.M. 2007: Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth. Plos one 2(8): E799
Scott, J.; Nguyen, S.V.; King, C.J.; Hendrickson, C.; McShan, W.Michael. 2012: Phage-Like Streptococcus pyogenes Chromosomal Islands (SpyCI) and Mutator Phenotypes: Control by Growth State and Rescue by a SpyCI-Encoded Promoter. Frontiers in Microbiology 3: 317
Scott, J.; Thompson-Mayberry, P.; Lahmamsi, S.; King, C.J.; McShan, W.M. 2008: Phage-associated mutator phenotype in group a streptococcus. Journal of Bacteriology 190(19): 6290-6301
Soffer, N.; Zaneveld, J.; Vega Thurber, R. 2015: Phage-bacteria network analysis and its implication for the understanding of coral disease. Environmental Microbiology 17(4): 1203-1218
Faruque, S.M.; Mekalanos, J.J. 2012: Phage-bacterial interactions in the evolution of toxigenic Vibrio cholerae. Virulence 3(7): 556-565
Goodridge, L.D.; Bisha, B. 2011: Phage-based biocontrol strategies to reduce foodborne pathogens in foods. Bacteriophage 1(3): 130-137
Van der Merwe, R.G.; van Helden, P.D.; Warren, R.M.; Sampson, S.L.; Gey van Pittius, N.C. 2014: Phage-based detection of bacterial pathogens. Analyst 139(11): 2617-2626
Stone, J.M. 2001: Phage-based expression cloning to identify interacting proteins. Current Protocols in Protein Science Chapter 19: Unit 19.3
Zhu, H.; White, I.M.; Suter, J.D.; Fan, X. 2008: Phage-based label-free biomolecule detection in an opto-fluidic ring resonator. Biosensors and Bioelectronics 24(3): 461-466
Cao, J.; Wen, Z.-M.; Deng, S.-H.; Zhou, X.; Chen, Q.-L.; Liao, W.-T.; Jiang, S.-H.; Jia, J.-A.; Qi, Z.-T.; Sun, S.-H.; Pan, W. 2012: Phage-based molecular directed evolution yields multiple tandem human IgA affibodies with intramolecular binding avidity. Journal of Biotechnology 158(3): 120-127
Cao, L.; Zeller, M.K.; Fiore, V.F.; Strane, P.; Bermudez, H.; Barker, T.H. 2012: Phage-based molecular probes that discriminate force-induced structural states of fibronectin in vivo. Proceedings of the National Academy of Sciences of the United States of America 109(19): 7251-7256
Farr, R.; Choi, D.S.; Lee, S.-W. 2014: Phage-based nanomaterials for biomedical applications. Acta Biomaterialia 10(4): 1741-1750
Schofield, D.A.; Sharp, N.J.; Westwater, C. 2012: Phage-based platforms for the clinical detection of human bacterial pathogens. Bacteriophage 2(2): 105-283
Fornelos, N.; Bamford, J.K.H.; Mahillon, J. 2011: Phage-borne factors and host LexA regulate the lytic switch in phage GIL01. Journal of Bacteriology 193(21): 6008-6019
Yoo, S.Y.; Oh, J.-W.; Lee, S.-W. 2012: Phage-chips for novel optically readable tissue engineering assays. Langmuir 28(4): 2166-2172
Rinderknecht, M.; Villa, A.; Ballmer-Hofer, K.; Neri, D.; Detmar, M. 2010: Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3. Plos one 5(8): E11941
Zaman, M.S.; Moon, C.H.; Bozhilov, K.N.; Haberer, E.D. 2013: Phage-directed synthesis of copper sulfide: structural and optical characterization. Nanotechnology 24(32): 325602
Kay, B. 2012: Phage-display and related areas. Methods 58(1): 1
Yang, M.; Liu, C.; Niu, M.; Hu, Y.; Guo, M.; Zhang, J.; Luo, Y.; Yuan, W.; Yang, M.; Yun, M.; Guo, L.; Yan, J.; Liu, D.; Liu, J.; Jiang, Y. 2014: Phage-display library biopanning and bioinformatic analysis yielded a high-affinity peptide to inflamed vascular endothelium both in vitro and in vivo. Journal of Controlled Release: Official Journal of the Controlled Release Society 174: 72-80
Goodyear, C.S.; Silverman, G.J. 2008: Phage-display methodology for the study of protein-protein interactions: overview. Csh Protocols 2008: Pdb.Top48
Goodyear, C.S.; Silverman, G.J. 2008: Phage-display methodology for the study of protein-protein interactions: stage 1, generating libraries. Csh Protocols 2008: Pdb.Prot 5020
Goodyear, C.S.; Silverman, G.J. 2008: Phage-display methodology for the study of protein-protein interactions: stage 2, panning. Csh Protocols 2008: Pdb.Prot 5021
Goodyear, C.S.; Silverman, G.J. 2008: Phage-display methodology for the study of protein-protein interactions: stage 3, binding analysis. Csh Protocols 2008: Pdb.Prot 5022
Sun, Y.; Shukla, G.S.; Weaver, D.; Pero, S.C.; Krag, D.N. 2009: Phage-display selection on tumor histological specimens with laser capture microdissection. Journal of Immunological Methods 347(1-2): 46-53
Cabezas, S.; Rojas, G.; Pavon, A.; Bernardo, L.; Castellanos, Y.; Alvarez, M.; Pupo, M.; Guillen, G.; Guzman, M.G. 2009: Phage-displayed antibody fragments recognizing dengue 3 and dengue 4 viruses as tools for viral serotyping in sera from infected individuals. Archives of Virology 154(7): 1035-1045
Shukla, G.S.; Krag, D.N. 2010: Phage-displayed combinatorial peptide libraries in fusion to beta-lactamase as reporter for an accelerated clone screening: Potential uses of selected enzyme-linked affinity reagents in downstream applications. Combinatorial Chemistry and High Throughput Screening 13(1): 75-87
Wang, Y.; Wang, H.; Li, P.; Zhang, Q.; Kim, H.J.; Gee, S.J.; Hammock, B.D. 2013: Phage-displayed peptide that mimics aflatoxins and its application in immunoassay. Journal of Agricultural and Food Chemistry 61(10): 2426-2433
Fogaça, R.L.; Capelli-Peixoto, J.ín.; Yamanaka, I.B.; de Almeida, R.P.M.; Muzzi, J.ão.C.D.; Borges, M.; Costa, A.J.; Chávez-Olortegui, C.; Thomaz-Soccol, V.; Alvarenga, L.M.; de Moura, J. 2014: Phage-displayed peptides as capture antigens in an innovative assay for Taenia saginata-infected cattle. Applied Microbiology and Biotechnology 98(21): 8887-8894
Bishop-Hurley, S.L.; Rea, P.J.; McSweeney, C.S. 2010: Phage-displayed peptides selected for binding to Campylobacter jejuni are antimicrobial. Protein Engineering Design and Selection: Peds 23(10): 751-757
Goldman, E.; Walper, S. 2014: Phage-displayed single domain antibodies as recognition elements. Methods in Molecular Biology 1108: 201-210
Laanto, E.; Bamford, J.K.H.; Laakso, J.; Sundberg, L.-R. 2012: Phage-driven loss of virulence in a fish pathogenic bacterium. Plos one 7(12): E53157
Kim, M.S.; Kim, Y.D.; Hong, S.S.; Park, K.; Ko, K.S.; Myung, H. 2015: Phage-encoded colanic acid-degrading enzyme permits lytic phage infection of a capsule-forming resistant mutant Escherichia coli strain. Applied and Environmental Microbiology 81(3): 900-909
Cenens, W.; Makumi, A.; Mebrhatu, M.T.; Lavigne, R.; Aertsen, A. 2013: Phage-host interactions during pseudolysogeny: Lessons from the Pid/dgo interaction. Bacteriophage 3(1): E25029
Chaturongakul, S.; Ounjai, P. 2014: Phage-host interplay: examples from tailed phages and Gram-negative bacterial pathogens. Frontiers in Microbiology 5: 442
Park, S.H.; Son, W.S.; Mukhopadhyay, R.; Valafar, H.; Opella, S.J. 2009: Phage-induced alignment of membrane proteins enables the measurement and structural analysis of residual dipolar couplings with dipolar waves and lambda-maps. Journal of the American Chemical Society 131(40): 14140-14141
Szekeres, M. 1981: Phage-induced development of a site-specific endonuclease in Anacystis nidulans, a cyanobacterium. Virology 111(1): 1-10
Young, J.C.; Dill, B.D.; Pan, C.; Hettich, R.L.; Banfield, J.F.; Shah, M.; Fremaux, C.; Horvath, P.; Barrangou, R.; Verberkmoes, N.C. 2012: Phage-induced expression of CRISPR-associated proteins is revealed by shotgun proteomics in Streptococcus thermophilus. Plos one 7(5): E38077
Imamovic, L.; Jofre, J.; Schmidt, H.; Serra-Moreno, R.; Muniesa, M. 2009: Phage-mediated Shiga toxin 2 gene transfer in food and water. Applied and Environmental Microbiology 75(6): 1764-1768
Schofield, D.A.; Westwater, C. 2009: Phage-mediated bioluminescent detection of Bacillus anthracis. Journal of Applied Microbiology 107(5): 1468-1478
Chen, J.; Novick, R.P. 2009: Phage-mediated intergeneric transfer of toxin genes. Science 323(5910): 139-141
Evans, T.J.; Ind, A.; Komitopoulou, E.; Salmond, G.P.C. 2010: Phage-selected lipopolysaccharide mutants of Pectobacterium atrosepticum exhibit different impacts on virulence. Journal of Applied Microbiology 109(2): 505-514
Kühn, K.; Richter, U.; Meyer, E.H.; Delannoy, E.; de Longevialle, A.éo.F.; O'Toole, N.; Börner, T.; Millar, A.H.; Small, I.D.; Whelan, J. 2009: Phage-type RNA polymerase RPOTmp performs gene-specific transcription in mitochondria of Arabidopsis thaliana. Plant Cell 21(9): 2762-2779
Hackl, E.; Konrad-Köszler, M.; Kilian, A.; Wenzl, P.; Kornschober, C.; Sessitsch, A. 2010: Phage-type specific markers identified by Diversity Arrays Technology (DArT) analysis of Salmonella enterica ssp. enterica serovars Enteritidis and Typhimurium. Journal of Microbiological Methods 80(1): 100-105
Gillespie, M.G. 1928: Phagedaenic Ulceration of the Skin. Annals of Surgery 88(2): 248-251
O'conner, G.B.; Kay, J.H. 1948: Phagedenic ulcer of the penis with plastic repair. Plastic and Reconstructive Surgery 3(3): 340-344
Mann, R.A. 1967: Phagedænic ulcer of the thigh. Proceedings of the Royal Society of Medicine 60(6): 543
Delhalle, S.; Schmit, J.-C.; Chevigné, A. 2012: Phages and HIV-1: from display to interplay. International Journal of Molecular Sciences 13(4): 4727-4794
Wang, X.; Li, G.; Ren, Y.; Ren, X. 2011: Phages bearing affinity peptides to bovine rotavirus differentiate the virus from other viruses. Plos one 6(12): E28667
Ren, X.; Wang, M.; Yin, J.; Li, G. 2010: Phages harboring specific peptides that recognize the N protein of the porcine reproductive and respiratory syndrome virus distinguish the virus from other viruses. Journal of Clinical Microbiology 48(5): 1875-1881
Cardarelli, L.; Pell, L.G.; Neudecker, P.; Pirani, N.; Liu, A.; Baker, L.A.; Rubinstein, J.L.; Maxwell, K.L.; Davidson, A.R. 2010: Phages have adapted the same protein fold to fulfill multiple functions in virion assembly. Proceedings of the National Academy of Sciences of the United States of America 107(32): 14384-14389
Clokie, M.Rj.; Millard, A.D.; Letarov, A.V.; Heaphy, S. 2011: Phages in nature. Bacteriophage 1(1): 31-45
Żaczek, M.; Weber-Dąbrowska, B.; Górski, A. 2015: Phages in the global fruit and vegetable industry. Journal of Applied Microbiology 118(3): 537-556
Ebdon, J.E.; Sellwood, J.; Shore, J.; Taylor, H.D. 2012: Phages of Bacteroides (GB-124): a novel tool for viral waterborne disease control?. Environmental Science and Technology 46(2): 1163-1169
Hagens, S.; Loessner, M.J. 2014: Phages of Listeria offer novel tools for diagnostics and biocontrol. Frontiers in Microbiology 5: 159
Knezevic, P.; Obreht, D.; Curcin, S.; Petrusic, M.; Aleksic, V.; Kostanjsek, R.; Petrovic, O. 2011: Phages of Pseudomonas aeruginosa: response to environmental factors and in vitro ability to inhibit bacterial growth and biofilm formation. Journal of Applied Microbiology 111(1): 245-254
Xia, G.; Wolz, C. 2014: Phages of Staphylococcus aureus and their impact on host evolution. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 21: 593-601
Mahony, J.; Ainsworth, S.; Stockdale, S.; van Sinderen, D. 2012: Phages of lactic acid bacteria: the role of genetics in understanding phage-host interactions and their co-evolutionary processes. Virology 434(2): 143-150
Cavanagh, D.; Guinane, C.M.; Neve, H.; Coffey, A.; Ross, R.P.; Fitzgerald, G.F.; McAuliffe, O. 2014: Phages of non-dairy lactococci: isolation and characterization of ΦL47, a phage infecting the grass isolate Lactococcus lactis ssp. cremoris DPC6860. Frontiers in Microbiology 4: 417
Gillis, A.; Mahillon, J. 2014: Phages preying on Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis: past, present and future. Viruses 6(7): 2623-2672
Estephan, E.; Saab, M.-B.; Martin, M.; Larroque, C.; Cuisinier, F.éd.ér.J.G.; Briot, O.; Ruffenach, S.; Moret, M.; Gergely, C. 2011: Phages recognizing the Indium Nitride semiconductor surface via their peptides. Journal of Peptide Science: An Official Publication of the European Peptide Society 17(2): 143-147
Bua, A.; Rosu, V.; Molicotti, P.; Das Gupta, S.K.; Ahmed, N.; Zanetti, S.; Sechi, L.A. 2009: Phages specific for mycobacterial lipoarabinomannan help serodiagnosis of tuberculosis. New Microbiologica 32(3): 293-296
Cambrosio, A.; Jacobi, D.; Keating, P. 2008: Phages, antibodies and de-monstration. History and Philosophy of the Life Sciences 30(2): 131-157
Chen, X.; Wei, Q.-Q.; Chen, Y.; Cao, B.; Ou, R.; Hou, Y.; Yuan, X.; Zhang, L.; Liu, H.; Shang, H. 2018: Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients. Frontiers in Neurology 9: 442
Henry, K.M.; Pase, L.; Ramos-Lopez, C.F.; Lieschke, G.J.; Renshaw, S.A.; Reyes-Aldasoro, C.C. 2013: PhagoSight: an open-source MATLAB® package for the analysis of fluorescent neutrophil and macrophage migration in a zebrafish model. Plos one 8(8): E72636
Schreiber, A.; Luft, F.C.; Kettritz, R. 2015: Phagocyte NADPH oxidase restrains the inflammasome in ANCA-induced GN. Journal of the American Society of Nephrology: Jasn 26(2): 411-424
Deffert, C.; Cachat, J.; Krause, K.-H. 2014: Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections. Cellular Microbiology 16(8): 1168-1178
Khanokh, E.V.; Rozhdestvenskiĭ, A.S.; Dolgikh, T.I.; Ershov, A.V.; Kakulia, A.V.; Delov, R.A. 2011: Phagocyte activity and the interferon system in patients with different types of multiple sclerosis. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(2 Part 2): 21-24
Kennel, S.J.; Macy, S.; Wooliver, C.; Huang, Y.; Richey, T.; Heidel, E.; Wall, J.S. 2014: Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice. Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis 21(1): 45-53
Rahman, F.Z.; Marks, D.J.B.; Hayee, B.H.; Smith, A.M.; Bloom, S.L.; Segal, A.W. 2008: Phagocyte dysfunction and inflammatory bowel disease. Inflammatory Bowel Diseases 14(10): 1443-1452
Álvarez-Rodríguez, L.; López-Hoyos, M.; Calvo-Alén, J.; Aurrecoechea, E.; Villa, I.; Martínez-Taboada, V.íc.M. 2013: Phagocyte dysfunction in polymyalgia rheumatica and other age-related, chronic, inflammatory conditions. Journal of Leukocyte Biology 94(5): 1071-1078
Li, W. 2013: Phagocyte dysfunction, tissue aging and degeneration. Ageing Research Reviews 12(4): 1005-1012
Bjo Rksten, B. 1980: Phagocyte function in pregnancy. Immunology Today 1(3): 55-56
Molaie, Y.; Latifynia, A.; Kalamzadeh, A.; Abofazeli, T.; Nuraie, M.; Khansarii, N. 2012: Phagocyte functions of human subjects living in high level of natural radiation areas in Iran. Journal of Ayub Medical College Abbottabad: Jamc 24(3-4): 177-179
Everson, C.A.; Thalacker, C.D.; Hogg, N. 2008: Phagocyte migration and cellular stress induced in liver, lung, and intestine during sleep loss and sleep recovery. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 295(6): R2067-R2074
Le Cabec, V.ér.; Van Goethem, E.; Guiet, R.; Maridonneau-Parini, I. 2011: Phagocyte migration: an overview. Medecine Sciences: M/S 27(12): 1112-1119
Libako, P.; Nowacki, W.; Rock, E.; Rayssiguier, Y.; Mazur, A. 2010: Phagocyte priming by low magnesium status: input to the enhanced inflammatory and oxidative stress responses. Magnesium Research 23(1): 1-4
Denkers, E.Y.; Schneider, A.G.; Cohen, S.B.; Butcher, B.A. 2012: Phagocyte responses to protozoan infection and how Toxoplasma gondii meets the challenge. Plos Pathogens 8(8): E1002794
Hasenberg, M.; Behnsen, J.; Krappmann, S.; Brakhage, A.; Gunzer, M. 2011: Phagocyte responses towards Aspergillus fumigatus. International Journal of Medical Microbiology: Ijmm 301(5): 436-444
Fenlon, L.A.; Slauch, J.M. 2014: Phagocyte roulette in Salmonella killing. Cell Host and Microbe 15(1): 7-8
Björkman, L.; Dahlgren, C.; Karlsson, A.; Brown, K.L.; Bylund, J. 2008: Phagocyte-derived reactive oxygen species as suppressors of inflammatory disease. Arthritis and Rheumatism 58(10): 2931-2935
Kowluru, A.; Kowluru, R.A. 2014: Phagocyte-like NADPH oxidase [Nox2] in cellular dysfunction in models of glucolipotoxicity and diabetes. Biochemical Pharmacology 88(3): 275-283
Syed, I.; Kyathanahalli, C.N.; Kowluru, A. 2011: Phagocyte-like NADPH oxidase generates ROS in INS 832/13 cells and rat islets: role of protein prenylation. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 300(3): R756-R762
Subasinghe, W.; Syed, I.; Kowluru, A. 2011: Phagocyte-like NADPH oxidase promotes cytokine-induced mitochondrial dysfunction in pancreatic β-cells: evidence for regulation by Rac1. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 300(1): R12-R20
Zhang, S.; Dehn, S.; DeBerge, M.; Rhee, K.-J.; Hudson, B.; Thorp, E.B. 2014: Phagocyte-myocyte interactions and consequences during hypoxic wound healing. Cellular Immunology 291(1-2): 65-73
Foell, D.; Wittkowski, H.; Ren, Z.; Turton, J.; Pang, G.; Daebritz, J.; Ehrchen, J.; Heidemann, J.; Borody, T.; Roth, J.; Clancy, R. 2008: Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. Journal of Pathology 216(2): 183-192
Saito, Y.; Sugino, K.; Takami, H.; Matsuzu, K.; Uruno, T.; Ohkuwa, K.; Kitagawa, W.; Nagahama, M.; Kawakubo, H.; Ito, K.; Kitagawa, Y. 2018: Clinical Status and Treatment of Liver Metastasis of Differentiated Thyroid Cancer Using Tyrosine Kinase Inhibitors. World Journal of Surgery 42(11): 3632-3637
Soyfoo, M.S.; Roth, J.; Vogl, T.; Pochet, R.; Decaux, G. 2009: Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus. Journal of Rheumatology 36(10): 2190-2194
Kolaczkowska, E.; Kubes, P. 2012: Phagocytes and granulocytes. Angiogenic neutrophils: a novel subpopulation paradigm. Blood 120(23): 4455-4457
Eisele, N.A.; Brown, C.R.; Anderson, D.M. 2012: Phagocytes and humoral immunity to pneumonic plague. Advances in Experimental Medicine and Biology 954: 165-171
Zander, H.A. 1946: Phagocytes in the dental pulp. Journal of Endodontia 1(3): 26-28
Toraya-Brown, S.; Sheen, M.Rie.; Baird, J.R.; Barry, S.; Demidenko, E.; Turk, M.Jo.; Hoopes, P.Jack.; Conejo-Garcia, J.R.; Fiering, S. 2013: Phagocytes mediate targeting of iron oxide nanoparticles to tumors for cancer therapy. Integrative Biology: Quantitative Biosciences from Nano to Macro 5(1): 159-171
Chauvin, C.; Peyrin-Biroulet, L.; Chamaillard, M.; Poulin, L.F. 2013: Phagocytes migration in response to an emergency call from the microbiota. Gastroenterology 145(5): 1150-1151
Shimanskiĭ, S.L.; Chilikin, V.N.; Malyshev, I.I.; Suvorova, I.A.; Rumiantsev, V.A.; Denis, A.G. 2013: Phagocytes protection of periodontium and its ways activation. Stomatologiia 92(5): 64-69
Zimmerman, L.M.; Vogel, L.A.; Edwards, K.A.; Bowden, R.M. 2010: Phagocytic B cells in a reptile. Biology Letters 6(2): 270-273
Meakins, J.C. 1909: Phagocytic Immunity. Journal of Experimental Medicine 11(1): 100-117
Strouse, S. 1911: Phagocytic Immunity in Pneumococcus Infections, and in Pneumonia with relation to the Crisis. Journal of Experimental Medicine 14(2): 109-115
Meakins, J.C. 1909: Phagocytic Immunity in Streptococcus Infections. Journal of Experimental Medicine 11(6): 815-824
Jayaram, B.; Kowluru, A. 2012: Phagocytic NADPH oxidase links ARNO-Arf6 signaling pathway in glucose-stimulated insulin secretion from the pancreatic β-cell. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 30(6): 1351-1362
Horn, L.; Leips, J.; Starz-Gaiano, M. 2014: Phagocytic ability declines with age in adult Drosophila hemocytes. Aging Cell 13(4): 719-728
Rapeah, S.; Dhaniah, M.; Nurul, A.A.; Norazmi, M.N. 2010: Phagocytic activity and pro-inflammatory cytokines production by the murine macrophage cell line J774A.1 stimulated by a recombinant BCG (rBCG) expressing the MSP1-C of Plasmodium falciparum. Tropical Biomedicine 27(3): 461-469
Jakovac-Strajn, B.; Ihan, A.; Kopitar, A.N.; Malovrh, T. 2011: Phagocytic activity in blood and proliferation of peripheral blood lymphocytes during the perinatal period in primiparous sows. Journal of Animal Physiology and Animal Nutrition 95(3): 328-334
Lecube, A.; Pachón, G.; Petriz, J.; Hernández, C.; Simó, R. 2011: Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. Plos one 6(8): E23366
De Lima, T.M.; Sampaio, S.C.; Petroni, R.; Brigatte, P.íc.; Velasco, I.T.; Soriano, F.G. 2014: Phagocytic activity of LPS tolerant macrophages. Molecular Immunology 60(1): 8-13
Coates, C.J.; Whalley, T.; Nairn, J. 2012: Phagocytic activity of Limulus polyphemus amebocytes in vitro. Journal of Invertebrate Pathology 111(3): 205-210
Bushmakina, I.M.; Drozdova, N.I.; Martynova, M.A. 2009: Phagocytic activity of alveolar macrophages in the presence of liposomal "biene". Bulletin of Experimental Biology and Medicine 148(2): 204-206
Hasegawa, T.; Hirota, K.; Tomoda, K.; Ito, F.; Inagawa, H.; Kochi, C.; Soma, G.-I.; Makino, K.; Terada, H. 2007: Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent. Colloids and Surfaces. B Biointerfaces 60(2): 221-228
Shutova, A.A. 1945: Phagocytic activity of leucocytes as affected by serums containing leucocytic trephones. Doklady Akademii Nauk Soiuza Sovetskikh Sotsialisticheskikh Respublik 48: 597-601
Atakhanov, E.I. 1949: Phagocytic activity of leukocytes in diseases of the hematopoietic system. Klinicheskaia Meditsina 27(3): 91
Arkhipov, S.A.; Shkurupy, V.A.; Troitsky, A.V.; Luzgina, N.G.; Ufimceva, E.G.; Zaikovskaja, M.V.; Iljine, D.A.; Akhramenko, E.S.; Gulyaeva, E.P.; Bistrova, T.N. 2009: Phagocytic activity of macrophages against liposomes with conjugates of oxidized dextrans and isonicotinic acid hydrazide during modeling of phagocytosis disturbances in vitro. Bulletin of Experimental Biology and Medicine 148(4): 689-691
Top, C.; Yildiz, S.; Oncül, O.; Qydedi, T.; Cevikbaş, A.; Soyogul, U.G.; Cavuşlu, S. 2007: Phagocytic activity of neutrophils improves over the course of therapy of diabetic foot infections. Journal of Infection 55(4): 369-373
Petrosian, É A.; Botashev, A.A.; Tereshchenko, O.A.; Pomeshchik, I.V.; Gubaz, S.G. 2011: Phagocytic activity of neutrophils in conditions of experimental choleperitonitis. Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 64-67
Asif, K.; Kothiwale, S.V. 2010: Phagocytic activity of peripheral blood and crevicular phagocytes in health and periodontal disease. Journal of Indian Society of Periodontology 14(1): 8-11
Xian, J.-A.; Wang, A.-L.; Ye, C.-X.; Chen, X.-D.; Wang, W.-N. 2010: Phagocytic activity, respiratory burst, cytoplasmic free-Ca(2+) concentration and apoptotic cell ratio of haemocytes from the black tiger shrimp, Penaeus monodon under acute copper stress. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 152(2): 182-188
Mehrzad, J.; Duchateau, L.; Burvenich, C. 2009: Phagocytic and bactericidal activity of blood and milk-resident neutrophils against Staphylococcus aureus in primiparous and multiparous cows during early lactation. Veterinary microbiology 134(1-2): 106-112
Sallenave, J.-M. 2014: Phagocytic and signaling innate immune receptors: are they dysregulated in cystic fibrosis in the fight against Pseudomonas aeruginosa?. International Journal of Biochemistry and Cell Biology 52: 103-107
Van Der Meeren, S.; Van Der Werff Ten Bosch, J.; Jochmans, K. 2013: Phagocytic blasts in B-lineage acute lymphoblastic leukaemia. British Journal of Haematology 160(2): 122
Ravetch, J.; Aderem, A. 2007: Phagocytic cells. Immunological Reviews 219: 5-7
Yasui, F.; Kohara, M.; Kitabatake, M.; Nishiwaki, T.; Fujii, H.; Tateno, C.; Yoneda, M.; Morita, K.; Matsushima, K.; Koyasu, S.; Kai, C. 2014: Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus. Virology 454-455: 157-168
Roy, R.; Chauhan, L.K.S.; Das, M.; Tripathi, A.; Dwivedi, P.D. 2014: Phagocytic cells internalize ZnO particles by FcγII/III-receptor pathway. Immunobiology 219(10): 746-755
Sokolowski, J.D.; Mandell, J.W. 2011: Phagocytic clearance in neurodegeneration. American Journal of Pathology 178(4): 1416-1428
Yun, J.H.; Henson, P.M.; Tuder, R.M. 2008: Phagocytic clearance of apoptotic cells: role in lung disease. Expert Review of Respiratory Medicine 2(6): 753-765
Tekle, E.; Wolfe, M.D.; Oubrahim, H.; Chock, P.B. 2008: Phagocytic clearance of electric field induced 'apoptosis-mimetic' cells. Biochemical and Biophysical Research Communications 376(2): 256-260
Harada, T.; Tanikawa, T.; Iwasaki, Y.; Yamada, M.; Imai, Y.; Miyake, M. 2012: Phagocytic entry of Legionella pneumophila into macrophages through phosphatidylinositol 3,4,5-trisphosphate-independent pathway. Biological and Pharmaceutical Bulletin 35(9): 1460-1468
Cheong, H.; Lee, S.S.; Lee, J.S.; Kim, J.; Kim, S.W.; Lee, W.J. 2015: Phagocytic function of Kupffer cells in mouse nonalcoholic fatty liver disease models: Evaluation with superparamagnetic iron oxide. Journal of Magnetic Resonance Imaging: Jmri 41(5): 1218-1227
Schafer, D.P.; Stevens, B. 2013: Phagocytic glial cells: sculpting synaptic circuits in the developing nervous system. Current Opinion in Neurobiology 23(6): 1034-1040
Robinson, J.M. 2009: Phagocytic leukocytes and reactive oxygen species. Histochemistry and Cell Biology 131(4): 465-469
Redondo-Castro, E.; Hernández, J.; Mahy, N.; Navarro, X. 2013: Phagocytic microglial phenotype induced by glibenclamide improves functional recovery but worsens hyperalgesia after spinal cord injury in adult rats. European Journal of Neuroscience 38(12): 3786-3798
Sayar Bahri, T.; Weerkamp, F.; Leys, M.B.L. 2013: Phagocytic plasma cells in a patient with smoldering myeloma. International Journal of Hematology 97(5): 547-548
Shen, Q.; He, B.; Lu, N.; Conradt, B.; Grant, B.D.; Zhou, Z. 2013: Phagocytic receptor signaling regulates clathrin and epsin-mediated cytoskeletal remodeling during apoptotic cell engulfment in C. elegans. Development 140(15): 3230-3243
Gitik, M.; Kleinhaus, R.; Hadas, S.; Reichert, F.; Rotshenker, S. 2014: Phagocytic receptors activate and immune inhibitory receptor SIRPα inhibits phagocytosis through paxillin and cofilin. Frontiers in Cellular Neuroscience 8: 104
Nakanishi, Y.; Nagaosa, K.; Shiratsuchi, A. 2011: Phagocytic removal of cells that have become unwanted: implications for animal development and tissue homeostasis. Development Growth and Differentiation 53(2): 149-160
He, B.-R.; Xie, S.-T.; Wu, M.-M.; Hao, D.-J.; Yang, H. 2014: Phagocytic removal of neuronal debris by olfactory ensheathing cells enhances neuronal survival and neurite outgrowth via p38MAPK activity. Molecular Neurobiology 49(3): 1501-1512
Ferreira, C.íl.K.O.; Prestes, J.; Donatto, F.F.; Verlengia, R.; Navalta, J.W.; Cavaglieri, C.áu.R. 2010: Phagocytic responses of peritoneal macrophages and neutrophils are different in rats following prolonged exercise. Clinics 65(11): 1167-1173
Kinchen, J.M.; Ravichandran, K.S. 2008: Phagocytic signaling: you can touch, but you can't eat. Current Biology: Cb 18(12): R521-R524
Craig, M.; Slauch, J.M. 2009: Phagocytic superoxide specifically damages an extracytoplasmic target to inhibit or kill Salmonella. Plos one 4(3): E4975
Qiu, L.; Chen, Y.; Gao, M.; Zheng, C.; Zhao, Q. 2013: Phagocytic uptake and ROS-mediated cytotoxicity in human hepatic cell line of amphiphilic polyphosphazene nanoparticles. Journal of Biomedical Materials Research. Part a 101(1): 285-297
Deshmukh, R.; Trivedi, V. 2014: Phagocytic uptake of oxidized heme polymer is highly cytotoxic to macrophages. Plos one 9(7): E103706
Mierke, C.T. 2013: Phagocytized beads reduce the α5β1 integrin facilitated invasiveness of cancer cells by regulating cellular stiffness. Cell Biochemistry and Biophysics 66(3): 599-622
Arnold, M.A.; Kahwash, S.B. 2014: Phagocytized neutrophil fragments in the bone marrow: a phenomenon most commonly associated with hodgkin lymphoma. Isrn Hematology 2014: 363854
Botelho, R.J.; Grinstein, S. 2011: Phagocytosis. Current Biology: Cb 21(14): R533-R538
Huddleson, I.F.; Johnson, H.W. 1931: Phagocytosis of Brucella, An Index of Immunity to Undulant Fever in man. Science 74(1917): 315-316
Spitzer, P.; Herrmann, M.; Klafki, H.-W.; Smirnov, A.; Lewczuk, P.; Kornhuber, J.; Wiltfang, J.; Maler, J.M. 2010: Phagocytosis and LPS alter the maturation state of β-amyloid precursor protein and induce different Aβ peptide release signatures in human mononuclear phagocytes. Journal of Neuroinflammation 7: 59
Blander, J.Magarian. 2008: Phagocytosis and antigen presentation: a partnership initiated by Toll-like receptors. Annals of the Rheumatic Diseases 67 Suppl. 3: Iii44-Iii49
Jönsson, B.; Ridell, M.; Wold, A.E. 2013: Phagocytosis and cytokine response to rough and smooth colony variants of Mycobacterium abscessus by human peripheral blood mononuclear cells. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 121(1): 45-55
Deschamps, C.; Echard, A.; Niedergang, F. 2013: Phagocytosis and cytokinesis: do cells use common tools to cut and to eat? Highlights on common themes and differences. Traffic 14(4): 355-364
Deschamps, C.; Echard, A.; Niedergang, F. 2013: Phagocytosis and cytokinesis: highlights on common themes and differences. Medecine sciences: M/S 29(11): 1004-1009
Schreiner, L.; Huber-Lang, M.; Weiss, M.E.; Hohmann, H.; Schmolz, M.; Schneider, E.M. 2011: Phagocytosis and digestion of pH-sensitive fluorescent dye (Eos-FP) transfected E. coli in whole blood assays from patients with severe sepsis and septic shock. Journal of Cell Communication and Signaling 5(2): 135-144
Kim, S.; Choi, I-Hong. 2012: Phagocytosis and endocytosis of silver nanoparticles induce interleukin-8 production in human macrophages. Yonsei Medical Journal 53(3): 654-657
Bozzaro, S.; Bucci, C.; Steinert, M. 2008: Phagocytosis and host-pathogen interactions in Dictyostelium with a look at macrophages. International Review of Cell and Molecular Biology 271: 253-300
Vonk, A.G.; Netea, M.G.; Kullberg, B.J. 2012: Phagocytosis and intracellular killing of Candida albicans by murine polymorphonuclear neutrophils. Methods in Molecular Biology 845: 277-287
Méhes, L.ór.; Taskó, S.; Székely, A.ár.; Tóth, Ák.; Ungvári, E.; Erdei, I.én.; Dombrádi, Z.; Szabó, J.; Maródi, L.ás.ó 2012: Phagocytosis and intracellular killing of heterogeneous vancomycin-intermediate Staphylococcus aureus strains. Journal of Medical Microbiology 61(Part 2): 198-203
Du, C.; Calderone, R.A. 2009: Phagocytosis and killing assays for Candida species. Methods in Molecular Biology 499: 17-26
Stefanova, T.; Nikolova, N.; Neychev, H.; Zlabinger, G. 2012: Phagocytosis and killing of Salmonella by 7-hydroxycoumarin activated macrophages. Immunological Investigations 41(2): 199-213
Lu, T.; Porter, A.R.; Kennedy, A.D.; Kobayashi, S.D.; DeLeo, F.R. 2014: Phagocytosis and killing of Staphylococcus aureus by human neutrophils. Journal of Innate Immunity 6(5): 639-649
Okamura, Y.; Sasaki, M. 2007: Phagocytosis and membrane potential. Seikagaku. Journal of Japanese Biochemical Society 79(5): 454-458
Paino, I.êd.M.M.; Miranda, J.C.; Marzocchi-Machado, C.M.; Cesarino, E.J.é; de Castro, F.ío.A.é; de Souza, A.M. 2011: Phagocytosis and nitric oxide levels in rheumatic inflammatory states in elderly women. Journal of Clinical Laboratory Analysis 25(1): 47-51
Ip, W.K.E.; Sokolovska, A.; Charriere, G.M.; Boyer, L.; Dejardin, S.; Cappillino, M.P.; Yantosca, L.M.; Takahashi, K.; Moore, K.J.; Lacy-Hulbert, A.; Stuart, L.M. 2010: Phagocytosis and phagosome acidification are required for pathogen processing and MyD88-dependent responses to Staphylococcus aureus. Journal of Immunology 184(12): 7071-7081
Haugland, G.T.; Jakobsen, R.A.; Vestvik, N.; Ulven, K.; Stokka, L.; Wergeland, H.I. 2012: Phagocytosis and respiratory burst activity in lumpsucker (Cyclopterus lumpus L.) leucocytes analysed by flow cytometry. Plos one 7(10): E47909
Cline, M.J. 1966: Phagocytosis and synthesis of ribonucleic acid in human granulocytes. Nature 212(5069): 1431-1433
Golodec, G.G. 1946: Phagocytosis as a method of detection of disorders of the vegetative nervous system. Biulleten' Eksperimental'noi Biologii i Meditsiny 21(1-2): 67-69
Øverland, H.S.; Pettersen, E.F.; Rønneseth, A.; Wergeland, H.I. 2010: Phagocytosis by B-cells and neutrophils in Atlantic salmon (Salmo salar L.) and Atlantic cod (Gadus morhua L.). Fish and Shellfish Immunology 28(1): 193-204
Nagasawa, T.; Nakayasu, C.; Rieger, A.M.; Barreda, D.R.; Somamoto, T.; Nakao, M. 2014: Phagocytosis by Thrombocytes is a Conserved Innate Immune Mechanism in Lower Vertebrates. Frontiers in Immunology 5: 445
Jovanović, M.; Vislavski, M.; Jovanović, M. 1994: Phagocytosis by neutrophils and monocytes in children with recurrent infections. Srpski Arhiv Za Celokupno Lekarstvo 122(Suppl 1): 69-72
Paul, D.; Achouri, S.; Yoon, Y.-Z.; Herre, J.; Bryant, C.E.; Cicuta, P. 2013: Phagocytosis dynamics depends on target shape. Biophysical Journal 105(5): 1143-1150
Ko, Y-Ping.; Kuipers, A.; Freitag, C.M.; Jongerius, I.; Medina, E.; van Rooijen, W.J.; Spaan, Aás.N.; van Kessel, K.P.M.; Höök, M.; Rooijakkers, S.H.M. 2013: Phagocytosis escape by a Staphylococcus aureus protein that connects complement and coagulation proteins at the bacterial surface. Plos Pathogens 9(12): E1003816
Neher, J.J.; Emmrich, J.V.; Fricker, M.; Mander, P.K.; Théry, C.; Brown, G.C. 2013: Phagocytosis executes delayed neuronal death after focal brain ischemia. Proceedings of the National Academy of Sciences of the United States of America 110(43): E4098-E4107
Grinstein, S. 2012: Phagocytosis here and now. Traffic 13(8): 1041
Bartlett, C.J.; Ozaki, Y. 1917: Phagocytosis in Vivo under various Conditions. Journal of Medical Research 37(1): 139-160
Dale, B.M.; Traum, D.; Erdjument-Bromage, H.; Tempst, P.; Greenberg, S. 2009: Phagocytosis in macrophages lacking Cbl reveals an unsuspected role for Fc gamma receptor signaling and actin assembly in target binding. Journal of Immunology 182(9): 5654-5662
Frouin, H.él.ïs.; Lebeuf, M.; Hammill, M.; Fournier, M. 2010: Phagocytosis in pup and adult harbour, grey and harp seals. Veterinary Immunology and Immunopathology 134(3-4): 160-168
Bartneck, M.; Keul, H.A.; Zwadlo-Klarwasser, G.; Groll, Jürgen. 2010: Phagocytosis independent extracellular nanoparticle clearance by human immune cells. Nano Letters 10(1): 59-63
Luo, Y.; Isaac, B.M.; Casadevall, A.; Cox, D. 2009: Phagocytosis inhibits F-actin-enriched membrane protrusions stimulated by fractalkine (CX3CL1) and colony-stimulating factor 1. Infection and Immunity 77(10): 4487-4495
Lima, J.é G.B.; de Freitas Vinhas, C.; Gomes, I.N.; Azevedo, C.M.; dos Santos, R.R.; Vannier-Santos, M.A.é; Veras, P.íc.S.T. 2011: Phagocytosis is inhibited by autophagic induction in murine macrophages. Biochemical and Biophysical Research Communications 405(4): 604-609
Fossati-Jimack, L.; Ling, G.S.; Cortini, A.; Szajna, M.; Malik, T.H.; McDonald, J.U.; Pickering, M.C.; Cook, H.T.; Taylor, P.R.; Botto, M. 2013: Phagocytosis is the main CR3-mediated function affected by the lupus-associated variant of CD11b in human myeloid cells. Plos one 8(2): E57082
Naka, M.; Kusakabe, K.; Takeshita, A.; Nakagawa, H.; Ito, Y.; Shibata, M.-A.; Otsuki, Y. 2009: Phagocytosis mechanism of apoptotic granulosa cells regulated by milk-fat globule-EGF factor 8. Medical Molecular Morphology 42(3): 143-149
Roth, O.; Kurtz, J. 2009: Phagocytosis mediates specificity in the immune defence of an invertebrate, the woodlouse Porcellio scaber (Crustacea: Isopoda). Developmental and Comparative Immunology 33(11): 1151-1155
Ozaki, Y. 1917: Phagocytosis of Bacteria in the excised Spleen after Perfusion with Locke's Solution. Journal of Medical Research 37(2): 247-258.1
Stroschein-Stevenson, S.L.; Foley, E.; O'Farrell, P.H.; Johnson, A.D. 2009: Phagocytosis of Candida albicans by RNAi-treated Drosophila S2 cells. Methods in Molecular Biology 470: 347-358
Chrisman, C.J.; Alvarez, M.; Casadevall, A. 2010: Phagocytosis of Cryptococcus neoformans by, and nonlytic exocytosis from, Acanthamoeba castellanii. Applied and Environmental Microbiology 76(18): 6056-6062
Peabody, F.W.; Broun, G.O. 1925: Phagocytosis of Erythrocytes in the Bone Marrow, with Special Reference to Pernicious Anemia. American Journal of Pathology 1(2): 169-184.3
Tatano, Y.; Sano, C.; Emori, M.; Saito, H.; Sato, K.; Shimizu, T.; Tomioka, H. 2012: Phagocytosis of Mycobacterium leprae down-regulates anti-microbial activity of murine macrophages against Mycobacterium intracellulare. Nihon Hansenbyo Gakkai Zasshi 81(3): 175-183
Schütte, D.; Umboock, A.; Pluschke, G. 2009: Phagocytosis of Mycobacterium ulcerans in the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesions. British Journal of Dermatology 160(2): 273-283
Fric, J.; Zelante, T.; Ricciardi-Castagnoli, P. 2014: Phagocytosis of Particulate Antigens - all Roads Lead to Calcineurin/NFAT Signaling Pathway. Frontiers in Immunology 4: 513
Greenlee-Wacker, M.C.; Rigby, K.M.; Kobayashi, S.D.; Porter, A.R.; DeLeo, F.R.; Nauseef, W.M. 2014: Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis. Journal of Immunology 192(10): 4709-4717
Koziel, J.; Maciag-Gudowska, A.; Mikolajczyk, T.; Bzowska, M.; Sturdevant, D.E.; Whitney, A.R.; Shaw, L.N.; DeLeo, F.R.; Potempa, J. 2009: Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors. Plos one 4(4): E5210
Nordenfelt, P.; Bauer, S.; Lönnbro, P.; Tapper, H. 2009: Phagocytosis of Streptococcus pyogenes by all-trans retinoic acid-differentiated HL-60 cells: roles of azurophilic granules and NADPH oxidase. Plos one 4(10): E7363
Lübbert, C.; Schubert, S. 2013: Phagocytosis of a mature schizont in severe falciparum malaria. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 17(12): E1265
Fiala, M.; Cribbs, D.H.; Rosenthal, M.; Bernard, G. 2007: Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease. Journal of Alzheimer's Disease: Jad 11(4): 457-463
Ohlsson, S.M.; Pettersson, Å; Ohlsson, S.; Selga, D.; Bengtsson, A.A.; Segelmark, M.; Hellmark, T. 2012: Phagocytosis of apoptotic cells by macrophages in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. Clinical and Experimental Immunology 170(1): 47-56
Esmann, L.; Idel, C.; Sarkar, A.; Hellberg, L.; Behnen, M.; Möller, S.; van Zandbergen, G.; Klinger, M.; Köhl, J.ör.; Bussmeyer, U.; Solbach, W.; Laskay, T.ás. 2010: Phagocytosis of apoptotic cells by neutrophil granulocytes: diminished proinflammatory neutrophil functions in the presence of apoptotic cells. Journal of Immunology 184(1): 391-400
Tso, G.H.W.; Law, H.K.W.; Tu, W.; Chan, G.C.F.; Lau, Y.L. 2010: Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic differentiation to enhance IL-17 and RANKL expression on CD4+ T cells. Stem Cells 28(5): 939-954
Dixon, K.O.; O'Flynn, J.; van der Kooij, S.W.; van Kooten, C. 2014: Phagocytosis of apoptotic or necrotic cells differentially regulates the transcriptional expression of IL-12 family members in dendritic cells. Journal of Leukocyte Biology 96(2): 313-324
Peng, B.; Koga, K.; Cardenas, I.; Aldo, P.; Mor, G. 2010: Phagocytosis of apoptotic trophoblast cells by human endometrial endothelial cells induces proinflammatory cytokine production. American Journal of Reproductive Immunology 64(1): 12-19
Da Silva Domingues, J.F.; van der Mei, H.C.; Busscher, H.J.; van Kooten, T.G. 2013: Phagocytosis of bacteria adhering to a biomaterial surface in a surface thermodynamic perspective. Plos one 8(7): E70046
Chung, Y.-S.A.; Kocks, C. 2012: Phagocytosis of bacterial pathogens. Fly 6(1): 21-25
Tsaplina, O.A. 2013: Phagocytosis of bacterial pathogens: modification of cellular processes by bacterial factors. Tsitologiia 55(2): 83-91
Inoue, S.; Setoyama, Y.; Odaka, A. 2014: Phagocytosis of bafilomycin A1-treated apoptotic neuroblastoma cells by bone marrow-derived dendritic cells initiates a CD8α+ lymphocyte response to neuroblastoma. Journal of Pediatric Hematology/Oncology 36(5): E290-E295
Krpetić, Z.; Porta, F.; Caneva, E.; Dal Santo, V.; Scarì, G. 2010: Phagocytosis of biocompatible gold nanoparticles. Langmuir 26(18): 14799-14805
Della Rovere, F.; Granata, A.; Monaco, M.; Basile, G. 2009: Phagocytosis of cancer cells by mast cells in breast cancer. Anticancer Research 29(8): 3157-3161
Petrovski, G.; Ayna, G.; Majai, G.ön.; Hodrea, J.; Benko, S.; Mádi, A.ás.; Fésüs, L.ás.ó 2011: Phagocytosis of cells dying through autophagy induces inflammasome activation and IL-1β release in human macrophages. Autophagy 7(3): 321-330
Guest, C.B.; Hartman, M.E.; O'Connor, J.C.; Chakour, K.S.; Sovari, A.A.; Freund, G.G. 2007: Phagocytosis of cholesteryl ester is amplified in diabetic mouse macrophages and is largely mediated by CD36 and SR-A. Plos one 2(6): E511
Saito, Y.; Guo, Y.M.; Hirokawa, M.; Saito, K.; Komatsuda, A.; Takahashi, N.; Fujishima, M.; Fujishima, N.; Yamashita, J.; Sawada, K. 2008: Phagocytosis of co-developing neutrophil progenitors by dendritic cells in a culture of human CD34(+) cells with granulocyte colony-stimulating factor and tumor necrosis factor-alpha. International Journal of Hematology 88(1): 64-72
Dini, L. 2010: Phagocytosis of dying cells: influence of smoking and static magnetic fields. Apoptosis: An International Journal on Programmed Cell Death 15(9): 1147-1164
Wagner, B.J.; Lindau, D.; Ripper, D.; Stierhof, Y.-D.; Glatzle, J.ör.; Witte, M.; Beck, H.; Keppeler, H.; Lauber, K.; Rammensee, H.-G.; Königsrainer, A. 2011: Phagocytosis of dying tumor cells by human peritoneal mesothelial cells. Journal of Cell Science 124(Part 10): 1644-1654
Schulte, B.M.; Kramer, M.; Ansems, M.; Lanke, K.H.W.; van Doremalen, N.; Piganelli, J.D.; Bottino, R.; Trucco, M.; Galama, J.M.D.; Adema, G.J.; van Kuppeveld, F.J.M. 2010: Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells. Diabetes 59(5): 1182-1191
Wang, R.; Chandawarkar, R.Y. 2010: Phagocytosis of fungal agents and yeast via macrophage cell surface scavenger receptors. Journal of Surgical Research 164(2): E273-E279
Hatano, Y.; Taniuchi, S.; Masuda, M.; Tsuji, S.; Ito, T.; Hasui, M.; Kobayashi, Y.; Kaneko, K. 2009: Phagocytosis of heat-killed Staphylococcus aureus by eosinophils: comparison with neutrophils. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 117(2): 115-123
Shkurupy, V.A.; Arkhipov, S.A.; Troitsky, A.V.; Luzgina, N.G.; Zaikovskaja, M.V.; Ufimceva, E.G.; Iljine, D.A.; Akhramenko, E.S.; Gulyaeva, E.P.; Bistrova, T.N. 2009: Phagocytosis of hybrid molecular nanosomal compositions containing oxidized dextrans conjugated with isonicotinic acid hydrazide by macrophages. Bulletin of Experimental Biology and Medicine 148(6): 874-876
Takahashi, D.; Azuma, H.; Sakai, H.; Sou, K.; Wakita, D.; Abe, H.; Fujihara, M.; Horinouchi, H.; Nishimura, T.; Kobayashi, K.; Ikeda, H. 2011: Phagocytosis of liposome particles by rat splenic immature monocytes makes them transiently and highly immunosuppressive in ex vivo culture conditions. Journal of Pharmacology and Experimental Therapeutics 337(1): 42-49
Fu, R.; Shen, Q.; Xu, P.; Luo, J.J.; Tang, Y. 2014: Phagocytosis of microglia in the central nervous system diseases. Molecular Neurobiology 49(3): 1422-1434
Benard, E.L.; Roobol, S.J.; Spaink, H.P.; Meijer, A.H. 2014: Phagocytosis of mycobacteria by zebrafish macrophages is dependent on the scavenger receptor Marco, a key control factor of pro-inflammatory signalling. Developmental and Comparative Immunology 47(2): 223-233
Sund, J.; Palomäki, J.; Ahonen, N.; Savolainen, K.; Alenius, H.; Puustinen, A. 2014: Phagocytosis of nano-sized titanium dioxide triggers changes in protein acetylation. Journal of Proteomics 108: 469-483
Niedźwiedzka-Rystwej, P.; Deptuła, W. 2012: Phagocytosis of neutrophils in rabbits infected with antigenic variants of RHD (rabbit haemorrhagic disease) virus. Polish Journal of Veterinary Sciences 15(1): 143-150
Cuenca, N.ás.; Fernández-Sánchez, L.; McGill, T.J.; Lu, B.; Wang, S.; Lund, R.; Huhn, S.; Capela, A. 2013: Phagocytosis of photoreceptor outer segments by transplanted human neural stem cells as a neuroprotective mechanism in retinal degeneration. Investigative Ophthalmology and Visual Science 54(10): 6745-6756
Abdel-Monem, H.; Dasgupta, S.K.; Le, A.; Prakasam, A.; Thiagarajan, P. 2010: Phagocytosis of platelet microvesicles and beta2- glycoprotein i. Thrombosis and Haemostasis 104(2): 335-341
Sarmiento, L.; Ayala, M.; Peña, S.; Rodríguez, G.ín.; Fermín, Z.; Tapia, F.J. 2006: Phagocytosis of promastigotes and amastigotes of Leishmania mexicana by the FSDC dendritic cell line: ultrastructural study. Biomedica: Revista del Instituto Nacional de Salud 26(Suppl 1): 17-25
Kevany, B.M.; Palczewski, K. 2010: Phagocytosis of retinal rod and cone photoreceptors. Physiology 25(1): 8-15
Riesgo, A. 2010: Phagocytosis of sperm by follicle cells of the carnivorous sponge Asbestopluma occidentalis (Porifera, Demospongiae). Tissue and Cell 42(3): 198-201
Gallegos-Avila, G.; Alvarez-Cuevas, S.ón.; Niderhauser-García, A.; Ancer-Rodríguez, J.ús.; Jaramillo-Rangel, G.; Ortega-Martínez, M. 2009: Phagocytosis of spermatozoa and leucocytes by epithelial cells of the genital tract in infertile men infected with Chlamydia trachomatis and mycoplasmas. Histopathology 55(2): 232-234
Nogueira, K.d.O.P.C.; Araújo, V.íc.A.; Rodrigues Sartori, S.S.; Neves, C.óv.A. 2011: Phagocytosis of spermatozoa by epithelial cells in the vagina of the lizard Hemidactylus mabouia (Reptilia, Squamata). Micron 42(5): 377-380
Guenther, F.; Stroh, P.; Wagner, C.; Obst, U.; Hänsch, G.M. 2009: Phagocytosis of staphylococci biofilms by polymorphonuclear neutrophils: S. aureus and S. epidermidis differ with regard to their susceptibility towards the host defense. International Journal of Artificial Organs 32(9): 565-573
Kuchel, R.P.; Aladaileh, S.; Birch, D.; Vella, N.; Raftos, D.A. 2010: Phagocytosis of the protozoan parasite, Marteilia sydneyi, by Sydney rock oyster (Saccostrea glomerata) hemocytes. Journal of Invertebrate Pathology 104(2): 97-104
Stefanidou, M.; Alevisopoulos, G.; Maravelias, C.; Loutsidis, C.; Koutselinis, A. 1999: Phagocytosis of the protozoon Tetrahymena pyriformis as an endpoint in the estimation of cocaine salt and cocaine freebase toxicity. Addiction Biology 4(4): 449-452
Smith, M.R.; Wood, W.B. 1947: Phagocytosis of virulent encapsulated bacteria in the absence of antibody. Journal of Bacteriology 54(1): 52
Miyauchi, M.; Murata, M.; Shibuya, K.; Koga-Yamakawa, E.; Yanagawa, Y.; Azuma, I.; Kashiwazaki, Y. 2010: Phagocytosis plays a dual role in activating dendritic cells; digestive production of active Toll-like receptor ligands and cooperation with Toll-like receptor signaling. Drug Discoveries and Therapeutics 4(2): 135-143
Restrepo, B.I.; Twahirwa, M.; Rahbar, M.H.; Schlesinger, L.S. 2014: Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia. Plos one 9(3): E92977
Kim, Y-June.; Park, S-Jung.; Broxmeyer, H.E. 2011: Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction. Journal of Immunology 187(5): 2291-2301
Ceragioli, M.; Cangiano, G.; Esin, S.; Ghelardi, E.; Ricca, E.; Senesi, S. 2009: Phagocytosis, germination and killing of Bacillus subtilis spores presenting heterologous antigens in human macrophages. Microbiology 155(Part 2): 338-346
Melendez, A.J.; Tay, H.K. 2008: Phagocytosis: a repertoire of receptors and Ca(2+) as a key second messenger. Bioscience Reports 28(5): 287-298
Carias, A.M.; Hope, T.J. 2014: Phagocytosis: cell biology view of antiviral function. Current Opinion in HIV and Aids 9(3): 271-277
Cereghetti, G.M.; Scorrano, L. 2011: Phagocytosis: coupling of mitochondrial uncoupling and engulfment. Current Biology: Cb 21(20): R852-R854
Huynh, K.K.; Grinstein, S. 2008: Phagocytosis: dynamin's dual role in phagosome biogenesis. Current Biology: Cb 18(13): R563-R565
Garg, M.; Chandawarkar, R.Y.; Metchnikoff, I.; Ehrlich, P. 2013: Phagocytosis: history's lessons. Connecticut Medicine 77(1): 23-26
Henson, P.M. 2009: Phagocytosis: invitation to a feast. Current Biology: Cb 19(21): R989-R991
Hatsuzawa, K. 2008: Phagocytosis: molecular mechanism of phagosome formation and maturation. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 53(16 Suppl): 2257-2262
Freeman, S.A.; Grinstein, S. 2014: Phagocytosis: receptors, signal integration, and the cytoskeleton. Immunological Reviews 262(1): 193-215
Krajewski, A.; Garg, M.; De, M.; Chandawarkar, R.Y. 2009: Phagocytosis: reemerging roles for a primitive function. Plastic and Reconstructive Surgery 123(3): 834-847
Lessig, J.; Neu, B.ör.; Glander, H.-J.ür.; Arnhold, J.ür.; Reibetanz, U. 2011: Phagocytotic competence of differentiated U937 cells for colloidal drug delivery systems in immune cells. Inflammation 34(2): 99-110
Soto, F.; Hilje, L.; Mora, G.A.; Carballo, M. 2011: Phagodeterrence by Quassia amara (Simaroubaceae) wood extract fractions on Hypsipyla grandella (Lepidoptera: Pyralidae) larvae. Revista de Biologia Tropical 59(1): 487-499
Barboza, J.; Hilje, L.; Durón, J.; Cartín, V.íc.; Calvo, M. 2010: Phagodeterrence by a crude extract of common rue (Ruta chalepensis, Rutaceae) and its partitions on Hypsipyla grandella (Lepidoptera: Pyralidae) larvae. Revista de Biologia Tropical 58(1): 1-14
Bagnarello, G.; Hilje, L.; Bagnarello, V.; Cartín, V.; Calvo, M. 2009: Phagodeterrent activity of the plants Tithonia diversifolia and Montanoa hibiscifolia (Asteraceae) on adults of the pest insect Bemisia tabaci (Homoptera: Aleyrodidae). Revista de Biologia Tropical 57(4): 1201-1215
Barboza, J.; Hilje, L.; Durón, J.; Cartín, V.íc.; Calvo, M.A. 2010: Phagodeterrent and systemic activity of a fomulation derived from an extract of common rue (Ruta chalepensis, Rutaceae) on Hypsipyla grandella (Lepidoptera: Pyralidae) larvae. Revista de Biologia Tropical 58(1): 15-29
Asheshov, I.N.; Strelitz, F.; Hall, E.A. 1952: Phagolessin A58: a new antibiotic active against bacterial viruses. Antibiotics and ChemoTherapy 2(7): 366-374
Lâm, T.ên.-T.í; Giese, B.; Chikkaballi, D.; Kühn, A.; Wolber, W.; Pané-Farré, J.; Schäfer, D.; Engelmann, S.; Fraunholz, M.; Sinha, B. 2010: Phagolysosomal integrity is generally maintained after Staphylococcus aureus invasion of nonprofessional phagocytes but is modulated by strain 6850. Infection and Immunity 78(8): 3392-3403
Laube, T.; Cortés, P.; Llagostera, M.; Alegret, S.; Pividori, M.ía.I. 2014: Phagomagnetic immunoassay for the rapid detection of Salmonella. Applied Microbiology and Biotechnology 98(4): 1795-1805
Liébana, S.; Spricigo, D.A.; Cortés, M.ía.P.; Barbé, J.; Llagostera, M.; Alegret, S.; Pividori, M.ía.I. 2013: Phagomagnetic separation and electrochemical magneto-genosensing of pathogenic bacteria. Analytical Chemistry 85(6): 3079-3086
Suraweera, C.; Hanwella, R.; de Silva, V. 2014: Phagophobia: a case report. Bmc Research Notes 7: 574
Briusov, P.G.; Zubritskiĭ, V.F.; Islamov, R.N.; Nizovoĭ, A.V.; Fominykh, E.M. 2011: Phagoprophylaxis and bacteriophage treatment of surgical infections. Voenno-Meditsinskii Zhurnal 332(4): 34-39
Cervantes, J.L.; Hawley, K.L.; Benjamin, S.J.; Weinerman, B.; Luu, S.M.; Salazar, J.C. 2014: Phagosomal TLR signaling upon Borrelia burgdorferi infection. Frontiers in Cellular and Infection Microbiology 4: 55
Simeone, R.; Bobard, A.; Lippmann, J.; Bitter, W.; Majlessi, L.; Brosch, R.; Enninga, J. 2012: Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. Plos Pathogens 8(2): E1002507
Cervantes, J.L.; Dunham-Ems, S.M.; La Vake, C.J.; Petzke, M.M.; Sahay, B.; Sellati, T.J.; Radolf, J.D.; Salazar, J.C. 2011: Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta. Proceedings of the National Academy of Sciences of the United States of America 108(9): 3683-3688
Kagan, J.C.; Iwasaki, A. 2012: Phagosome as the organelle linking innate and adaptive immunity. Traffic 13(8): 1053-1061
Nordenfelt, P.; Tapper, H. 2011: Phagosome dynamics during phagocytosis by neutrophils. Journal of Leukocyte Biology 90(2): 271-284
Wavre-Shapton, S.èn.T.; Meschede, I.P.; Seabra, M.C.; Futter, C.E. 2014: Phagosome maturation during endosome interaction revealed by partial rhodopsin processing in retinal pigment epithelium. Journal of Cell Science 127(Part 17): 3852-3861
Canton, J. 2014: Phagosome maturation in polarized macrophages. Journal of Leukocyte Biology 96(5): 729-738
Griffiths, G.; Mayorga, L. 2007: Phagosome proteomes open the way to a better understanding of phagosome function. Genome Biology 8(3): 207
Li, Q. 2011: Phagosome proteomics: a powerful tool to assess bacteria-mediated immunomodulation. Bioengineered Bugs 2(4): 194-198
Carrasco-Marín, E.; Rodriguez-Del Rio, E.; Frande-Cabanes, E.; Tobes, R.; Pareja, E.; Lecea-Cuello, M.J.ús.; Ruiz-Sáez, M.; Madrazo-Toca, F.; Hölscher, C.; Alvarez-Dominguez, C. 2012: Phagosomes induced by cytokines function as anti-Listeria vaccines: novel role for functional compartmentalization of STAT-1 protein and cathepsin-D. Journal of Biological Chemistry 287(18): 14310-14324
Hirota, K.; Hasegawa, T.; Nakajima, T.; Makino, K.; Terada, H. 2011: Phagostimulatory effect of uptake of PLGA microspheres loaded with rifampicin on alveolar macrophages. Colloids and Surfaces. B Biointerfaces 87(2): 293-298
Saran, R.K.; Rust, M.K. 2008: Phagostimulatory sugars enhance uptake and horizontal transfer of hexaflumuron in the western subterranean termite (Isoptera: Rhinotermitidae). Journal of Economic Entomology 101(3): 873-879
Tamariz, J.ús.H.; Lezameta, L.; Guerra, H. 2014: Phagotherapy faced with Staphylococcus aureus methicilin resistant infections in mice. Revista Peruana de Medicina Experimental y Salud Publica 31(1): 69-77
Debarbieux, L.; Saussereau, E.; Maura, D. 2013: Phagotherapy: a nightmare for bacteria, a dream for physicians?. Biologie Aujourd'hui 207(3): 181-190
Raven, J.A.; Beardall, J.; Flynn, K.J.; Maberly, S.C. 2009: Phagotrophy in the origins of photosynthesis in eukaryotes and as a complementary mode of nutrition in phototrophs: relation to Darwin's insectivorous plants. Journal of Experimental Botany 60(14): 3975-3987
Donahue, S.P.; Olitsky, S.E.; Paysse, E.A.; Levin, A.V.; Hertle, R.W.; Cruz, O.A. 2008: Phakic IOLs in Children. Ophthalmology 115(3): 592
Ibrahim, A.A.H.; Carrim, Z.I.; Mahomed, I. 2013: Phakic YAG capsulotomy: the penny dropped after the nucleus. Clinical and Experimental Ophthalmology 41(8): 809-810
Evanger, K.; Vaagbø, G.; Thorsen, E.; Haugen, O.H. 2011: Phakic and pseudophakic eyes in patients during hyperbaric oxygen therapy. Optometry and Vision Science: Official Publication of the American Academy of Optometry 88(6): 691-696
Pirouzian, A.; Ip, K.C.; O'Halloran, H.S. 2009: Phakic anterior chamber intraocular lens (Verisyse) implantation in children for treatment of severe ansiometropia myopia and amblyopia: Six-month pilot clincial trial and review of literature. Clinical Ophthalmology 3: 367-371
Dunn, E.N.; Gregori, N.Z.; Goldhardt, R. 2013: Phakic cystoid macular edema secondary to idiopathic macular telangiectasia type 1 responsive to topical anti-inflammatory agents. Seminars in Ophthalmology 28(2): 84-87
Tsui, J.Y.M.; Goins, K.M.; Sutphin, J.E.; Wagoner, M.D. 2011: Phakic descemet stripping automated endothelial keratoplasty: prevalence and prognostic impact of postoperative cataracts. Cornea 30(3): 291-295
Snyder, M.E.; Perez, M.A. 2012: Phakic implantation of flexible iris prosthesis. Journal of cataract and refractive surgery 38(12): 2208-9; author reply 2209
Fernandes, M.; Goyal, J.; Shah, S. 2012: Phakic intraocular collamer lens. Ophthalmology 119(1): 201; Author Reply 201-2
Tychsen, L.; Hoekel, J.; Ghasia, F.; Yoon-Huang, G. 2008: Phakic intraocular lens correction of high ametropia in children with neurobehavioral disorders. Journal of Aapos: the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus 12(3): 282-289
Kato, N.; Toda, I.; Hori-Komai, Y.; Sakai, C.; Arai, H.; Tsubota, K. 2011: Phakic intraocular lens for keratoconus. Ophthalmology 118(3): 605-605.E2
Ferraz, C.Amaral.; Allemann, N.; Chamon, W. 2007: Phakic intraocular lens for presbyopia correction. Arquivos Brasileiros de Oftalmologia 70(4): 603-608
Koivula, A.; Zetterström, C. 2009: Phakic intraocular lens for the correction of hyperopia. Journal of Cataract and Refractive Surgery 35(2): 248-255
Mirza, H.Cenk.; Tuncer, Özlem.; Ölmez, S.; Şener, Bçin.; Tuğcu, Gökçen.Dilşa.; Özçelik, Uğur.; Gürsoy, N.Canan.; Otlu, Bış.; Büyükçam, Aşe.; Kara, Aş.; Sancak, B. 2018: Clinical Strains of Chryseobacterium and Elizabethkingia spp. Isolated from Pediatric Patients in a University Hospital: Performance of MALDI-TOF MS-Based Identification, Antimicrobial Susceptibilities, and Baseline Patient Characteristics. Microbial Drug Resistance 24(6): 816-821
Alió, J.L.; Toffaha, B.T.; Laria, C.; Piñero, D.P. 2011: Phakic intraocular lens implantation for treatment of anisometropia and amblyopia in children: 5-year follow-up. Journal of Refractive Surgery 27(7): 494-501
Parkhurst, G.D.; Psolka, M.; Kezirian, G.M. 2011: Phakic intraocular lens implantation in United States military warfighters: a retrospective analysis of early clinical outcomes of the Visian ICL. Journal of Refractive Surgery 27(7): 473-481
Espandar, L.; Meyer, J.J.; Moshirfar, M. 2008: Phakic intraocular lenses. Current Opinion in Ophthalmology 19(4): 349-356
Mamalis, N. 2010: Phakic intraocular lenses. Journal of Cataract and Refractive Surgery 36(11): 1805-1806
Chaudhry, I.A.; El Danasoury, M.Alaa. 2013: Phakic intraocular lenses. Saudi Journal of Ophthalmology: Official Journal of the Saudi Ophthalmological Society 27(4): 231-233
Leccisotti, A. 2007: Phakic intraocular lenses after scleral buckling for retinal detachment. European Journal of Ophthalmology 17(3): 388-391
Güell, J.Luis.; Morral, M.; Kook, D.; Kohnen, T. 2010: Phakic intraocular lenses part 1: historical overview, current models, selection criteria, and surgical techniques. Journal of Cataract and Refractive Surgery 36(11): 1976-1993
Kohnen, T.; Kook, D.; Morral, M.; Güell, J.L. 2010: Phakic intraocular lenses: part 2: results and complications. Journal of Cataract and Refractive Surgery 36(12): 2168-2194
Ozcetin, H.; Baykara, M.; Ozmen, A.T.; Yalcinbayir, O. 2009: Phakic iris-claw IOL implantation, with Bursa technique, through a self-sealing scleral tunnel and without iridotomy or iridectomy. European Journal of Ophthalmology 19(1): 18-23
Hepsen, I.; Sbeity, Z.; Liebmann, J.; Ritch, R. 2009: Phakic pattern of exfoliation material on a posterior chamber intraocular lens. Acta Ophthalmologica 87(1): 106-107
Gil-Cazorla, R.; Teus, M.A.; Arranz-Marquez, E.; Marina-Verde, C. 2008: Phakic refractive lens (Medennium) for correction of +4.00 to +6.00 diopters: 1-year follow-up. Journal of Refractive Surgery 24(4): 350-354
Koivula, A.; Taube, M.; Zetterström, C. 2008: Phakic refractive lens: two-year results. Journal of Refractive Surgery 24(5): 507-515
Kamiya, K.; Shimizu, K.; Ando, W.; Asato, Y.; Fujisawa, T. 2008: Phakic toric Implantable Collamer Lens implantation for the correction of high myopic astigmatism in eyes with keratoconus. Journal of Refractive Surgery 24(8): 840-842
Chiu, H-Hui.; Chen, G-Shing.; Wu, C-Shan.; Ke, C-Li.Khale.; Cheng, S-Tsung. 2009: Phakomatosis cesioflammea with late-onset glaucoma and acquired nevus spilus-like lesion - 15 years of follow-up. International journal of dermatology 48(4): 416-418
Jeon, S.-Y.; Ha, S.-M.; Ko, D.-Y.; Hong, J.-W.; Song, K.-H.; Kim, K.-H. 2013: Phakomatosis pigmentovascularis Ib with left-sided hemihypertrophy, interdigital gaps and scoliosis: a unique case of phakomatosis pigmentovascularis. Journal of Dermatology 40(1): 78-79
Turk, B.G.; Turkmen, M.; Tuna, A.; Kilinc Karaarslan, I.; Ozdemir, F. 2011: Phakomatosis pigmentovascularis type IIb associated with Klippel-Trénaunay syndrome and congenital triangular alopecia. Journal of the American Academy of Dermatology 65(2): E46-E49
Okunola, P.; Ofovwe, G.; Abiodun, M.; Isah, A.; Ikubor, J. 2012: Phakomatosis pigmentovascularis type IIb in association with external hydrocephalus. BMJ Case Reports
Fernández-Guarino, M.; Boixeda, P.; de Las Heras, E.; Aboin, S.; García-Millán, C.; Olasolo, P.Jaén. 2008: Phakomatosis pigmentovascularis: Clinical findings in 15 patients and review of the literature. Journal of the American Academy of Dermatology 58(1): 88-93
Keklikci, S.Ugur.; Cakmak, A.; Cakmak, S.Soker.; Soker, S.Ipek. 2007: Phakomatous choristoma of the lower eyelid: a case study with a review of the literature. Annals of Ophthalmology 39(3): 255-258
Verb, S.P.; Roarty, J.D.; Black, E.H.; Poulik, J.; Grynspan, D. 2009: Phakomatous choristoma: a rare orbital tumor presenting as an eyelid mass with obstruction of the nasolacrimal duct. Journal of Aapos: the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus 13(1): 85-87
Brown, R.; Hazen, E.L. 1953: Phalamycin, an antibacterial agent produced by a Streptomyces noursei variant. Antibiotics and ChemoTherapy 3(8): 819-821
Shrivastava, R.; Singh, K.K.; Umbarker, B.R.; Karle, R.; Shrivastava, M. 2009: Phalange metastasis from carcinoma of alveolus. Indian Journal of Dental Research: Official Publication of Indian Society for Dental Research 20(4): 496-498
Drinkwater, H. 1917: Phalangeal Anarthrosis (Synostosis, Ankylosis) transmitted through Fourteen Generations. Proceedings of the Royal Society of Medicine 10(Pathol Sect): 60-68
Bentley, L.; Fridén, J. 2009: Phalangeal and metacarpal fractures. Lakartidningen 106(13): 936-941
Friis-Holmberg, T.; Brixen, K.; Rubin, K.H.; Grønbæk, M.; Bech, M. 2012: Phalangeal bone mineral density predicts incident fractures: a prospective cohort study on men and women--results from the Danish Health Examination Survey 2007–2008 (DANHES 2007–2008). Archives of Osteoporosis 7: 291-299
Dhainaut, A.; Rohde, G.; Hoff, M.; Syversen, U.; Haugeberg, G. 2011: Phalangeal densitometry compared with dual energy X-ray absorptiometry for assessment of bone mineral density in elderly women. Journal of Women's Health 20(12): 1789-1795
Cheskin, L.J.; Sonzone, C.M.; Davis, L.M. 2012: Clinical strategies for managing the overweight neurology patient. Neurology. Clinical Practice 2(1): 33-39
Yoong, P.; Goodwin, R.W.; Chojnowski, A. 2010: Phalangeal fractures of the hand. Clinical Radiology 65(10): 773-780
Gaston, R.G.; Chadderdon, C. 2012: Phalangeal fractures: displaced/nondisplaced. Hand Clinics 28(3): 395-401 X
Gillis, J.; Blaser, S.; Miller, S.; Li, C. 2009: Phalangeal hypoplasia, mental retardation, agenesis of the corpus callosum, brainstem abnormalities and ectopic grey matter: unique case or newly recognized syndrome?. Clinical Dysmorphology 18(3): 160-163
Cherif, E.; Ben Hassine, L.; Kechaou, I.; Khalfallah, N. 2013: Phalangeal lytic lesion: do not forget osseous sarcoidosis. BMJ Case Reports
Capalbo, S.; Mascolo, V. 2007: Phalangeal lytic lesions in multiple myeloma. Clinical Lymphoma and Myeloma 7(9): 597
Colson, G.M.; Willcox, A. 1948: Phalangeal metastases in bronchogenic carcinoma; report of three cases. Lancet 1(6490): 100-102
Al-Qattan, M.M. 2010: Phalangeal neck fractures of the proximal phalanx of the fingers in adults. Injury 41(10): 1084-1089
Al-Qattan, M.M. 2009: Phalangeal neck fractures with concurrent vascular injury. Journal of Hand Surgery European Volume 34(1): 104-109
Cipriani, C.; Romagnoli, E.; Scarpiello, A.; Angelozzi, M.; Montesano, T.; Minisola, S. 2009: Phalangeal quantitative ultrasound and bone mineral density in evaluating cortical bone loss: a study in postmenopausal women with primary hyperparathyroidism and subclinical iatrogenic hyperthyroidism. Journal of Clinical Densitometry: the Official Journal of the International Society for Clinical Densitometry 12(4): 456-460
Catalano, A.; Morabito, N.; Di Vieste, G.; Pintaudi, B.; Cucinotta, D.; Lasco, A.; Di Benedetto, A. 2013: Phalangeal quantitative ultrasound and metabolic control in pre-menopausal women with type 1 diabetes mellitus. Journal of Endocrinological Investigation 36(5): 347
Porta, F.; Spada, M.; Lala, R.; Mussa, A. 2008: Phalangeal quantitative ultrasound in children with phenylketonuria: a pilot study. Ultrasound in Medicine and Biology 34(7): 1049-1052
Zywiec, J.; Pluskiewicz, W.; Adamczyk, P.; Skubala, A.; Gumprecht, J. 2012: Phalangeal quantitative ultrasound measurements in chronic hemodialysis patients: a 4-year follow-up. Ultrasound in Medicine and Biology 38(6): 962-971
Prinapori, R.; Rosso, R.; Di Biagio, A.; Nicolini, L.; Giacobbe, D.R.; De Hoffer, L.; Grignolo, S.; De Terlizzi, F.; Vignolo, M.; Borderi, M.; Martelli, G.; Calza, L.; Viale, P.; Vescini, F.; Viscoli, C. 2013: Phalangeal quantitative ultrasound: cheaper methods for screening and follow-up of bone pathologies in HIV-infected women?. New Microbiologica 36(4): 345-351
Glassman, F.; Wolin, I.; Sidman, S. 1949: Phalangectomy for toe deformities. Surgical Clinics of North America 29(1): 275-280
Hagiwara, H.; Hagiwara, S.; Ajiki, T.; Hoshino, Y. 2012: Phalanges deformity associated with neurofibromatosis-1: a case report. Hand Surgery: An International Journal Devoted to Hand and Upper Limb Surgery and Related Research: Journal of the Asia-Pacific Federation of Societies for Surgery of the Hand 17(3): 379-381
Gołka, K.Agnieszka.; Kobierski, J.; Milczek, T.; Emerich, J. 2009: Phalanges necrosis--a rare manifestation of "hand-foot" syndrome induced by gemcitabine used in the second--line therapy for progressive ovarian cancer. A case report. Ginekologia Polska 80(4): 295-298
Enders, L.R.; Seo, N.J. 2011: Phalanx force magnitude and trajectory deviation increased during power grip with an increased coefficient of friction at the hand-object interface. Journal of Biomechanics 44(8): 1447-1453
Binder, E.M.; Blodgett, D.J.; Currin, J.F.; Caudell, D.; Cherney, J.H.; LeRoith, T. 2010: Phalaris arundinacea (reed canarygrass) grass staggers in beef cattle. Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians Inc 22(5): 802-805
Tsymbal, A.N. 2009: Phaleristics in medical units and establishments of the Leningrad Military District. Voenno-Meditsinskii Zhurnal 330(4): 85-87
Tsymbal, A.N. 2014: Phaleristics of Sisters of Charity. Voenno-Meditsinskii Zhurnal 335(3): 79-82
Figlio, K. 2010: Phallic and seminal masculinity: a theoretical and clinical confusion. International Journal of Psycho-Analysis 91(1): 119-139
Angulo, J.C.; García-Díez, M.; Martínez, M. 2011: Phallic decoration in paleolithic art: genital scarification, piercing and tattoos. Journal of Urology 186(6): 2498-2503
Blanton, S. 1947: Phallic women. Psychoanalytic Quarterly 16(2): 214-224
Rudhran, V.; Thippeswamy, H.; Chaturvedi, S.K. 2013: Phallicide: a case of auto penile amputation as a mode of suicide. Australian and New Zealand Journal of Psychiatry 47(5): 491-492
Kervégant, M.; de Haro, L.; Patat, A.M.; Pons, C.; Thomachot, L.; Minodier, P. 2013: Phalloides syndrome poisoning after ingestion of lepiota mushrooms. Wilderness and Environmental Medicine 24(2): 170-172
Diensthuber, R.P.; Müller, M.; Heissler, S.M.; Taft, M.H.; Chizhov, I.; Manstein, D.J. 2011: Phalloidin perturbs the interaction of human non-muscle myosin isoforms 2A and 2C1 with F-actin. Febs Letters 585(5): 767-771
Marshall, W.L. 2014: Phallometric assessments of sexual interests: an update. Current Psychiatry Reports 16(1): 428
Caso, J.R.; Myers, M.D.; Wiegand, L.; Rodriguez, A.; Hann, S.; Carrion, R. 2009: Phalloplasty and penile implant surgery. Current Urology Reports 10(6): 475-477
Descamps, M.J.L.; Hayes, P.M.; Hudson, D.A. 2009: Phalloplasty in complete aphallia: pedicled anterolateral thigh flap. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 62(3): E51-E54
Kim, S.-K.; Lee, K.-C.; Kwon, Y.-S.; Cha, B.-H. 2009: Phalloplasty using radial forearm osteocutaneous free flaps in female-to-male transsexuals. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 62(3): 309-317
Hasegawa, K.; Namba, Y.; Kimata, Y. 2013: Phalloplasty with an innervated island pedicled anterolateral thigh flap in a female-to-male transsexual. Acta Medica Okayama 67(5): 325-331
Callens, N.; Hoebeke, P. 2014: Phalloplasty: a panacea for 46,XY disorder of sex development conditions with penile deficiency?. Endocrine Development 27: 222-233
Rashid, M.; Tamimy, M.S. 2013: Phalloplasty: the dream and the reality. Indian Journal of Plastic Surgery: Official Publication of the Association of Plastic Surgeons of India 46(2): 283-293
Huber, A. 2000: Phallucies of trauma care (or, Getting shafted on night shift). Cjem 2(4): 276-277
Bendick, C. 2010: Phallus depictions in Bhutan. Der Urologe. Ausg. a 49(12): 1535-1542
Larkins, C.E.; Cohn, M.J. 2015: Phallus development in the turtle Trachemys scripta. Sexual Development: Genetics Molecular Biology Evolution Endocrinology Embryology and Pathology of Sex Determination and Differentiation 9(1): 34-42
Essig, L. 2008: Phallus envy. Journal of Lesbian Studies 12(1): 115-118
Imperatore, C.; D'Aniello, F.; Aiello, A.; Fiorucci, S.; D'Amore, C.; Sepe, V.; Menna, M. 2014: Phallusiasterols a and B: two new sulfated sterols from the Mediterranean tunicate Phallusia fumigata and their effects as modulators of the PXR receptor. Marine Drugs 12(4): 2066-2078
Raynal, C.éc.; Lefebvre, T. 2007: Phamaceutical effervescence around soda water. Revue d'Histoire de la Pharmacie 54(352): 511-523
Stefan-Mikić, S.; Jovanović, J.; Jovanović, N.; Aleksić-Dordević, M.; Cvjetković, D.; Krajcir, I. 2008: Phamacoeconomic analysis of antibiotics use in the Clinical Center of Vojvodina. Medicinski Pregled 61(Suppl 1): 50-58
Ma, Y.; Li, W.; Hu, F.; Shi, Y.; Bi, Y.; Feng, S. 2012: Phamacokinetic study of bergapten in rats plasma by LC-MS/MS. Zhongguo Zhong Yao Za Zhi 37(3): 381-383
Beyer-Westendorf, J.; Gehrisch, S. 2014: Phamacokinetics of rivaroxaban in adolescents. Hamostaseologie 34(1): 85-87
Bresseel, J.; Constant, J. 2013: Phamartes coronatus gen. nov. sp. nov. a new genus and species of stick insect from Bach Ma National Park, central Vietnam (Phasmida, Diapheromeridae, Necrosciinae). Zootaxa 3741: 141-150
Michael, N.L.; Robb, M.L. 2014: Phambili: moving forward without the blindfold. LANCET. Infectious Diseases 14(5): 361-362
Cresawn, S.G.; Bogel, M.; Day, N.; Jacobs-Sera, D.; Hendrix, R.W.; Hatfull, G.F. 2011: Phamerator: a bioinformatic tool for comparative bacteriophage genomics. Bmc Bioinformatics 12: 395
Noreen, R.; Asgher, M.; Bhatti, H.Nawaz.; Batool, S.; Asad, M.Javaid. 2011: Phanerochaete chrysosporium IBL-03 secretes high titers of manganese peroxidase during decolorization of Drimarine Blue K2RL textile dye. Environmental Technology 32(11-12): 1239-1246
Zhang, J.; Zeng, G.; Chen, Y.; Liang, J.; Zhang, C.; Huang, B.; Sun, W.; Chen, M.; Yu, M.; Huang, H.; Zhu, Y. 2014: Phanerochaete chrysosporium inoculation shapes the indigenous fungal communities during agricultural waste composting. Biodegradation 25(5): 669-680
Ray, A.; Saykhedkar, S.; Ayoubi-Canaan, P.; Hartson, S.D.; Prade, R.; Mort, A.J. 2012: Phanerochaete chrysosporium produces a diverse array of extracellular enzymes when grown on sorghum. Applied Microbiology and Biotechnology 93(5): 2075-2089
McWilliams, M. 1994: Phanerozoic geology. Science 265(5168): 126
Don Paul, C.; Kiss, C.; Traore, D.A.K.; Gong, L.; Wilce, M.C.J.; Devenish, R.J.; Bradbury, A.; Prescott, M. 2013: Phanta: a non-fluorescent photochromic acceptor for pcFRET. Plos one 8(9): E75835
Cocchini, G.; Lello, O.; McIntosh, R.D.; Della Sala, S. 2014: Phantabulation: a case of visual imagery interference on visual perception. Neurocase 20(5): 581-590
Moloney, J.C. 1948: Phantasia; a contribution to the structure of schizophrenia. Psychoanalytic Review 35(2): 140-150
Bodman, F.; Stephen, E.; Sambrook, L.K. 1945: Phantasies in evacuated children. Journal of Mental Science 91: 499-502
Timms, J. 2012: Phantasm of Freud: Nandor Fodor and the psychoanalytic approach to the supernatural in interwar Britain. Psychoanalysis and History 14(1): 5-27
Fitch, R.W.; Spande, T.F.; Garraffo, H.M.; Yeh, H.J.C.; Daly, J.W. 2010: Phantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyi. Journal of Natural Products 73(3): 331-337
James, W. 1887: Phantasms of the Living. Science 9(205s): 18-20
Tuckett, D.; Taffler, R. 2008: Phantastic objects and the financial market's sense of reality: a psychoanalytic contribution to the understanding of stock market instability. International Journal of Psycho-Analysis 89(2): 389-412
Schmid, G.B.; Wanderer, S. 2007: Phantasy therapy: statistical evaluation of a new approach to group psychotherapy for stationary and ambulatory psychotic patients. Forschende Komplementarmedizin 14(4): 216-223
Tietze, R.; Dürr, S.; Lyer, S.; Taccardi, N.; Wasserscheid, P.; Canella, L.; Wagner, F.; Petry, W.; Alexiou, C. 2013: Phantom Studies of Neutron Capture of Boron Containing Magnetic Nanoparticles. Biomedizinische Technik. Biomedical Engineering 58 Suppl. 1
Lee, J.; Napadow, V.; Kim, J.; Lee, S.; Choi, W.; Kaptchuk, T.J.; Park, K. 2014: Phantom acupuncture: dissociating somatosensory and cognitive/affective components of acupuncture stimulation with a novel form of placebo acupuncture. Plos one 9(8): E104582
Tan, K.; Dong, S.; Liu, X.; Chen, W.; Wang, Y.; Oldroyd, B.P.; Latty, T. 2015: Phantom alternatives influence food preferences in the eastern honeybee Apis cerana. Journal of Animal Ecology 84(2): 509-517
Batra, Y.K.; Rajeev, S. 2007: Phantom anaesthetic agent trace?. Journal of Clinical Monitoring and Computing 21(3): 171-172
Rodt, T.; Luepke, M.; Boehm, C.; von Falck, C.; Stamm, G.; Borlak, J.ür.; Seifert, H.; Galanski, M. 2011: Phantom and cadaver measurements of dose and dose distribution in micro-CT of the chest in mice. Acta Radiologica 52(1): 75-80
Shirai, K.; Nishiyama, K.; Katsuda, T.; Teshima, T.; Ueda, Y.; Miyazaki, M.; Tsujii, K. 2014: Phantom and clinical study of differences in cone beam computed tomographic registration when aligned to maximum and average intensity projection. International Journal of Radiation Oncology Biology Physics 88(1): 189-194
Okawa, S.; Yano, A.; Uchida, K.; Mitsui, Y.; Yoshida, M.; Takekoshi, M.; Marjono, A.; Gao, F.; Hoshi, Y.; Kida, I.; Masamoto, K.; Yamada, Y. 2013: Phantom and mouse experiments of time-domain fluorescence tomography using total light approach. Biomedical Optics Express 4(4): 635-651
Bauer, B. 2010: Phantom arcs: now you see them.. Perception 39(12): 1681-1683
Tanaka, H.; Arai, M.; Kadowaki, T.; Takekawa, H.; Kokubun, N.; Hirata, K. 2008: Phantom arm and leg after pontine hemorrhage. Neurology 70(1): 82-83
Kolonic, K.G.; Avina, L.G.; Shoho, A.; Ismail, A. 2009: Phantom arrhythmia: is it a clinical myth?. Journal of the American Osteopathic Association 109(2): 98-100
Marsh, H.W.; Seaton, M.; Kuyper, H.; Dumas, F.; Huguet, P.; Régner, I.; Buunk, A.P.; Monteil, J.-M.; Gibbons, F.X. 2010: Phantom behavioral assimilation effects: systematic biases in social comparison choice studies. Journal of Personality 78(2): 671-710
Ligas, B.B.; Galang, M.T.S.; BeGole, E.A.; Evans, C.A.; Klasser, G.D.; Greene, C.S. 2011: Phantom bite: a survey of US orthodontists. Orthodontics: the Art and Practice of Dentofacial Enhancement 12(1): 38-47
Park, K-Eon.; Cheon, K-Seong.; Ok, S-Ho.; Jeong, Y.Ju.; Lee, H.Keun. 2012: Phantom bladder pain. Korean Journal of Anesthesiology 63(4): 376-377
Björkman, B.; Arnér, S.; Hydén, L.-C. 2008: Phantom breast and other syndromes after mastectomy: eight breast cancer patients describe their experiences over time: a 2-year follow-up study. Journal of Pain 9(11): 1018-1025
Hansen, D.M.H.; Kehlet, H.; Gärtner, R. 2011: Phantom breast sensations are frequent after mastectomy. Danish Medical Bulletin 58(4): A4259
Ramesh; Shukla, N.K.; Bhatnagar, S. 2009: Phantom breast syndrome. Indian Journal of Palliative Care 15(2): 103-107
Guerreiro Godoy, M.d.F.; Pereira de Godoy, A.C.; de Matos, M.J.R.; Guimarães, T.D.; Barufi, S. 2013: Phantom breast syndrome in women after mastectomy. Breast Journal 19(3): 349-350
Markopoulos, C.J.; Spyropoulou, A.C.; Zervas, I.M.; Christodoulou, G.N.; Papageorgiou, C. 2010: Phantom breast syndrome: the effect of in situ breast carcinoma. Psychiatry Research 179(3): 333-337
Timmers, L.; Stroobandt, S.Y.; Van Heuverswyn, F.E.; Stroobandt, R.X. 2012: Phantom crosstalk. Heart Rhythm 9(12): 2086-2088
Pina, D.R.; Duarte, S.B.; Ghilardi Netto, T.; Morceli, J. 2009: Phantom development for radiographic image optimization of chest, skull and pelvis examination for nonstandard patient. Applied Radiation and Isotopes: Including Data Instrumentation and Methods for use in Agriculture Industry and Medicine 67(1): 61-69
Kinhikar, R.A.; Tambe, C.M.; Upreti, R.R.; Patkar, S.; Patil, K.; Deshpande, D.D. 2008: Phantom dosimetric study of nondivergent aluminum tissue compensator using ion chamber, TLD, and gafchromic film. Medical Dosimetry: Official Journal of the American Association of Medical Dosimetrists 33(4): 286-292
Van Houten, E.E.W.; Peters, A.; Chase, J.G. 2011: Phantom elasticity reconstruction with Digital Image Elasto-Tomography. Journal of the Mechanical Behavior of Biomedical Materials 4(8): 1741-1754
Bai, C.; Conwell, R.; Kindem, J.; Babla, H.; Gurley, M.; De Los Santos, R.; Old, R.; Weatherhead, R.; Arram, S.; Maddahi, J. 2010: Phantom evaluation of a cardiac SPECT/VCT system that uses a common set of solid-state detectors for both emission and transmission scans. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 17(3): 459-469
Ploquin, N.; Rangel, A.; Dunscombe, P. 2008: Phantom evaluation of a commercially available three modality image guided radiation therapy system. Medical Physics 35(12): 5303-5311
Majewski, S.; Black, R.; Kross, B.; Popov, V.; Welch, B.; Wojécik, R.; Williams, M.B.; Moré, M.J.; Goodale, P. 2006: Phantom evaluations of a dedicated dual-head scintimammography system. Physica Medica: Pm: An International Journal Devoted to the Applications of Physics to Medicine and Biology: Official Journal of the Italian Association of Biomedical Physics 21(Suppl 1): 35-38
Fukuhara, T.; Matsuda, E.; Fujiwara, K.; Tanimura, C.; Izawa, S.; Kataoka, H.; Kitano, H. 2014: Phantom experiment and clinical utility of quantitative shear wave elastography for differentiating thyroid nodules. Endocrine Journal 61(6): 615-621
Kim, S.; McClish, M.; Alhassen, F.; Seo, Y.; Shah, K.S.; Gould, R.G. 2010: Phantom experiments on a PSAPD-based compact gamma camera with submillimeter spatial resolution for small animal SPECT. IEEE Transactions on Nuclear Science 57(5): 2518-2523
Nichols, K.J.; Tronco, G.G.; Tomas, M.B.; Kunjummen, B.D.; Siripun, L.; Rini, J.N.; Palestro, C.J. 2007: Phantom experiments to improve parathyroid lesion detection. Medical Physics 34(12): 4792-4797
Roed Rasmussen, M.L.; Prause, J.U.; Johnson, M.; Toft, P.B. 2009: Phantom eye syndrome: types of visual hallucinations and related phenomena. Ophthalmic Plastic and Reconstructive Surgery 25(5): 390-393
Demetriou, G.A. 2014: Phantom first metacarpal. Emergency Medicine Journal: Emj 31(5): 383
Chatterjee, G.; Wu, D.-A.; Sheth, B.R. 2011: Phantom flashes caused by interactions across visual space. Journal of Vision 11(2)
Winfield, J.M.; Douglas, N.H.M.; deSouza, N.M.; Collins, D.J. 2014: Phantom for assessment of fat suppression in large field-of-view diffusion-weighted magnetic resonance imaging. Physics in Medicine and Biology 59(9): 2235-2248
Weymouth, A.J.; Wutscher, T.; Welker, J.; Hofmann, T.; Giessibl, F.J. 2011: Phantom force induced by tunneling current: a characterization on Si(111). Physical Review Letters 106(22): 226801
Hribar, A.; Koritnik, B.; Munih, M. 2009: Phantom haptic device upgrade for use in fMRi. Medical and Biological Engineering and Computing 47(6): 677-684
Prakash, S.; Golwala, P. 2011: Phantom headache: pain-memory-emotion hypothesis for chronic daily headache?. Journal of Headache and Pain 12(3): 281-286
Zhang, R.; Zhan, H.; Wang, D. 2014: Phantom holder of CT couch. Zhongguo Yi Liao Qi Xie Za Zhi 38(2): 117; 129
Jafri, H.H.; Singh, T.U.; Ramaswamy, R. 2012: Phantom instabilities in adiabatically driven systems: dynamical sensitivity to computational precision. Chaos 22(3): 033103
Shen, C-Chou.; Su, S-Yuan.; Cheng, C-Hao.; Yeh, C-Kuang. 2012: Phantom investigation of phase-inversion-based dual-frequency excitation imaging for improved contrast display. Ultrasonics 52(1): 25-32
Trotter, P.A. 1948: Phantom jaw for use in the teaching of prophylaxis. British Dental Journal 84(7): 146
Mal, R.K.; Baldwin, D.L. 2009: Phantom larynx: a clinical survey. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 266(3): 397-401
Wen, L.S. 2010: Phantom leg edema. Annals of Emergency Medicine 56(5): 580-581
Antoniello, D.; Kluger, B.M.; Sahlein, D.H.; Heilman, K.M. 2010: Phantom limb after stroke: an underreported phenomenon. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior 46(9): 1114-1122
Corfield, L.; Gurprashad, R.; Halawa, M.; Yusuf, S.W. 2007: Phantom limb claudication. British Journal of Hospital Medicine 68(10): 558
Ramchandran, K.; Hauser, J. 2010: Phantom limb pain #212. Journal of Palliative Medicine 13(10): 1285-1286
Giummarra, M.J.; Moseley, G.L. 2011: Phantom limb pain and bodily awareness: current concepts and future directions. Current Opinion in Anaesthesiology 24(5): 524-531
Sakai, T.; Sumikawa, K. 2014: Phantom limb pain exacerbated by intravenous ketamine. Journal of Anesthesia 28(4): 643
Cruz, E.; Dangaria, H.T. 2013: Phantom limb pain from spinal sarcoma: a case report. Pm and R: the Journal of Injury Function and Rehabilitation 5(7): 629-632
Sumitani, M.; Miyauchi, S.; Yozu, A.; Otake, Y.; Saitoh, Y.; Yamada, Y. 2010: Phantom limb pain in the primary motor cortex: topical review. Journal of Anesthesia 24(2): 337-341
Burgoyne, L.L.; Billups, C.A.; Jirón, J.é L.; Kaddoum, R.N.; Wright, B.B.; Bikhazi, G.B.; Parish, M.E.; Pereiras, L.A. 2012: Phantom limb pain in young cancer-related amputees: recent experience at St Jude children's research hospital. Clinical Journal of Pain 28(3): 222-225
Sumitani, M.; Miyauchi, S.; Uematsu, H.; Yozu, A.; Otake, Y.; Yamada, Y. 2010: Phantom limb pain originates from dysfunction of the primary motor cortex. Masui. Japanese Journal of Anesthesiology 59(11): 1364-1369
Casale, R.; Ceccherelli, F.; Labeeb, A.A.E.M.; Biella, G.E.M. 2009: Phantom limb pain relief by contralateral myofascial injection with local anaesthetic in a placebo-controlled study: preliminary results. Journal of Rehabilitation Medicine 41(6): 418-422
Nandi, D.; Yianni, J.; Humphreys, J.; Wang, S.; O'sullivan, V.; Shepstone, B.; Stein, J.F.; Aziz, T.Z. 2004: Phantom limb pain relieved with different modalities of central nervous system stimulation: a clinical and functional imaging case report of two patients. Neuromodulation: Journal of the International Neuromodulation Society 7(3): 176-183
González García, P.; Manzano Hernández, M.Pilar.; Muñoz Tomás, M.Teresa.; Martín Hernández, C.; Forcano García, M. 2013: Phantom limb pain syndrome: therapeutic approach using mirror therapy in a Geriatric Department. Revista Espanola de Geriatria y Gerontologia 48(4): 198-201
Huang, C.-Y.; Yang, R.-S.; Kuo, T.-S.; Hsu, K.-H. 2009: Phantom limb pain treated by far infrared ray. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2009: 1589-1591
Anderson-Barnes, V.C.; McAuliffe, C.; Swanberg, K.M.; Tsao, J.W. 2009: Phantom limb pain--a phenomenon of proprioceptive memory?. Medical Hypotheses 73(4): 555-558
Diers, M.; Flor, H. 2013: Phantom limb pain. Psychological treatment strategies. Schmerz 27(2): 205
Virani, A.; Green, T.; Turin, T.C. 2014: Phantom limb pain: a nursing perspective. Nursing Standard: 29(1): 44-50
McCormick, Z.; Chang-Chien, G.; Marshall, B.; Huang, M.; Harden, R.N. 2014: Phantom limb pain: a systematic neuroanatomical-based review of pharmacologic treatment. Pain Medicine 15(2): 292-305
Leskowitz, E. 2014: Phantom limb pain: an energy/trauma model. Explore 10(6): 389-397
Roullet, S.; Nouette-Gaulain, K.; Brochet, B.; Sztark, F. 2009: Phantom limb pain: from physiopathology to prevention. Annales Francaises d'Anesthesie et de Reanimation 28(5): 460-472
Di Rollo, A.; Pallanti, S. 2011: Phantom limb pain: low frequency repetitive transcranial magnetic stimulation in unaffected hemisphere. Case Reports in Medicine 2011: 130751
Subedi, B.; Grossberg, G.T. 2011: Phantom limb pain: mechanisms and treatment approaches. Pain Research and Treatment 2011: 864605
Weeks, S.R.; Anderson-Barnes, V.C.; Tsao, J.W. 2010: Phantom limb pain: theories and therapies. Neurologist 16(5): 277-286
Nikolajsen, L.; Christensen, K.F.; Haroutiunian, S. 2013: Phantom limb pain: treatment strategies. Pain Management 3(6): 421-424
Ventura, M.; Gamba, A. 1950: Phantom limb phenomenon and pain of amputated. Bollettino-Societa Medico-Chirurgicadi Modena 4(3): Cxxiii
Casale, R.; Alaa, L.; Mallick, M.; Ring, H. 2009: Phantom limb related phenomena and their rehabilitation after lower limb amputation. European Journal of Physical and Rehabilitation Medicine 45(4): 559-566
Millonig, A. 2011: Phantom limbs - or phantoms of phantom limbs?. Cortex; a journal devoted to the study of the nervous system and behavior 47(9): 1063-4; author reply 1065
Wirth, A.; Kron, T.; Wittwer, H.; Sullivan, K.; Sorell, G.; Cramb, J. 2008: Phantom measurements and computed estimates of breast dose with radiotherapy for Hodgkin's lymphoma: dose reduction with the use of the involved field. Journal of Medical Imaging and Radiation Oncology 52(4): 394-402
Köhler, F.M.; Boda-Heggemann, J.; Küpper, B.; Wolff, D.; Wertz, H.ör.; Lohr, F.; Wenz, F. 2009: Phantom measurements to quantify the accuracy of a commercially available cone-beam CT gray-value matching algorithm using multiple Fiducials. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 185(1): 49-55
Bottan, S.; Poulikakos, D.; Kurtcuoglu, V. 2012: Phantom model of physiologic intracranial pressure and cerebrospinal fluid dynamics. IEEE Transactions on Bio-Medical Engineering 59(6): 1532-1538
Hansen, K. 2009: Phantom of the article. South Dakota Medicine: the Journal of the South Dakota State Medical Association 62(5): 191
Sandridge, T.G. 2014: Phantom of the opera-ting room. Radiologic Technology 85(4): 467-468
Roldan, C.J.; Lesnick, J.S. 2014: Phantom organ pain syndrome, a ghostly visitor to the ED. American Journal of Emergency Medicine 32(9): 1152.E1-2
Rasmussen, M.L.R.; Prause, J.U.; Toft, P.B. 2011: Phantom pain after eye amputation. Acta Ophthalmologica 89(1): 10-16
Modirian, E.; Shojaei, H.; Soroush, M.Reza.; Masoumi, M. 2009: Phantom pain in bilateral upper limb amputation. Disability and Rehabilitation 31(22): 1878-1881
Bókkon, I.án.; Till, A.; Grass, F.; Erdöfi Szabó, A. 2011: Phantom pain reduction by low-frequency and low-intensity electromagnetic fields. Electromagnetic Biology and Medicine 30(3): 115-127
Kapoor, S. 2010: Phantom pain: emerging new therapeutic options. Disability and Rehabilitation 32(5): 429
Wade, N.J.; Finger, S. 2010: Phantom penis: historical dimensions. Journal of the History of the Neurosciences 19(4): 299-312
Pirowska, A.; Wloch, T.; Nowobilski, R.; Plaszewski, M.; Hocini, A.; Ménager, Dénico. 2014: Phantom phenomena and body scheme after limb amputation: a literature review. Neurologia i Neurochirurgia Polska 48(1): 52-59
Cowen, R. 2013: Phantom planets. Why hyperactive stars are planet hunters' biggest headache. Scientific American 309(2): 25
Martínez-Pascual, M.; García-Gómez, Jé.; Villegas-García, M. 2012: Phantom pneumonia. Revista Espanola de Cardiologia 65(9): 851-852
Nasseri, Y.; Kohanzadeh, S.; Murrell, Z.; Berel, D.; Melmed, G.; Fleshner, P. 2011: Phantom publications among applicants to a colorectal surgery residency program. Diseases of the Colon and Rectum 54(2): 220-225
DeGregoris, G.; Diwan, S. 2010: Phantom radiculitis effectively treated by fluoroscopically guided transforaminal epidural steroid injections. Pain Physician 13(6): 505-508
Reategui, C.; Chiang, F.F.; Rosen, L.; Sands, D.; Weiss, E.G.; Wexner, S.D. 2013: Phantom rectum following abdominoperineal excision for rectal neoplasm: appearance and disappearance. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland 15(10): 1309-1312
Dempewolf, S.; Bunten, S.; Happe, S. 2011: Phantom restless legs syndrome in a patient with unilateral above knee amputation. Sleep Medicine 12(1): 105-106
Myles, I.A. 2010: Phantom rhinitis. International Archives of Allergy and Immunology 153(4): 424-427
Mattheis, C.; Schwarzer, M.C.; Frenking, G.; Agarwal, S. 2011: Phantom ring-closing condensation polymerization: towards antibacterial oligoguanidines. Macromolecular Rapid Communications 32(13): 994-999
Bokemeyer, C.; Frank, B.; Schoffski, P.; Poliwoda, H.; Schmoll, H. 1993: Phantom sensations after orchiectomy for testicular cancer. International Journal of Oncology 2(4): 633-636
Drysdale, D.G.; Shem, K.; Walbom, A.; Miner, M.D.; Maclachlan, M. 2009: Phantom sensations in people with complete spinal cord lesions: a grounded theory perspective. Disability and Rehabilitation 31(4): 267-276
Juan, E.A.; Pollack, M. 2010: Phantom shocks in patients with an implantable cardioverter defibrillator. Journal of Emergency Medicine 38(1): 22-24
Maass, A.H. 2013: Phantom shocks: innocent bystander or complication of implantable cardioverter defibrillator therapy?. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 21(4): 189-190
Zielinski, A.; Behrendt, F.F.; Verburg, F.A.; Mottaghy, F.M.; Krohn, T. 2014: Phantom studies and clinical application of high resolution, image reconstruction using (18)F-fluoromethylcholine PET/CT for prostate cancer. Hellenic Journal of Nuclear Medicine 17(3): 194-199
Ferretti, A.; Chondrogiannis, S.; Marcolongo, A.; Rubello, D. 2013: Phantom study of a new hand-held γ-imaging probe for radio-guided surgery. Nuclear Medicine Communications 34(1): 86-90
Kuru, T.H.; Roethke, M.; Popeneciu, V.; Teber, D.; Pahernik, S.; Zogal, P.; Schlemmer, H.-P.; Hadaschik, B.A.; Hohenfellner, M. 2012: Phantom study of a novel stereotactic prostate biopsy system integrating preinterventional magnetic resonance imaging and live ultrasonography fusion. Journal of Endourology 26(7): 807-813
Huang, J.; Lee, K.-s.; Clarkson, E.; Kupinski, M.; Maki, K.L.; Ross, D.S.; Aquavella, J.V.; Rolland, J.P. 2013: Phantom study of tear film dynamics with optical coherence tomography and maximum-likelihood estimation. Optics Letters 38(10): 1721-1723
Ferretti, A.; Bellan, E.; Gava, M.; Chondrogiannis, S.; Massaro, A.; Nibale, O.; Rubello, D. 2012: Phantom study of the impact of reconstruction parameters on the detection of mini- and micro-volume lesions with a low-dose PET/CT acquisition protocol. European Journal of Radiology 81(11): 3363-3370
Uto, F.; Shiba, E.; Onoue, S.; Yoshimura, H.; Takada, M.; Tsuji, Y.; Fukugami, S.; Asakawa, I.; Tamamoto, T.; Hasegawa, M. 2010: Phantom study on radiotherapy planning using PET/CT--delineation of GTV by evaluating SUV. Journal of Radiation Research 51(2): 157-164
Zhang, T.; Tachiya, Y.; Sakaguchi, Y.; Mitsumoto, K.; Mitsumoto, T.; Ohya, N.; Sasaki, M. 2010: Phantom study on three-dimensional target volume delineation by PET/CT-based auto-contouring. Fukuoka Igaku Zasshi 101(11): 238-246
Palma, B.A.; Rosado-Méndez, I.; Villaseñor, Y.; Brandan, M.E. 2010: Phantom study to evaluate contrast-medium-enhanced digital subtraction mammography with a full-field indirect-detection system. Medical Physics 37(2): 577-589
Lair, L.; Gibbons, C.; Freeman, R. 2008: Phantom sweating: a novel autonomic paresthesia. Clinical Autonomic Research: Official Journal of the Clinical Autonomic Research Society 18(6): 352-354
Medina, J.; Rapp, B. 2008: Phantom tactile sensations modulated by body position. Current Biology: Cb 18(24): 1937-1942
Pühse, G.; Wachsmuth, J.U.; Kemper, S.; Husstedt, I.W.; Kliesch, S.; Evers, S. 2010: Phantom testis syndrome: prevalence, phenomenology and putative mechanisms. International Journal of Andrology 33(1): E216-E220
Barral, J.ér.ém.; Martin, P. 2012: Phantom tones and suppressive masking by active nonlinear oscillation of the hair-cell bundle. Proceedings of the National Academy of Sciences of the United States of America 109(21): E1344-E1351
Celiker, C.; Aliyev, F.; Türkoğlu, C.; Uzunhasan, I.şi. 2009: Phantom tumor of the lung in a patient with preserved left ventricular systolic function. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir 37(7): 512
Lozo, M.; Lozo Vukovac, E.; Ivancevic, Z.; Pletikosic, I. 2014: Phantom tumor of the lung: localized interlobar effusion in congestive heart failure. Case Reports in Cardiology 2014: 207294
Gómez Senent, S.; Gómez Raposo, C.és.; Segura Cabral, J.é M.ía. 2008: Phantom tumor of the pancreas. Gastroenterologia y Hepatologia 31(3): 129-131
Lobão, Bárbara.; Dias, E. 2013: Phantom tumour of the lung. BMJ Case Reports
Althomali, S.A.; Almalki, M.M.; Mohiuddin, S.A. 2014: Phantom tumour of the lung in a patient with renal failure misdiagnosed as chest infection. BMJ Case Reports
Arlen, A.M.; Dewhurst, L.L.; Kirsch, S.S.; Dingle, A.D.; Scherz, H.C.; Kirsch, A.J. 2014: Phantom urinary incontinence in children with bladder-bowel dysfunction. Urology 84(3): 685-688
Ong, Y.H.; Zhu, C.; Liu, Q. 2014: Phantom validation of Monte Carlo modeling for noncontact depth sensitive fluorescence measurements in an epithelial tissue model. Journal of Biomedical Optics 19(8): 085006
Deb, A. 2015: Phantom vibration and phantom ringing among mobile phone users: A systematic review of literature. Asia-Pacific Psychiatry: Official Journal of the Pacific Rim College of Psychiatrists 7(3): 231-239
Rothberg, M.B.; Arora, A.; Hermann, J.; Kleppel, R.; St Marie, P.; Visintainer, P. 2010: Phantom vibration syndrome among medical staff: a cross sectional survey. Bmj 341: C6914
Baillie, D.W.H. 2011: Phantom vibration syndrome. Sixty eight per cent of us hallucinate. Bmj 342: D299
Stuban, N.; Niwayama, M.; Santha, H. 2012: Phantom with pulsatile arteries to investigate the influence of blood vessel depth on pulse oximeter signal strength. Sensors 12(1): 895-904
Domanitskaya, E.; Anllo, L.; Schüpbach, T. 2014: Phantom, a cytochrome P450 enzyme essential for ecdysone biosynthesis, plays a critical role in the control of border cell migration in Drosophila. Developmental Biology 386(2): 408-418
Marquez, C.P.; Pritham, E.J. 2010: Phantom, a new subclass of Mutator DNA transposons found in insect viruses and widely distributed in animals. Genetics 185(4): 1507-1517
Sun, Q.; Groth, A.; Bertram, M.; Waechter, I.; Bruijns, T.; Hermans, R.; Aach, T. 2010: Phantom-based experimental validation of computational fluid dynamics simulations on cerebral aneurysms. Medical Physics 37(9): 5054-5065
Mannila, V.; Sipilä, O. 2013: Phantom-based quality assurance measurements in B-mode ultrasound. Acta Radiologica Short Reports 2(8): 2047981613511967
Serafin, Z.; Lasek, W.; Laskowska, K. 2008: Phantom-calibrated versus automatic coronary artery mass quantification with multidetector-row computed tomography: in vitro and in vivo study. Acta Radiologica 49(9): 1007-1015
Mueller, D.K.; Kutscherenko, A.; Bartel, H.; Vlassenbroek, A.; Ourednicek, P.; Erckenbrecht, J. 2011: Phantom-less QCT BMD system as screening tool for osteoporosis without additional radiation. European journal of radiology 79(3): 375-381
Handsfield, L.L.; Jones, R.; Wilson, D.D.; Siebers, J.V.; Read, P.W.; Chen, Q. 2014: Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation. Medical Physics 41(10): 101703
Martelli, F.; Pifferi, A.; Contini, D.; Spinelli, L.; Torricelli, A.; Wabnitz, H.; Macdonald, R.; Sassaroli, A.; Zaccanti, G. 2013: Phantoms for diffuse optical imaging based on totally absorbing objects, part 1: Basic concepts. Journal of Biomedical Optics 18(6): 066014
Martelli, F.; Di Ninni, P.; Zaccanti, G.; Contini, D.; Spinelli, L.; Torricelli, A.; Cubeddu, R.; Wabnitz, H.; Mazurenka, M.; Macdonald, R.; Sassaroli, A.; Pifferi, A. 2014: Phantoms for diffuse optical imaging based on totally absorbing objects, part 2: experimental implementation. Journal of Biomedical Optics 19(7): 076011
Bouwman, R.W.; Diaz, O.; van Engen, R.E.; Young, K.C.; den Heeten, G.J.; Broeders, M.J.M.; Veldkamp, W.J.H.; Dance, D.R. 2013: Phantoms for quality control procedures in digital breast tomosynthesis: dose assessment. Physics in Medicine and Biology 58(13): 4423-4438
Tatu, L.; Bogousslavsky, J.; Boller, Fçois.; Cendrars, B.; Rimbaud, A.; Wittgenstein, P. 2014: Phantoms in artists: the lost limbs of Blaise Cendrars,Arthur Rimbaud, and Paul Wittgenstein. Journal of the History of the Neurosciences 23(4): 355-366
Carlson, B.A. 2008: Phantoms in the brain: ambiguous representations of stimulus amplitude and timing in weakly electric fish. Journal of Physiology Paris 102(4-6): 209-222
Ayuga-Loro, F.; Torres-Llacsa, M.; Brocalero, A.; Florensa-Vila, J.; Oliviero, A. 2011: Phantoms in the brain: transient mass in the posterior fossa after traumatic cervical SCI and vertebral artery obstruction. Acta Neurologica Belgica 111(3): 258
Schwark, T.; Poetsch, M.; Preusse-Prange, A.; Kamphausen, T.; von Wurmb-Schwark, N. 2012: Phantoms in the mortuary--DNA transfer during autopsies. Forensic Science International 216(1-3): 121-126
Cabin, W.D. 2007: Phantoms of home care: regulatory constraints on home care nurse care management of persons with Alzheimer's disease. American Journal of Alzheimer's Disease and other Dementias 22(5): 378-388
Landis, B.N.; Burkhard, P.R. 2008: Phantosmias and Parkinson disease. Archives of Neurology 65(9): 1237-1239
Xu, M.; Xing, Q.; Li, S.; Zheng, Y.; Wu, S.; Gao, R.; Yu, L.; Guo, T.; Yang, Y.; Liu, J.; Zhang, A.; Zhao, X.; He, G.; Zhou, J.; Wang, L.; Xuan, J.; Du, J.; Li, X.; Feng, G.; Lin, Z.; Xu, Y.; St Clair, D.; Lin, Z.; He, L. 2010: Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34(6): 1026-1032
Mihaljević-Peles, A.; Sagud, M.; Bozina, N.; Zivković, M. 2008: Pharamacogenetics and antidepressant treatment in integrative psychiatry perspective. Psychiatria Danubina 20(3): 399-401
Taminau, J.; Thijs, G.; De Winter, H. 2008: Pharao: pharmacophore alignment and optimization. Journal of Molecular Graphics and Modelling 27(2): 161-169
Nau, J.-Y. 2010: Pharaoh DNA analysis. Revue Medicale Suisse 6(238): 478
Evans, R.G.; Barer, M.L.; Schneider, D.G. 2010: Pharaoh and the Prospects for Productivity in HHR. Healthcare Policy 5(3): 17-26
Ali, F.R.; Finlayson, A.E.T. 2013: Pharaonic trichology: the Ebers Papyrus. JAMA Dermatology 149(8): 920
Xu, H.-Z.; Huang, Y.; Wu, Y.-L.; Zhao, Y.; Xiao, W.-L.; Lin, Q.-S.; Sun, H.-D.; Dai, W.; Chen, G.-Q. 2010: Pharicin A, a novel natural ent-kaurene diterpenoid, induces mitotic arrest and mitotic catastrophe of cancer cells by interfering with BubR1 function. Cell Cycle 9(14): 2897-2907
Gu, Z-Min.; Wu, Y-Li.; Zhou, M-Yi.; Liu, C-Xu.; Xu, H-Zhang.; Yan, H.; Zhao, Y.; Huang, Y.; Sun, H-Dong.; Chen, G-Qiang. 2010: Pharicin B stabilizes retinoic acid receptor-α and presents synergistic differentiation induction with ATRA in myeloid leukemic cells. Blood 116(24): 5289-5297
Deshpande, P.R.; Farooq, K.K.A.; John, D.M.; Rao, E.J. 2012: Pharm D: a new concept in India. Journal of Pharmacy and Bioallied Sciences 4(1): 84-86
El Bahri, L. 2008: Pharm profile: activated charcoal. Compendium 30(11): 596-598
Barrett, P.M.; Topol, E.J. 2013: Pharm-econogenomics: a new appraisal. Clinical Chemistry 59(4): 592-594
Bauman, J.L.; Evans, W.E. 2009: Pharm.D.-only investigators are critical to the profession: let's preserve the fellowship as an equally important way to prepare future clinical pharmaceutical scientists: or the case against the "all-Ph.D.". Pharmacotherapy 29(2): 129-133
Munroe, J. 2012: PharmACTION!. Canadian Journal of Hospital Pharmacy 65(2): 168
Alecu, I.; Bousquet, C.éd.; Degoulet, P.; Jaulent, M.-C. 2007: PharmARTS: terminology web services for drug safety data coding and retrieval. Studies in Health Technology and Informatics 129(Part 1): 699-704
Bhuvan, K.C.; Subish, P.; Mohamed Izham, M.I. 2011: PharmD Education in Nepal: the challenges ahead. American Journal of Pharmaceutical Education 75(2): 38c
Hadi, M.A. 2010: PharmD and needs-based education: an alternate view. American Journal of Pharmaceutical Education 74(7): 125a
Jamshed, S.; Babar, Z.-u.-d.; Izham, M.; Ibrahim, M. 2009: PharmD in Pakistan: a tag or a degree?. American Journal of Pharmaceutical Education 73(1): 13
Anderson, C.; Futter, B. 2009: PharmD or needs based education: which comes first?. American Journal of Pharmaceutical Education 73(5): 92
Hu, B.; Lill, M.A. 2014: PharmDock: a pharmacophore-based docking program. Journal of Cheminformatics 6: 14
Forbey, J.S.; Foley, W.J. 2009: PharmEcology: A pharmacological approach to understanding plant-herbivore interactions: an introduction to the symposium. Integrative and Comparative Biology 49(3): 267-273
Zhu, Q.; Freimuth, R.R.; Pathak, J.; Chute, C.G. 2013: PharmGKB Drug Data Normalization with NDF-RT. AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science 2013: 180
Owen, R.P.; Altman, R.B.; Klein, T.E. 2008: PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics. Human Mutation 29(4): 456-460
Thorn, C.F.; Ellison, D.H.; Turner, S.T.; Altman, R.B.; Klein, T.E. 2013: PharmGKB summary: Diuretics pathway, pharmacodynamics. Pharmacogenetics and Genomics 23(8): 449-453
Barbarino, J.M.; Kroetz, D.L.; Altman, R.B.; Klein, T.E. 2014: PharmGKB summary: abacavir pathway. Pharmacogenetics and Genomics 24(5): 276-282
Thorn, C.F.; Aklillu, E.; McDonagh, E.M.; Klein, T.E.; Altman, R.B. 2012: PharmGKB summary: caffeine pathway. Pharmacogenetics and Genomics 22(5): 389-395
Thorn, C.F.; Leckband, S.G.; Kelsoe, J.; Leeder, J.Steven.; Müller, D.J.; Klein, T.E.; Altman, R.B. 2011: PharmGKB summary: carbamazepine pathway. Pharmacogenetics and Genomics 21(12): 906-910
Sangkuhl, K.; Klein, T.E.; Altman, R.B. 2011: PharmGKB summary: citalopram pharmacokinetics pathway. Pharmacogenetics and Genomics 21(11): 769-772
Barbarino, J.M.; Staatz, C.E.; Venkataramanan, R.; Klein, T.E.; Altman, R.B. 2013: PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenetics and Genomics 23(10): 563-585
Berlin, D.S.; Sangkuhl, K.; Klein, T.E.; Altman, R.B. 2011: PharmGKB summary: cytochrome P450, family 2, subfamily J, polypeptide 2: CYP2J2. Pharmacogenetics and Genomics 21(5): 308-311
Mi, H.; Thomas, P.D.; Ring, H.Z.; Jiang, R.; Sangkuhl, K.; Klein, T.E.; Altman, R.B. 2011: PharmGKB summary: dopamine receptor D2. Pharmacogenetics and Genomics 21(6): 350-356
Thorn, C.F.; Marsh, S.; Carrillo, M.Whirl.; McLeod, H.L.; Klein, T.E.; Altman, R.B. 2011: PharmGKB summary: fluoropyrimidine pathways. Pharmacogenetics and Genomics 21(4): 237-242
Alvarellos, M.L.; Lamba, J.; Sangkuhl, K.; Thorn, C.F.; Wang, L.; Klein, D.J.; Altman, R.B.; Klein, T.E. 2014: PharmGKB summary: gemcitabine pathway. Pharmacogenetics and Genomics 24(11): 564-574
Lowenberg, D.; Thorn, C.F.; Desta, Z.; Flockhart, D.A.; Altman, R.B.; Klein, T.E. 2014: PharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics. Pharmacogenetics and Genomics 24(2): 133-138
Mikkelsen, T.S.; Thorn, C.F.; Yang, J.J.; Ulrich, C.M.; French, D.; Zaza, G.; Dunnenberger, H.M.; Marsh, S.; McLeod, H.L.; Giacomini, K.; Becker, M.L.; Gaedigk, R.; Leeder, J.Steven.; Kager, L.; Relling, M.V.; Evans, W.; Klein, T.E.; Altman, R.B. 2011: PharmGKB summary: methotrexate pathway. Pharmacogenetics and Genomics 21(10): 679-686
McDonagh, E.M.; Bautista, Jé.M.; Youngster, I.; Altman, R.B.; Klein, T.E. 2013: PharmGKB summary: methylene blue pathway. Pharmacogenetics and Genomics 23(9): 498-508
Lamba, V.; Sangkuhl, K.; Sanghavi, K.; Fish, A.; Altman, R.B.; Klein, T.E. 2014: PharmGKB summary: mycophenolic acid pathway. Pharmacogenetics and Genomics 24(1): 73-79
Thorn, C.F.; Whirl-Carrillo, M.; Leeder, J.Steven.; Klein, T.E.; Altman, R.B. 2012: PharmGKB summary: phenytoin pathway. Pharmacogenetics and Genomics 22(6): 466-470
Klein, D.J.; Thorn, C.F.; Desta, Z.; Flockhart, D.A.; Altman, R.B.; Klein, T.E. 2013: PharmGKB summary: tamoxifen pathway, pharmacokinetics. Pharmacogenetics and Genomics 23(11): 643-647
Gong, L.; Stamer, U.M.; Tzvetkov, M.V.; Altman, R.B.; Klein, T.E. 2014: PharmGKB summary: tramadol pathway. Pharmacogenetics and Genomics 24(7): 374-380
McDonagh, E.M.; Thorn, C.F.; Callaghan, J.T.; Altman, R.B.; Klein, T.E. 2014: PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics. Pharmacogenetics and Genomics 24(9): 464-476
Sangkuhl, K.; Stingl, J.C.; Turpeinen, M.; Altman, R.B.; Klein, T.E. 2014: PharmGKB summary: venlafaxine pathway. Pharmacogenetics and Genomics 24(1): 62-72
Thorn, C.F.; Aklillu, E.; Klein, T.E.; Altman, R.B. 2012: PharmGKB summary: very important pharmacogene information for CYP1A2. Pharmacogenetics and genomics 22(1): 73-77
Thorn, C.F.; Lamba, J.K.; Lamba, V.; Klein, T.E.; Altman, R.B. 2010: PharmGKB summary: very important pharmacogene information for CYP2B6. Pharmacogenetics and genomics 20(8): 520-523
Lamba, J.; Hebert, J.M.; Schuetz, E.G.; Klein, T.E.; Altman, R.B. 2012: PharmGKB summary: very important pharmacogene information for CYP3A5. Pharmacogenetics and genomics 22(7): 555-558
Alvarellos, M.L.; Sangkuhl, K.; Daneshjou, R.; Whirl-Carrillo, M.; Altman, R.B.; Klein, T.E. 2015: PharmGKB summary: very important pharmacogene information for CYP4F2. Pharmacogenetics and genomics 25(1): 41-47
McDonagh, E.M.; Thorn, C.F.; Bautista, Jé.M.; Youngster, I.; Altman, R.B.; Klein, T.E. 2012: PharmGKB summary: very important pharmacogene information for G6PD. Pharmacogenetics and genomics 22(3): 219-228
Thorn, C.F.; Ji, Y.; Weinshilboum, R.M.; Altman, R.B.; Klein, T.E. 2012: PharmGKB summary: very important pharmacogene information for GSTT1. Pharmacogenetics and genomics 22(8): 646-651
McDonagh, E.M.; Boukouvala, S.; Aklillu, E.; Hein, D.W.; Altman, R.B.; Klein, T.E. 2014: PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2. Pharmacogenetics and genomics 24(8): 409-425
Thorn, C.F.; Grosser, T.; Klein, T.E.; Altman, R.B. 2011: PharmGKB summary: very important pharmacogene information for PTGS2. Pharmacogenetics and genomics 21(9): 607-613
Goswami, S.; Gong, L.; Giacomini, K.; Altman, R.B.; Klein, T.E. 2014: PharmGKB summary: very important pharmacogene information for SLC22A1. Pharmacogenetics and genomics 24(6): 324-328
Barbarino, J.M.; Haidar, C.E.; Klein, T.E.; Altman, R.B. 2014: PharmGKB summary: very important pharmacogene information for UGT1A1. Pharmacogenetics and genomics 24(3): 177-183
Thorn, C.F.; Klein, T.E.; Altman, R.B. 2010: PharmGKB summary: very important pharmacogene information for angiotensin-converting enzyme. Pharmacogenetics and genomics 20(2): 143-146
McDonagh, E.M.; Wassenaar, C.; David, S.P.; Tyndale, R.F.; Altman, R.B.; Whirl-Carrillo, M.; Klein, T.E. 2012: PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6. Pharmacogenetics and genomics 22(9): 695-708
Scott, S.A.; Sangkuhl, K.; Shuldiner, A.R.; Hulot, J-Sébastien.; Thorn, C.F.; Altman, R.B.; Klein, T.E. 2012: PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19. Pharmacogenetics and genomics 22(2): 159-165
Aquilante, C.L.; Niemi, M.; Gong, L.; Altman, R.B.; Klein, T.E. 2013: PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8. Pharmacogenetics and genomics 23(12): 721-728
Hodoglugil, U.; Carrillo, M.W.; Hebert, J.M.; Karachaliou, N.; Rosell, R.C.; Altman, R.B.; Klein, T.E. 2013: PharmGKB summary: very important pharmacogene information for the epidermal growth factor receptor. Pharmacogenetics and genomics 23(11): 636-642
Ghodke, Y.; Anderson, P.L.; Sangkuhl, K.; Lamba, J.; Altman, R.B.; Klein, T.E. 2012: PharmGKB summary: zidovudine pathway. Pharmacogenetics and Genomics 22(12): 891-894
Oshiro, C.; Mangravite, L.; Klein, T.; Altman, R. 2010: PharmGKB very important pharmacogene: SLCO1B1. Pharmacogenetics and Genomics 20(3): 211-216
Gong, L.; Owen, R.P.; Gor, W.; Altman, R.B.; Klein, T.E. 2008: PharmGKB: an integrated resource of pharmacogenomic data and knowledge. Current Protocols in Bioinformatics Chapter 14: 14.7.1-14.7.17
Thorn, C.F.; Klein, T.E.; Altman, R.B. 2013: PharmGKB: the Pharmacogenomics Knowledge Base. Methods in Molecular Biology 1015: 311-320
Medina, M.W.; Sangkuhl, K.; Klein, T.E.; Altman, R.B. 2011: PharmGKB: very important pharmacogene--HMGCR. Pharmacogenetics and Genomics 21(2): 98-101
Liu, X.; Ouyang, S.; Yu, B.; Liu, Y.; Huang, K.; Gong, J.; Zheng, S.; Li, Z.; Li, H.; Jiang, H. 2010: PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Research 38(Web Server Issue): W609-W614
Souza, L.J.é d.; Reis, A.F.F.; de Almeida, F.C.R.; Souza, L.A.d.; Abukater, M.; Gomes, M.íc.A.E.; Abicair, O.ív.A.; Gonçalves, P.A. 2008: Alteration in the erythrocyte sedimentation rate in dengue patients: analysis of 1,398 cases. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 12(6): 472-475
Bartfai, T.; Lees, G.Vaughan. 2011: Pharma TARP: a troubled asset relief program for novel, abandoned projects in the pharmaceutical industry. Thescientificworldjournal 11: 454-457
Fletcher, S. 2008: Pharma and CME: View from the US. Bmj 337: A1023
Evans, T. 2012: Pharma and the NHS: challenging, not cosy. Health Service Journal 122(6300): 18; 19
Holm, R.P. 2014: Prolonging life and suffering. South Dakota Medicine: the Journal of the South Dakota State Medical Association 67(5): 208
Anonymous 2014: Pharma giants swap research programs. Cancer discovery 4(7): OF3
Kondro, W. 2008: Pharma giants to create databases on gifts to physicians. Cmaj: Canadian Medical Association Journal 179(11): 1118
Fox, N.J.; Ward, K.J. 2008: Pharma in the bedroom ... and the kitchen....The pharmaceuticalisation of daily life. Sociology of Health and Illness 30(6): 856-868
Sundaram, V.M. 2008: Pharma industry in India. Drug News and Perspectives 21(1): 59-63
Addy, G.; Banicevic, A.; Katz, M.; Rosen, H. 2010: Pharma industry under antitrust security. Health Law in Canada 30(3): 146-148
Blesch, G. 2009: Pharma industry's bitter pill ... could be impetus for devicemaker legislation, too. Modern Healthcare 39(10): 11
Glauser, W. 2013: Pharma influence widespread at medical schools: study. Cmaj: Canadian Medical Association Journal 185(13): 1121-1122
Huberfeld, N. 2007: Pharma on the hot seat. Journal of Health Law 40(2): 241-265
Becker, K. 2009: Pharma patents in Europe: where are we going?. Future Medicinal Chemistry 1(2): 227-230
Ali, O.G.ür.; Mantrala, M. 2010: Pharma rebates, pharmacy benefit managers and employer outcomes. Health Care Management Science 13(4): 281-293
Reisman, M. 2010: Pharma twitters cautiously before advertising guidelines are released. P and T: a Peer-Reviewed Journal for Formulary Management 35(7): 373-416
Nakanishi, T.; Soga, T.; Ueda, K. 2014: Pharma valley project. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 144(2): 88-94
Morrison, J.C. 2009: Pharma "phree". Obstetrics and Gynecology 113(6): 1369-1370
McKernan, R.; McNeish, J.; Smith, D. 2010: Pharma's developing interest in stem cells. Cell Stem Cell 6(6): 517-520
Greene, J. 2009: Pharma's influence on the fourth estate: health care journalists' conflicts also scrutinized. Annals of Emergency Medicine 53(3): 18a-20a
Wornock, J.P. 2009: Pharma-free. Family Practice Management 16(3): 7
Georgiou, N.A.; Garssen, J.; Witkamp, R.F. 2011: Pharma-nutrition interface: the gap is narrowing. European Journal of Pharmacology 651(1-3): 1-8
Schneidman-Duhovny, D.; Dror, O.; Inbar, Y.; Nussinov, R.; Wolfson, H.J. 2008: PharmaGist: a webserver for ligand-based pharmacophore detection. Nucleic Acids Research 36(Web Server Issue): W223-W228
Bawa, R. 2007: PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine. Idrugs: the Investigational Drugs Journal 10(7): 455-458
den Exter, Aé.P. 2009: PharmaNostra under fire. Croatian Medical Journal 50(5): 507-508
Buonaguro, F.M.; Butler-Ransohoff, J.-E. 2010: PharmaPlant: the new frontier in vaccines. Forward. Expert Review of Vaccines 9(8): 805-807
Carrascosa, M.C.; Massaguer, O.L.; Mestres, J. 2012: PharmaTrek: A Semantic Web Explorer for Open Innovation in Multitarget Drug Discovery. Molecular Informatics 31(8): 537-541
Lynas, K. 2012: PharmaTrust files for bankruptcy. Canadian Pharmacists Journal: Cpj 145(5): 213
Shanahan, F.; Collins, S.M. 2010: Pharmabiotic manipulation of the microbiota in gastrointestinal disorders, from rationale to reality. Gastroenterology Clinics of North America 39(3): 721-726
Thompson, C.A. 2008: Pharmabridge links pharmacists from developing countries with U.S. sites. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(3): 194-195
Petrichenko, N.A. 1945: Pharmacal economics. Farmatsiia 2: 3-9
Moulton, D. 2007: Pharmacare for children slow to gain ground in NS. Cmaj: Canadian Medical Association Journal 176(8): 1073
Zollner, B.; Sucha, M.; Berg, C.; Muß, N.; Amann, P.; Amann-Neher, B.; Oestreicher, D.; Engelhardt, S.; Sarikas, A. 2013: Pharmacases.de - a student-centered e-learning project of clinical pharmacology. Medical Teacher 35(3): 251-253
Kadar, T. 1955: Pharmaceutic collective agreement. A Gyogyszeresz 10(2): 37
Hassard, H. 1960: Tax Deductibility-The Status of Accident and Health Insurance Premiums. California Medicine 92(2): 179-180
Schlauch, R.S.; Carney, E. 2018: Clinical Strategies for Sampling Word Recognition Performance. Journal of Speech Language and Hearing Research: Jslhr 61(4): 936-944
Silva Oliveira, T.de.Alencar.; Maria, T.de.Oliveira.Silva.; Alves do Nascimento, A.Maria.; do Nascimento, A.Alves. 2011: Pharmaceutical Assistance in the Family Healthcare Program: points of affinity and discord in the organization process. Ciencia and Saude Coletiva 16(9): 3939-3949
Doran, E.; Robertson, J.; Salkeld, G. 2011: Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability. Australian Health Review: a Publication of the Australian Hospital Association 35(1): 37-44
Lewandowski, C.; Pezzuto, J.M. 2012: Pharmaceutical Biology: a retrospective. Pharmaceutical Biology 50(1): 1-5
Schultheiss, N.; Newman, A. 2009: Pharmaceutical Cocrystals and their Physicochemical Properties. Crystal Growth and Design 9(6): 2950-2967
Hamoudi, N.M.; Shirwaikar, A.A.; Ali, H.S.; Al Ayoubi, E.I. 2011: Pharmaceutical Consultation in UAE Community Pharmacies. Indian Journal of Pharmaceutical Sciences 73(4): 404-408
Akers, M.J. 2012: Pharmaceutical Development and Technology (PDT) announcements. Pharmaceutical Development and Technology 17(2): 129-130
Kraemer, H. 1893: Pharmaceutical Educsation. Science 21(537): 268-269
Anonymous 1962: Pharmaceutical Hazards and Drug Evaluation. Canadian Medical Association Journal 86(18): 838-839
Persson, L.; Westerhäll, L. 1997: Pharmaceutical Injury Insurance in the Nordic countries - an alternative to the traditional law of tort. International Journal of Risk and Safety in Medicine 10(3): 147-185
Ellis, C. 2009: Pharmaceutical Latin. South African Medical Journal 99(4): 222
Young, M.M. 1933: Pharmaceutical Notes. Journal of the National Medical Association 25(1): 41
Beecher, N. 2009: Pharmaceutical Portfolio & Product Life Cycle Management--SMi's fourth annual conference. 29-30 June 2009, London, UK. IDrugs: the investigational drugs journal 12(9): 558-560
Ogbighele, E. 2010: Pharmaceutical Pricing and Market Access Outlook Europe 2010-HealthNetwork Communications' fourth annual conference. 24-25 March 2010, London, UK. Idrugs: the Investigational Drugs Journal 13(5): 317-320
Prosen, H. 1962: Pharmaceutical Product Information. Canadian Medical Association Journal 87(3): 139
Anonymous 1965: Pharmaceutical Profits and the Nation's Health. British Medical Journal 2(5476): 1483
Schmid, E.F.; Smith, D.A. 2007: Pharmaceutical R&D in the spotlight: why is there still unmet medical need?. Drug Discovery Today 12(23-24): 998-1006
DiMasi, J.A. 2014: Pharmaceutical R&D performance by firm size: approval success rates and economic returns. American Journal of Therapeutics 21(1): 26-34
Caldwell, G.W. 2012: Pharmaceutical R&D: a knowledge-intensive multidisciplinary approach. Current Topics in Medicinal Chemistry 12(11): 1223
Baldwin, J.J. 2014: Pharmaceutical R&D: an age of change?. Future Medicinal Chemistry 6(10): 1109-1112
Anonymous 1957: Pharmaceutical Research. British Medical Journal 1(5027): 1107-1108
Buckley, J.P. 1964: Pharmaceutical Sciences (Np). Science 143(3608): 849-850
Buckley, J.P. 1965: Pharmaceutical Sciences (Np). Science 147(3660): 929-932
Christian, J.E. 1962: Pharmaceutical Sciences (Section Np). Science 135(3503): 558-560
Stewart, F.E. 1902: Necessity of Standardizing Materia Medica Products. California State Journal of Medicine 1(2): 37-39
Te, A.E.; Kaplan, S.A. 1994: Pharmaceutical Treatment of BPH and its Effect on Indications for Prostate Surgery. Surgical Technology International 3: 305-312
Villanova, J.C.O.; Ayres, E.; Carvalho, S.M.; Patrício, P.S.; Pereira, F.V.; Oréfice, R.L. 2011: Pharmaceutical acrylic beads obtained by suspension polymerization containing cellulose nanowhiskers as excipient for drug delivery. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 42(4): 406-415
Yoneda, M.; Imajo, K.; Takahashi, H.; Ogawa, Y.; Eguchi, Y.; Sumida, Y.; Yoneda, M.; Kawanaka, M.; Saito, S.; Tokushige, K.; Nakajima, A. 2018: Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods. Journal of Gastroenterology 53(2): 181-196
Lakdawalla, D.; Sood, N.; Gu, Q. 2013: Pharmaceutical advertising and Medicare Part D. Journal of Health Economics 32(6): 1356-1367
Merino, J.é G. 2014: Clinical stroke challenges: a practical approach. NEUROLOGY. Clinical Practice 4(5): 376-377
Kahawita, S.K.; Casson, R.J. 2012: Pharmaceutical advertising in ophthalmology. Clinical and Experimental Ophthalmology 40(2): 216-217
Gaddis, G.M.; Olson, J.E.; Wright, D.W. 2011: Pharmaceutical advertising policy of Academic Emergency Medicine was incompletely reported and mischaracterized in the statement of EMA's new no-pharmaceutical ads policy. Emergency Medicine Australasia: Ema 23(5): 654-655
Hont, G. 2014: Pharmaceutical advertising--history today. Lakartidningen 111(32-33): 1312
Szakonyi, G.; Zelkó, R.án. 2010: Pharmaceutical advice concerning different pharmaceutical dosage forms. Acta Pharmaceutica Hungarica 80(3): 121-127
Hanif, S.N.M.; Garcia-Contreras, L. 2012: Pharmaceutical aerosols for the treatment and prevention of tuberculosis. Frontiers in Cellular and Infection Microbiology 2: 118
Inoue, T. 2012: Pharmaceutical agents and medical devices--similar but different. Masui. Japanese Journal of Anesthesiology 61(12): 1311
Kircher, W. 2013: Pharmaceutical aids in gerontopharmacology. Der Internist 54(1): 110-117
D'Souza, A.; Theis, J.D.; Vrana, J.A.; Dogan, A. 2014: Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration. Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis 21(2): 71-75
Nishimura, N.; Doi, N.; Uemura, T.; Taketani, T.; Hayashi, G.; Kasai, T.; Kanai, R.; Yamaguchi, S.; Iwamoto, K.; Naora, K. 2009: Pharmaceutical analysis and clinical efficacy of Kampo medicine, maoto, extract suppository against pediatric febrile symptoms. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 129(6): 759-766
Yang, Y.; Deng, J.; Yao, Z.-P. 2014: Pharmaceutical analysis by solid-substrate electrospray ionization mass spectrometry with wooden tips. Journal of the American Society for Mass Spectrometry 25(1): 37-47
Alves, J.Cesar.L.; Poppi, R.J. 2013: Pharmaceutical analysis in solids using front face fluorescence spectroscopy and multivariate calibration with matrix correction by piecewise direct standardization. Spectrochimica Acta. Part A Molecular and Biomolecular Spectroscopy 103: 311-318
Benziane, H.; Karfo, R.; Siah, S.; Taoufik, J. 2011: Pharmaceutical analysis of antibiotic drug prescription in the burns and plastic surgery departiment of the Mohammed Military Teaching Hospital. Annals of Burns and Fire Disasters 24(3): 126-131
Nakazawa, H. 2014: Pharmaceutical analysis of chemicals related with daily life products for safe and secure. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 134(3): 413-426
Beltagy, Y.A.; Issa, A.S.; Mahrous, M.S. 1978: Pharmaceutical analysis of some tranquillizers and antidepressants with iodine monochloride. Talanta 25(6): 349
Savarikar, S.S.; Barbhind, M.M.; Halde, U.K.; Kulkarni, A.P. 2011: Pharmaceutical and analytical evaluation of triphalaguggulkalpa tablets. Journal of Ayurveda and Integrative Medicine 2(1): 21-25
Hage, D.S.; Anguizola, J.A.; Bi, C.; Li, R.; Matsuda, R.; Papastavros, E.; Pfaunmiller, E.; Vargas, J.; Zheng, X. 2012: Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments. Journal of Pharmaceutical and Biomedical Analysis 69: 93-105
Carbone, C.; Leonardi, A.; Cupri, S.; Puglisi, G.; Pignatello, R. 2014: Pharmaceutical and biomedical applications of lipid-based nanocarriers. Pharmaceutical Patent Analyst 3(2): 199-215
Akhtar, N.; Khan, B.A.; Majid, A.; Khan, H.M.S.; Mahmood, T.; Gulfishan; Saeed, T. 2011: Pharmaceutical and biopharmaceutical evaluation of extracts from different plant parts of indigenous origin for their hypoglycemic responses in rabbits. Acta Poloniae Pharmaceutica 68(6): 919-925
Tuszynski, G.; Sharma, M. 2009: Pharmaceutical and cellular strategies of recent advances in immunotherapy. Current Pharmaceutical Design 15(17)
Abahussain, E.A.; Ball, D.E. 2010: Pharmaceutical and chemical pediatric poisoning in Kuwait: a retrospective survey. Pharmacy Practice 8(1): 43-49
Pápay, Z.óf.E.; Kósa, A.ár.; Boldizsár, I.; Ruszkai, A.; Balogh, E.; Klebovich, I.; Antal, I.án. 2012: Pharmaceutical and formulation aspects of Petroselinum crispum extract. Acta Pharmaceutica Hungarica 82(1): 3-14
Askeroglu, U.; Alleyne, B.; Guyuron, B. 2013: Pharmaceutical and herbal products that may contribute to dry eyes. Plastic and Reconstructive Surgery 131(1): 159-167
Mangal, S.; Pawar, D.; Garg, N.K.; Jain, A.K.; Vyas, S.P.; Rao, D.S.V.Raman.; Jaganathan, K.S. 2011: Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally. Vaccine 29(31): 4953-4962
Amara, A.A.-A.-F. 2013: Pharmaceutical and industrial protein engineering: where we are?. Pakistan Journal of Pharmaceutical Sciences 26(1): 217-232
Badawi, A.A.; El-Laithy, H.M.; Nesseem, D.I.; El-Husseney, S.S. 2013: Pharmaceutical and medical aspects of hyaluronic acid-ketorolac combination therapy in osteoarthritis treatment: radiographic imaging and bone mineral density. Journal of Drug Targeting 21(6): 551-563
Shimizu, M.; Shirakami, Y.; Hanai, T.; Imai, K.; Suetsugu, A.; Takai, K.; Shiraki, M.; Moriwaki, H. 2014: Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids. Molecular Nutrition and Food Research 58(1): 124-135
Iravani, S.; Zolfaghari, B. 2011: Pharmaceutical and nutraceutical effects of Pinus pinaster bark extract. Research in Pharmaceutical Sciences 6(1): 1-11
Rae, J. 1946: Pharmaceutical and other uses for ethylene and propylene glycols. Manufacturing Chemist and Aerosol News 17: 53
Bonnemain, B. 2007: Pharmaceutical and parapharmaceutical advertising of Annales vertes in 1927. Revue d'Histoire de la Pharmacie 55(355): 307-328
Gottschall, N.; Topp, E.; Metcalfe, C.; Edwards, M.; Payne, M.; Kleywegt, S.; Russell, P.; Lapen, D.R. 2012: Pharmaceutical and personal care products in groundwater, subsurface drainage, soil, and wheat grain, following a high single application of municipal biosolids to a field. Chemosphere 87(2): 194-203
Edwards, M.; Topp, E.; Metcalfe, C.D.; Li, H.; Gottschall, N.; Bolton, P.; Curnoe, W.; Payne, M.; Beck, A.; Kleywegt, S.; Lapen, D.R. 2009: Pharmaceutical and personal care products in tile drainage following surface spreading and injection of dewatered municipal biosolids to an agricultural field. Science of the Total Environment 407(14): 4220-4230
Zhang, H.; Meng, Y.; Wang, X.; Dai, W.; Wang, X.; Zhang, Q. 2014: Pharmaceutical and pharmacokinetic characteristics of different types of fenofibrate nanocrystals prepared by different bottom-up approaches. Drug Delivery 21(8): 588-594
Fischer, A.; Jönsson, M.; Hjelmström, P. 2015: Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine/naloxone tablet formulation in healthy volunteers. Drug Development and Industrial Pharmacy 41(1): 79-84
Abdelbary, A.; Bendas, E.R.; Ramadan, A.A.; Mostafa, D.A. 2014: Pharmaceutical and pharmacokinetic evaluation of a novel fast dissolving film formulation of flupentixol dihydrochloride. Aaps Pharmscitech 15(6): 1603-1610
Najar, I.A.; Johri, R.K. 2014: Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide. Journal of Biosciences 39(1): 139-144
Brandsch, M.; Knütter, I.; Bosse-Doenecke, E. 2008: Pharmaceutical and pharmacological importance of peptide transporters. Journal of Pharmacy and Pharmacology 60(5): 543-585
Salmon, D.; Pont, E.; Chevallard, H.él.èn.; Diouf, E.; Tall, M.-L.; Pivot, C.; Pirot, F. 2013: Pharmaceutical and safety considerations of tablet crushing in patients undergoing enteral intubation. International Journal of Pharmaceutics 443(1-2): 146-153
Palombo, M.; Deshmukh, M.; Myers, D.; Gao, J.; Szekely, Z.; Sinko, P.J. 2014: Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery. Annual Review of Pharmacology and Toxicology 54: 581-598
Bridges, T.M. 2007: Pharmaceutical aphrodisia. Current Topics in Medicinal Chemistry 7(11): 1152
Rezazade Bazaz, M.; Mashreghi, M.; Mahdavi Shahri, N.; Mashreghi, M.; Asoodeh, A.; Behnam Rassouli, M.; Golmohammadzadeh, S. 2013: Pharmaceutical application of frog skin on full-thickness skin wound healing in mice. Pharmaceutical Biology 51(12): 1600-1606
Al-Dhubiab, B.E. 2012: Pharmaceutical applications and phytochemical profile of Cinnamomum burmannii. Pharmacognosy Reviews 6(12): 125-131
Corá, L.A.; Américo, M.F.; Romeiro, F.G.; Oliveira, R.B.; Miranda, J.é R.A. 2010: Pharmaceutical applications of AC biosusceptometry. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 74(1): 67-77
Loftsson, T.; Brewster, M.E. 2010: Pharmaceutical applications of cyclodextrins: basic science and product development. Journal of Pharmacy and Pharmacology 62(11): 1607-1621
Loftsson, T.; Brewster, M.E. 2011: Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes. Journal of Pharmacy and Pharmacology 63(9): 1119-1135
Cheng, Y.; Wang, J.; Rao, T.; He, X.; Xu, T. 2008: Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery. Frontiers in Bioscience: a Journal and Virtual Library 13: 1447-1471
Jones, D.S.; Tian, Y.; Abu-Diak, O.; Andrews, G.P. 2012: Pharmaceutical applications of dynamic mechanical thermal analysis. Advanced Drug Delivery Reviews 64(5): 440-448
Kim, M.-G.; Park, J.Y.; Shon, Y.; Shim, G.; Oh, Y.-K. 2014: Pharmaceutical applications of graphene-based nanosheets. Current Pharmaceutical Biotechnology 14(12): 1016-1026
Repka, M.A.; Battu, S.Kumar.; Upadhye, S.B.; Thumma, S.; Crowley, M.M.; Zhang, F.; Martin, C.; McGinity, J.W. 2007: Pharmaceutical applications of hot-melt extrusion: Part II. Drug Development and Industrial Pharmacy 33(10): 1043-1057
Crowley, M.M.; Zhang, F.; Repka, M.A.; Thumma, S.; Upadhye, S.B.; Battu, S.Kumar.; McGinity, J.W.; Martin, C. 2007: Pharmaceutical applications of hot-melt extrusion: part I. Drug Development and Industrial Pharmacy 33(9): 909-926
Burlage, H.M. 1947: Pharmaceutical applications of isoprophyl alcohol; solubilities of local anesthetics. Journal of the American Pharmaceutical Association. American Pharmaceutical Association 36(1): 16
Burlage, H.M.; Hawkins, D.B. 1946: Pharmaceutical applications of isopropyl alcohol; as a solvent in pharmaceutical manufacturing. Journal of the American Pharmaceutical Association. American Pharmaceutical Association 35(12): 379-384
Burlage, H.M. 1948: Pharmaceutical applications of isopropyl alcohol; solubilities of sedatives, hypnotics, and sulfonamides. Journal of the American Pharmaceutical Association. American Pharmaceutical Association 37(9): 345
Strachan, C.J.; Windbergs, M.; Offerhaus, H.L. 2011: Pharmaceutical applications of non-linear imaging. International Journal of Pharmaceutics 417(1-2): 163-172
Shi, Z.; Anderson, C.A. 2010: Pharmaceutical applications of separation of absorption and scattering in near-infrared spectroscopy (NIRS). Journal of Pharmaceutical Sciences 99(12): 4766-4783
Sebestyén, Z.; Szepesi, K.; Szabó, B.ás. 2013: Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin. Acta Pharmaceutica Hungarica 83(2): 57-67
Ong, H.X.; Traini, D.; Young, P.M. 2013: Pharmaceutical applications of the Calu-3 lung epithelia cell line. Expert Opinion on Drug Delivery 10(9): 1287-1302
Rubio-Pina, J.; Vazquez-Flota, F. 2013: Pharmaceutical applications of the benzylisoquinoline alkaloids from Argemone mexicana L. Current Topics in Medicinal Chemistry 13(17): 2200-2207
Prajapati, V.D.; Jani, G.K.; Moradiya, N.G.; Randeria, N.P. 2013: Pharmaceutical applications of various natural gums, mucilages and their modified forms. Carbohydrate Polymers 92(2): 1685-1699
Gendrin, C.; Roggo, Y.; Collet, C. 2008: Pharmaceutical applications of vibrational chemical imaging and chemometrics: a review. Journal of Pharmaceutical and Biomedical Analysis 48(3): 533-553
Russo, R.; Guillarme, D.; T-T Nguyen, D.; Bicchi, C.; Rudaz, S.; Veuthey, J-Luc. 2008: Pharmaceutical applications on columns packed with sub-2 microm particles. Journal of Chromatographic Science 46(3): 199-208
Trivedi, N.R.; Rajan, M.G.; Johnson, J.R.; Shukla, A.J. 2007: Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process. Critical Reviews in Therapeutic Drug Carrier Systems 24(1): 1-40
Oblozinský, M.; Bezáková, L.ýd.; Kollárová, R.át. 2011: Pharmaceutical aspects of animal lipoxygenases. Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 60(3): 116-124
Czejka, M. 2008: Pharmaceutical aspects of clinical trials: concepts of pharmacokinetic investigations. Onkologie 31(Suppl 2): 29-33
Deconinck, E.; Sohier, J.; De Scheerder, I.; Van den Mooter, G. 2008: Pharmaceutical aspects of drug eluting stents. Journal of Pharmaceutical Sciences 97(12): 5047-5060
Sharma, S.; Mukkur, T.K.S.; Benson, H.A.E.; Chen, Y. 2009: Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems. Journal of Pharmaceutical Sciences 98(3): 812-843
Taguchi, K.; Chuang, V.T.G.; Maruyama, T.; Otagiri, M. 2012: Pharmaceutical aspects of the recombinant human serum albumin dimer: structural characteristics, biological properties, and medical applications. Journal of Pharmaceutical Sciences 101(9): 3033-3046
Vieira, F.S. 2010: Pharmaceutical assistance in the Brazilian public health care system. Revista Panamericana de Salud Publica 27(2): 149-156
de Oliveira, L.Cristina.Feltrin.; Assis, M.Maria.Araújo.; Barboni, Aé.René. 2010: Pharmaceutical assistance in the basic units of health: from the national drug policy to the basic attention to health. Ciencia and Saude Coletiva 15 Suppl. 3: 3561-3567
Sheppard, I.; Hyland, S.; Leonard, P.; Koczmara, C. 2009: Pharmaceutical bar coding: moving forward in Canada. Dynamics 20(3): 28-30
Naito, M.; Masumi, A. 2013: Pharmaceutical basic researches aiming at clinical applications. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 133(12): 1361-1362
Du, B.; Haddad, S.P.; Scott, W.C.; Chambliss, C.K.; Brooks, B.W. 2015: Pharmaceutical bioaccumulation by periphyton and snails in an effluent-dependent stream during an extreme drought. Chemosphere 119: 927-934
Derme, A.I.; Tiono, A.; Hirsch, F.; Sirima, S.B. 2009: Pharmaceutical black market in Burkina Faso: an illicit but socially adapted market. Medecine Tropicale: Revue du Corps de Sante Colonial 69(1): 103-104
Klein, F. 2014: Pharmaceutical bleeding reduction with one dose or multiple doses?. Laryngo- Rhino- Otologie 93(4): 228-229
Kalisch, L.M.; Roughead, E.E.; Gilbert, A.L. 2007: Pharmaceutical brand substitution in Australia--are there multiple switches per prescription?. Australian and New Zealand Journal of Public Health 31(4): 348-352
Brown, M.C.; Hanggi, A. 2007: Pharmaceutical calculations instruction and assessment in US colleges and schools of pharmacy. American journal of pharmaceutical education 71(5): 87
Hill, P. 2012: Pharmaceutical care R.I.P?. International Journal of Pharmacy Practice 20(1): 2-3
Ogbogu, U.; Morton, S. 2013: Pharmaceutical care and access to health information decisions involving minors: Characterizing the pharmacist's obligation to the patient. Canadian Pharmacists Journal: Cpj 146(2): 101-108
Pádula, M.d.; Pinto, A.V.; Matos, G.C.êa.d.; Siqueira, D.T.; Vieira, R.C. 2014: Pharmaceutical care and attention suspended: compromise-formations between pharmacy and psychoanalysis [corrected. Ciencia and Saude Coletiva 19(2): 609-618
Danladi, J.; Falang, K.D.; Barde, R.A.; Jimam, N.S.; Dangiwa, D.A.; Jimoh, H.O. 2013: Pharmaceutical care and medication adherence in management of psychosis in a Nigerian tertiary hospital. Journal of Research in Pharmacy Practice 2(2): 83-87
Eloranta, S.; Hannukainen, S.; Routasalo, P.; Viitanen, M.; Arve, S. 2011: Pharmaceutical care as described by home-dwelling older people in Finland. Medicina 47(11): 629-634
Katoue, M.G.; Awad, A.I.; Schwinghammer, T.L.; Kombian, S.B. 2014: Pharmaceutical care education in Kuwait: pharmacy students' perspectives. Pharmacy Practice 12(3): 411
Schulte, S.; Annicotte, I.; Mowitz, A.; Zerres, M.; Braun, U.; Joeres, U.; Jaehde, R. 2011: Pharmaceutical care for Parkinson's patients with orthostatic dysregulation. Medizinische Monatsschrift für Pharmazeuten 34(7): 250-256
Kraff, S.; Frisse, S.; Ringsdorf, S.; Zerres, M.; Braun, U.; Joeres, R.; Jaehde, U. 2009: Pharmaceutical care for a multimorbid patient mainly suffering from chronic obstructive pulmonary disease. Medizinische Monatsschrift für Pharmazeuten 32(3): 97-101
Hohmann, C.; Radziwill, R.; Walter, A.; Klotz, J.ür.M.; Stock, A.; Jacobs, A.H. 2008: Pharmaceutical care for a patient with ischemic stroke. Medizinische Monatsschrift für Pharmazeuten 31(2): 61-66
Shanmugam, S.; Varughese, J.; Nair, M.A.S.; Balasubramanian, R.; Velu, S.; Bhojan, C.; Devarajan, V.; Sabzghabaee, A.M. 2012: Pharmaceutical care for asthma patients: a Developing Country's Experience. Journal of Research in Pharmacy Practice 1(2): 66-71
Petkova, V.B. 2008: Pharmaceutical care for asthma patients: a community pharmacy-based pilot project. Allergy and Asthma Proceedings 29(1): 55-61
Hoffmann, W.; Herzog, B.; Mühlig, S.; Kayser, H.; Fabian, R.üd.; Thomsen, M.; Cramer, M.; Fiss, T.; Gresselmeyer, D.; Janhsen, K. 2008: Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention. Annals of PharmacoTherapy 42(12): 1804-1813
Tommelein, E.; Tollenaere, K.; Mehuys, E.; Boussery, K. 2014: Pharmaceutical care for patients with COPD in Belgium and views on protocol implementation. International Journal of Clinical Pharmacy 36(4): 697-701
Argay, M.ár.; Koós, I.án.; Takács, I.án.; Dormaeva, I.; Meskó, A.; Zelkó, R.án.; Hankó, B.áz. 2013: Pharmaceutical care for patients with acute myocardial infarction in Hungary. International Journal of Clinical Pharmacology and Therapeutics 51(2): 91-95
Hohmann, C.; Klotz, J.ür.M.; Radziwill, R.; Jacobs, A.H.; Kissel, T. 2009: Pharmaceutical care for patients with ischemic stroke: improving the patients quality of life. Pharmacy World and Science: Pws 31(5): 550-558
Santos, D.d.O.; Martins, M.C.; Cipriano, S.L.; Pinto, R.M.C.; Cukier, A.; Stelmach, R. 2010: Pharmaceutical care for patients with persistent asthma: assessment of treatment compliance and use of inhaled medications. Jornal Brasileiro de Pneumologia: Publicacao Oficial da Sociedade Brasileira de Pneumologia e Tisilogia 36(1): 14-22
Yoshiyama, Y. 2009: Pharmaceutical care for the healthy and ill. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 129(12): 1459-1460
Katoue, M.G.; Awad, A.I.; Schwinghammer, T.L.; Kombian, S.B. 2014: Pharmaceutical care in Kuwait: hospital pharmacists' perspectives. International Journal of Clinical Pharmacy 36(6): 1170-1178
Prot-Labarthe, S.; Therrien, R.; Demanche, C.; Larocque, D.; Bussières, J.-F.ço. 2008: Pharmaceutical care in an inpatient pediatric hematopoietic stem cell transplant service. Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners 14(3): 147-152
Belaiche, S.; Romanet, T.; Bell, R.; Calop, J.; Allenet, B.; Zaoui, P. 2012: Pharmaceutical care in chronic kidney disease: experience at Grenoble University Hospital from 2006 to 2010. Journal of Nephrology 25(4): 558-565
Alvarez-Risco, A.; van Mil, J.W.Foppe. 2007: Pharmaceutical care in community pharmacies: practice and research in Peru. Annals of PharmacoTherapy 41(12): 2032-2037
Devesa García, C.; Matoses Chirivella, C.; Peral Ballester, L.; Sanz Tamargo, G.; Murcia López, A.C.; Navarro Ruiz, A. 2012: Pharmaceutical care in renal insufficiency inpatients. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 36(6): 483-491
Lai, P.S.M.; Chua, S.S.; Chan, S.P. 2012: Pharmaceutical care issues encountered by post-menopausal osteoporotic women prescribed bisphosphonates. Journal of Clinical Pharmacy and Therapeutics 37(5): 536-543
Chua, S.S.; Kok, L.C.; Yusof, F.A.M.; Tang, G.H.; Lee, S.W.H.; Efendie, B.; Paraidathathu, T. 2012: Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings. Bmc Health Services Research 12: 388
Heslop, I.M.; Bellingan, M.; Speare, R.; Glass, B.D. 2014: Pharmaceutical care model to assess the medication-related risks of travel. International Journal of Clinical Pharmacy 36(6): 1196-1204
Ascunce Saldaña, M.P.; Iglesias Neiro, P. 2009: Pharmaceutical care of a patient diagnosed with mastocytosis. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 33(2): 116-118
Kaufmann, D.; Walkenbach, K.; Döhler, N.; Wagemann, G.; Menzen, M.; Homann, J.ür.; Jaehde, U. 2011: Pharmaceutical care of a patient with acute diabetic foot syndrome. Medizinische Monatsschrift für Pharmazeuten 34(2): 55-60
Heumüller, R.; Kretschmer, I.; Döhler, N.; Wittich, R.üd.; Menzen, M.; Homann, J.ür.; Jaehde, U. 2009: Pharmaceutical care of an osteoporosis patient with hypothyroidism. Medizinische Monatsschrift für Pharmazeuten 32(12): 459-463
Renner, K. 2008: Pharmaceutical care of depressive patients. Compliance in focus. Pharmazie in Unserer Zeit 37(3): 242-248
Krämer, I.; Ganso, M. 2007: Pharmaceutical care of epilepsy patients. Pharmazie in Unserer Zeit 36(4): 288-297
Gysen, C.; De Loof, H.; De Meyer, G. 2011: Pharmaceutical care of heart failure: theory and clinical practice. Journal de Pharmacie de Belgique 3: 68-75
Wood, K.; Gibson, F.; Radley, A.; Williams, B. 2015: Pharmaceutical care of older people: what do older people want from community pharmacy?. International Journal of Pharmacy Practice 23(2): 121-130
Li, C.Xiao.; Liu, F.; Zhang, X.Yu.; Zhai, S.Di. 2009: Pharmaceutical care of patient with cryptococcal meningitis: a case report. Beijing da Xue Xue Bao. Yi Xue Ban 41(5): 602-604
Vlcek, J.; Malý, J.; Dosedel, M. 2009: Pharmaceutical care of patients with diabetes mellitus and its relationship to clinical pharmacy. Vnitrni Lekarstvi 55(4): 384-388
Elnour, A.A.; El Mugammar, I.T.; Jaber, T.; Revel, T.; McElnay, J.C. 2008: Pharmaceutical care of patients with gestational diabetes mellitus. Journal of Evaluation in Clinical Practice 14(1): 131-140
Dong, S-jie.; Zhang, T.; Li, Y.; Zhai, S-di. 2014: Pharmaceutical care of serious bleeding induced by tramadol-warfarin interaction: a case report. Beijing da Xue Xue Bao. Yi Xue Ban 46(5): 809-813
Kniggendorf, K.; Klima, K.; Krolop, L.; Zerres, M.; Jaehde, U. 2013: Pharmaceutical care of the geriatric patient in the hospital. Medizinische Monatsschrift für Pharmazeuten 36(8): 299-304
Abah, I.O.; Ojeh, V.B.; Falang, K.D.; Darin, K.M.; Olaitan, O.O.; Agbaji, O.O. 2014: Pharmaceutical care outcomes in an outpatient human immunodeficiency virus treatment center in Jos, Nigeria. Journal of Basic and Clinical Pharmacy 5(3): 57-61
Culbertson, V.L. 2008: Pharmaceutical care plan examinations to identify students at risk for poor performance in advanced pharmacy practice experiences. American Journal of Pharmaceutical Education 72(5): 111
Aguiar, P.M.; Balisa-Rocha, B.J.; Brito, G.C.; Lyra, D.P. 2012: Pharmaceutical care program for elderly patients with uncontrolled hypertension. Journal of the American Pharmacists Association: Japha 52(4): 515-8 1 P Following 518
Mourão, A.Oliveira.Magalhães.; Ferreira, Wécia.Rodrigues.; Martins, M.Auxiliadora.Parreiras.; Reis, A.Max.Moreira.; Carrillo, M.Ruth.Gaede.; Guimarães, A.Grabe.; Ev, L.Silveira. 2013: Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial. International Journal of Clinical Pharmacy 35(1): 79-86
Ucha-Samartín, M.; Martínez-López de Castro, Ní.; Troncoso-Mariño, A.; Campelo-Sánchez, E.; Vázquez-López, C.; Inaraja-Bobo, Mía.Teresa. 2009: Pharmaceutical care strategies to prevent medication errors. Revista de Calidad Asistencial: Organo de la Sociedad Espanola de Calidad Asistencial 24(4): 149-154
Marques, L.A.M.; Galduroz, J.C.F.; Noto, A.R. 2012: Pharmaceutical care to patients treated with antidepressants. Revista de Calidad Asistencial: Organo de la Sociedad Espanola de Calidad Asistencial 27(1): 55-64
Isetts, B.J. 2012: Pharmaceutical care, MTM, and payment: the past, present, and future. Annals of PharmacoTherapy 46(4): S47-S56
Angonesi, D.; Sevalho, G. 2010: Pharmaceutical care: conceptual and critical basis to a Brazilian model. Ciencia and Saude Coletiva 15(Suppl 3): 3603-3614
Tumkur, A.; Muragundi, P.; Shetty, R.; Naik, A. 2012: Pharmaceutical care: need of the hour in India. Journal of Young Pharmacists: Jyp 4(4): 282-286
Allemann, S.S.; van Mil, J.W.F.; Botermann, L.; Berger, K.; Griese, N.; Hersberger, K.E. 2014: Pharmaceutical care: the PCNE definition 2013. International Journal of Clinical Pharmacy 36(3): 544-555
Liu, L.; Wu, L.-p.; Liu, Q. 2010: Pharmaceutical characteristics of Glycyrrhizae radix micropowder. Nan Fang Yi Ke da Xue Xue Bao 30(5): 1079-1081
Chen, J.; Wang, W.; Cai, B.-c.; Hu, W.; Wang, L.-j. 2008: Pharmaceutical characteristics of brucine stealth liposomes. Zhongguo Zhong Yao Za Zhi 33(17): 2100-2104
Leyva-Moral, J.M. 2009: Pharmaceutical characteristics of oral anti-diabetes medicines. Revista de Enfermeria 32(2): 6-7
Shah, R.B.; Yang, Y.; Khan, M.A.; Raw, A.; Yu, L.X.; Faustino, P.J. 2014: Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose. International Journal of Pharmaceutics 464(1-2): 46-52
Ivanova, M.V.; Lamprecht, C.; Loureiro, M.J.; Huzil, J.T.; Foldvari, M. 2012: Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients. International Journal of Nanomedicine 7: 403-415
Brieva, A.J. 1949: Pharmaceutical chemical concept of new drugs introduced in the years 1947-1948. Revista de Quimica E Farmacia 7(73): 4-14
Brindle, H. 1945: Pharmaceutical chemistry; whence and whither?. Quarterly Journal of Pharmacy and Pharmacology 18: 149-162
Soparawalla, S.; Salazar, G.A.; Perry, R.H.; Nicholas, M.; Cooks, R.G. 2009: Pharmaceutical cleaning validation using non-proximate large-area desorption electrospray ionization mass spectrometry. Rapid Communications in Mass Spectrometry: Rcm 23(1): 131-137
Miroshnyk, I.; Mirza, S.; Sandler, N. 2009: Pharmaceutical co-crystals-an opportunity for drug product enhancement. Expert Opinion on Drug Delivery 6(4): 333-341
Surov, A.O.; Voronin, A.P.; Manin, A.N.; Manin, N.G.; Kuzmina, L.G.; Churakov, A.V.; Perlovich, G.L. 2014: Pharmaceutical cocrystals of diflunisal and diclofenac with theophylline. Molecular Pharmaceutics 11(10): 3707-3715
Chadha, R.; Saini, A.; Arora, P.; Bhandari, S. 2012: Pharmaceutical cocrystals: a novel approach for oral bioavailability enhancement of drugs. Critical Reviews in Therapeutic Drug Carrier Systems 29(3): 183-218
Qiao, N.; Li, M.; Schlindwein, W.; Malek, N.; Davies, A.; Trappitt, G. 2011: Pharmaceutical cocrystals: an overview. International Journal of Pharmaceutics 419(1-2): 1-11
Brittain, H.G. 2013: Pharmaceutical cocrystals: the coming wave of new drug substances. Journal of Pharmaceutical Sciences 102(2): 311-317
Compagni, A.; Cavalli, L.; Jommi, C. 2008: Pharmaceutical companies and Italian Regional Governments: managing relationships in an increasing institutional complexity. Health Policy 87(3): 333-341
Christensen, R.C.; Tueth, M.J. 1998: Pharmaceutical companies and academic departments of psychiatry : a call for ethics education. Academic Psychiatry: the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 22(2): 135-137
Grover, A.; Citro, B.; Mankad, M.; Lander, F. 2012: Pharmaceutical companies and global lack of access to medicines: strengthening accountability under the right to health. Journal of Law Medicine and Ethics: a Journal of the American Society of Law Medicine and Ethics 40(2): 234-250
't Hoen, E. 2010: Pharmaceutical companies and the UNITAID patent pool. Lancet 375(9708): 30
Kim, H. 2011: Pharmaceutical companies as a source of health information: a pilot study of the effects of source, web site interactivity, and involvement. Health Marketing Quarterly 28(1): 57-85
Wang, D.Wei.L.; Ferraz, O.Luiz.Motta. 2012: Pharmaceutical companies vs. the State: who is responsible for post-trial provision of drugs in Brazil?. Journal of Law Medicine and Ethics: a Journal of the American Society of Law Medicine and Ethics 40(2): 188-196
Bergmann, M. 2009: Pharmaceutical companies' medication assistance programs. Southern Medical Journal 102(8): 870
Mello, M.M.; Abiola, S.; Colgrove, J. 2012: Pharmaceutical companies' role in state vaccination policymaking: the case of human papillomavirus vaccination. American Journal of Public Health 102(5): 893-898
Lichtenberg, F.R. 2011: Pharmaceutical companies' variation of drug prices within and among countries can improve long-term social well-being. Health Affairs 30(8): 1539-1544
Anonymous 2012: Pharmaceutical companies: safe stock market investments. Prescrire International 21(131): 251
Chang, P.Lee. 2013: Pharmaceutical companies: the perfect scapegoat for everything. American Journal of Bioethics: Ajob 13(5): 30-32
Spurling, G.; Mansfield, P.; Lexchin, J. 2011: Pharmaceutical company advertising in The Lancet. Lancet 378(9785): 30
Naik, A.D.; Woofter, A.L.; Skinner, J.M.; Abraham, N.S. 2009: Pharmaceutical company influence on nonsteroidal anti-inflammatory drug prescribing behaviors. American Journal of Managed Care 15(4): E9-15
Kyle, G.J.; Nissen, L.M.; Tett, S.E. 2008: Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines. Journal of Clinical Pharmacy and Therapeutics 33(5): 553-559
Urushihara, H.; Kobashi, G.; Masuda, H.; Taneichi, S.; Yamamoto, M.; Nakayama, T.; Kawakami, K.; Matsuda, T.; Ohta, K.; Sugimori, H. 2014: Pharmaceutical company perspectives on current safety risk communications in Japan. Springerplus 3: 51
Miller, H.I. 2009: Pharmaceutical company user fees: their uses and abuses. American Journal of Therapeutics 16(6): 475-476
Gartlehner, G.; Fleg, A. 2010: Pharmaceutical company-sponsored drug trials: the system is broken. Journal of Clinical Epidemiology 63(2): 128-129
Shekelle, P. 2010: Pharmaceutical company-sponsored drug trials: what are we to believe?. Journal of Clinical Epidemiology 63(2): 126-127
Rosse, G. 2012: Pharmaceutical composition comprising indole compound for treatment of diseases associated with oxidative stress: patent highlight. ACS medicinal chemistry letters 3(12): 953
Wang, S.; Cunnusamy, K. 2013: Pharmaceutical composition for treating macular degeneration (WO2012079419). Expert Opinion on Therapeutic Patents 23(2): 269-272
Pires, M.A.S.; Souza Dos Santos, R.A.; Sinisterra, R.én.D. 2011: Pharmaceutical composition of hydrochlorothiazide:β-cyclo-dextrin: preparation by three different methods, physico-chemical characterization and in vivo diuretic activity evaluation. Molecules 16(6): 4482-4499
Jensen, C.E.d.M.; dos Santos, R.A.S.; Denadai, A.M.ár.L.; Santos, C.F.F.; Braga, A.N.G.ça.; Sinisterra, R.én.D. 2010: Pharmaceutical composition of valsartan: beta-cyclodextrin: physico-chemical characterization and anti-hypertensive evaluation. Molecules 15(6): 4067-4084
Musson, S.E.; Townsend, T.G. 2009: Pharmaceutical compound content of municipal solid waste. Journal of Hazardous Materials 162(2-3): 730-735
Tosh, E. 2004: Pharmaceutical compounding calculations. International Journal of Pharmaceutical Compounding 8(3): 203-205
Timko, R.J.; Crooker, P.E.M. 2014: Pharmaceutical compounding or pharmaceutical manufacturing? a regulatory perspective. International Journal of Pharmaceutical Compounding 18(2): 101-111
Kormeset, P.O. 2008: Pharmaceutical consultants and drug information. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 128(15): 1684-1685
Reseland, S. 2008: Pharmaceutical consultants don't give neutral information. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 128(22): 2620
Brandon, M-T.; Charpiat, B. 2009: Pharmaceutical consultation for liver transplant patients: a contribution to therapeutic education. Annales Pharmaceutiques Francaises 67(1): 41-53
Berger, K.; Griese, N. 2012: Pharmaceutical consultation: the patient is the center. Pharmazie in Unserer Zeit 41(4): 276-282
Cavaco, A.; Roter, D. 2010: Pharmaceutical consultations in community pharmacies: utility of the Roter Interaction Analysis System to study pharmacist-patient communication. International Journal of Pharmacy Practice 18(3): 141-148
Metcalfe, C.D. 2013: Pharmaceutical contaminants of emerging concern in the environment. Environmental Toxicology and Chemistry 32(8): 1683-1684
Sargison, N.D. 2011: Pharmaceutical control of endoparasitic helminth infections in sheep. Veterinary Clinics of North America. Food Animal Practice 27(1): 139-156
Abecia, J.é A.; Forcada, F.; González-Bulnes, A. 2011: Pharmaceutical control of reproduction in sheep and goats. Veterinary Clinics of North America. Food Animal Practice 27(1): 67-79
Prados-Torres, A.; Calderón-Larrañaga, A.; Sicras-Mainar, A.; March-Llull, S.à; Oliván-Blázquez, B.ár. 2009: Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionals. Bmc Health Services Research 9: 209
Vivas-Consuelo, D.; Usó-Talamantes, R.; Guadalajara-Olmeda, N.; Trillo-Mata, J.é-L.; Sancho-Mestre, C.; Buigues-Pastor, L. 2014: Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool. Bmc Health Services Research 14: 462
Kenneally, M.; Walshe, V. 2012: Pharmaceutical cost-containment policies and sustainability: recent Irish experience. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 15(2): 389-393
Lorente, M.-R.; Hernández, J.; Antoñanzas, F. 2013: Pharmaceutical costs of assisted reproduction in Spain. Clinical Drug Investigation 33(11): 789-794
Goebel, R. 2012: Pharmaceutical counseling of patients with hypertension. Pharmazie in Unserer Zeit 41(4): 332-342
Coustasse, A.; Arvidson, C.; Rutsohn, P. 2010: Pharmaceutical counterfeiting and the RFID technology intervention. Journal of Hospital Marketing and Public Relations 20(2): 100-115
Weerts, A.él.P.; De Meyer, G.; Pauwels, G.; Vanspauwen, R.; Dornhoffer, J.L.; Van de Heyning, P.H.; Wuyts, F.L. 2012: Pharmaceutical countermeasures have opposite effects on the utricles and semicircular canals in man. Audiology and Neuro-Otology 17(4): 235-242
Viscasillas Clerch, A.; Fernandez Campos, F.; Del Pozo, A.; Calpena Campmany, A.C. 2013: Pharmaceutical design of a new lactose-free coprocessed excipient: application of hydrochlorothiazide as a low solubility drug model. Drug Development and Industrial Pharmacy 39(7): 961-969
Hoffman, M.N. 2012: Pharmaceutical detailing is not for everyone: side effects may include sub-optimal prescribing decisions, compromised patient health, and increased prescription drug spending. Journal of Legal Medicine 33(3): 381-397
Kauss, T.; Gaubert, A.; Boyer, C.; Ba, B.B.; Manse, M.; Massip, S.; Léger, J.-M.; Fawaz, F.; Lembege, M.; Boiron, J.-M.; Lafarge, X.; Lindegardh, N.; White, N.J.; Olliaro, P.; Millet, P.; Gaudin, K. 2013: Pharmaceutical development and optimization of azithromycin suppository for paediatric use. International Journal of Pharmaceutics 441(1-2): 218-226
Moes, J.J.; Koolen, S.L.W.; Huitema, A.D.R.; Schellens, J.H.M.; Beijnen, J.H.; Nuijen, B. 2011: Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001). International Journal of Pharmaceutics 420(2): 244-250
Narang, A.S.; Chang, R-Kun.; Hussain, M.A. 2013: Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems. Journal of Pharmaceutical Sciences 102(11): 3867-3882
Su, J.; Mazzeo, J.; Subbarao, N.; Jin, T. 2011: Pharmaceutical development of biologics: fundamentals, challenges and recent advances. Therapeutic Delivery 2(7): 865-871
Ferreira, A.d.O.; Holandino, C. 2008: Pharmaceutical development of enteric-release hard gelatin capsules in the compounding setting. International Journal of Pharmaceutical Compounding 12(2): 163-169
Friend, D.R. 2010: Pharmaceutical development of microbicide drug products. Pharmaceutical Development and Technology 15(6): 562-581
Kanagale, P.; Patel, V.; Venkatesan, N.; Jain, M.; Patel, P.; Misra, A. 2008: Pharmaceutical development of solid dispersion based osmotic drug delivery system for nifedipine. Current Drug Delivery 5(4): 306-311
Jiang, Z.; Shao, J.; Yang, T.; Wang, J.; Jia, L. 2014: Pharmaceutical development, composition and quantitative analysis of phthalocyanine as the photosensitizer for cancer photodynamic therapy. Journal of Pharmaceutical and Biomedical Analysis 87: 98-104
Mackey, T.K.; Liang, B.A. 2013: Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health. Globalization and Health 9: 45
Angonesi, D. 2008: Pharmaceutical dispensing: an analysis of different concepts and models. Ciencia and Saude Coletiva 13 Suppl: 629-640
Senior, K. 2008: Pharmaceutical downsizing and oncology drug development. LANCET. Oncology 9(1): 11
Bowles, V.M.; VanLuvanee, L.J.; Alsop, H.; Hazan, L.; Shepherd, K.; Sidgiddi, S.; Allenby, K.; Ahveninen, T.; Hanegraaf, S. 2018: Clinical studies evaluating abametapir lotion, 0.74%, for the treatment of head louse infestation. Pediatric Dermatology 35(5): 616-621
Kell, D.B.; Dobson, P.D.; Oliver, S.G. 2011: Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. Drug Discovery Today 16(15-16): 704-714
Wiley, M.T.; Jin, C.; Hristidis, V.; Esterling, K.M. 2014: Pharmaceutical drugs chatter on Online Social Networks. Journal of Biomedical Informatics 49: 245-254
Ishihara, H.; Tanaka, I.; Yakumaru, H.; Tanaka, M.; Yokochi, K.; Akashi, M. 2013: Pharmaceutical drugs supporting regeneration of small-intestinal mucosa severely damaged by ionizing radiation in mice. Journal of Radiation Research 54(6): 1057-1064
Campbell, A.W. 2014: Pharmaceutical drugs-the good and the not so good: together, we can make it better. Alternative Therapies in Health and Medicine 20(1): 9-11
Nielsen, S.; Bruno, R. 2011: Pharmaceutical drugs: the delicate balance between reducing pain and reducing harm. Drug and Alcohol Review 30(3): 233-235
Fent, K.W.; Durgam, S.; Mueller, C. 2014: Pharmaceutical dust exposure at pharmacies using automatic dispensing machines: a preliminary study. Journal of Occupational and Environmental Hygiene 11(11): 695-705
Goodness, J.H. 1947: Pharmaceutical economics in the postwar curriculum. American Journal of Pharmaceutical Education 11(1): 146-149
Beal, G.D. 1947: Pharmaceutical education and industrial research. American Journal of Pharmaceutical Education 11(3): 373-389
Ghosh, A.K. 2012: Pharmaceutical education and research. Journal of Advanced Pharmaceutical Technology and Research 3(3): 141
Iwakiri, U.; Senba, J.; Suenaga, K.; Shimazoe, T. 2011: Pharmaceutical education for psychotic patients with physical complications. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 131(4): 493-496
Kendig, H.E. 1947: Pharmaceutical education for the future. American Journal of Pharmaceutical Education 11(1): 33-43
Manning, N.C. 1946: Pharmaceutical education in Canada. Australasian Journal of Pharmacy 27(320): 640-643
Galbis, B. 1947: Pharmaceutical education in Cuba. Tile and Till 33(6): 143
Baldwin, P. 1949: Pharmaceutical education in new South Wales. Australasian Journal of Pharmacy 30(353): 582
Grabowski, M.B. 1946: Pharmaceutical education in Poland. Australasian Journal of Pharmacy 27(319): 556-559
Blom, L.; Wolters, M.; Ten Hoor-Suykerbuyk, M.; van Paassen, J.; van Oyen, A. 2011: Pharmaceutical education in patient counseling: 20h spread over 6 years?. Patient Education and Counseling 83(3): 465-471
Hayakawa, N.; Asayama, S.; Noda, Y.; Shimizu, T.; Kawakami, H. 2012: Pharmaceutical effect of manganese porphyrins on manganese superoxide dismutase deficient mice. Molecular Pharmaceutics 9(10): 2956-2959
Fang, H.S.; Hou, T.L. 1948: Pharmaceutical effects of Pyrola rotundifolia on the circulatory system. Chinese Review of Tropical Medicine 1(1): 43-46
Verissimo, L.M.; Lima, L.F.A.; Egito, L.C.M.; de Oliveira, A.G.; do Egito, E.S.óc.T. 2010: Pharmaceutical emulsions: a new approach for gene therapy. Journal of Drug Targeting 18(5): 333-342
Enck, G.G. 2014: Pharmaceutical enhancement and medical professionals. Medicine Health Care and Philosophy 17(1): 23-28
Raw, A.é S.; Lionberger, R.; Yu, L.X. 2011: Pharmaceutical equivalence by design for generic drugs: modified-release products. Pharmaceutical Research 28(7): 1445-1453
Andrade-Lima, M.; Pereira, L.F.F.; Fernandes, A.L.G. 2012: Pharmaceutical equivalence of the combination formulation of budesonide and formoterol in a single capsule with a dry powder inhaler. Jornal Brasileiro de Pneumologia: Publicacao Oficial da Sociedade Brasileira de Pneumologia e Tisilogia 38(6): 748-756
Tefferi, A. 2007: Pharmaceutical erythropoietin use in patients with cancer: is it time to abandon ship or just drop anchor?. Mayo Clinic Proceedings 82(11): 1316-1318
Dhiman, G.J.; Amber, K.T. 2013: Pharmaceutical ethics and physician liability in Side Effects. Journal of Medical Humanities 34(4): 497-503
Cavero, R.Y.; Akerreta, S.; Calvo, M.I. 2011: Pharmaceutical ethnobotany in Northern Navarra (Iberian Peninsula). Journal of Ethnopharmacology 133(1): 138-146
Cavero, R.Y.; Akerreta, S.; Calvo, M.I. 2011: Pharmaceutical ethnobotany in the Middle Navarra (Iberian Peninsula). Journal of Ethnopharmacology 137(1): 844-855
Calvo, M.I.; Akerreta, S.; Cavero, R.Y. 2011: Pharmaceutical ethnobotany in the Riverside of Navarra (Iberian Peninsula). Journal of Ethnopharmacology 135(1): 22-33
Benítez, G.; González-Tejero, M.R.; Molero-Mesa, J. 2010: Pharmaceutical ethnobotany in the western part of Granada province (southern Spain): ethnopharmacological synthesis. Journal of Ethnopharmacology 129(1): 87-105
Arya, A.; Sharma, V.; Pathak, K. 2013: Pharmaceutical evaluation and dynamic vapor sorption studies of fast dissolving intraoral films of Loratadine. Pharmaceutical Development and Technology 18(6): 1329-1338
Cook, A.K.; Nieuwoudt, C.D.; Longhofer, S.L. 2012: Pharmaceutical evaluation of compounded trilostane products. Journal of the American Animal Hospital Association 48(4): 228-233
Pu, X.-H.; Sun, J.; Qin, Y.-M.; Zhang, X.; Zhang, P.; He, Z.-G. 2011: Pharmaceutical evaluation of hydroxycamptothecin nanosuspensions with the action of inhibiting P-gp. Yao Xue Xue Bao 46(7): 834-838
Engel, A.; Oswald, S.; Siegmund, W.; Keiser, M. 2012: Pharmaceutical excipients influence the function of human uptake transporting proteins. Molecular Pharmaceutics 9(9): 2577-2581
Ren, X.; Mao, X.; Si, L.; Cao, L.; Xiong, H.; Qiu, J.; Schimmer, A.D.; Li, G. 2008: Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 70(1): 279-288
Grondal, G.; Bjornsson, E.S. 2013: Pharmaceutical expenditure - a burning issue. Laeknabladid 99(5): 233
Segura Benito, M.J.ús.; Moya Martínez, P.; Escribano Sotos, F. 2012: Pharmaceutical expenditure among primary care physicians in the health area of Cuenca (Spain). Response. Gaceta Sanitaria 26(4): 389-390
Segura Benito, M.ía.J.ús.; Moya Martínez, P.; Escribano Sotos, F. 2010: Pharmaceutical expenditure among primary care physicians in the province of Cuenca (Spain). Gaceta Sanitaria 24(5): 391-396
Clemente, J.ús.; Marcuello, C.; Montañés, A. 2008: Pharmaceutical expenditure, total health-care expenditure and GDP. Health Economics 17(10): 1187-1206
Hardardóttir, H. 2009: Pharmaceutical expenses during economic crisis--opportunity for reform. Laeknabladid 95(7-8): 489
Kessler, R. 2010: Pharmaceutical factories as a source of drugs in water. Environmental Health Perspectives 118(9): A383
Hawe, A.; Schaubhut, F.; Geidobler, R.; Wiggenhorn, M.; Friess, W.; Rast, M.; de Muynck, C.; Winter, G. 2013: Pharmaceutical feasibility of sub-visible particle analysis in parenterals with reduced volume light obscuration methods. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 85(3 Pt B): 1084-1087
Baumgartner, A.R. 1983: Pharmaceutical firms and Canadian regulations. Canadian Medical Association Journal 128(8): 900
Zhao, Y.; Brown, M.B.; Jones, S.A. 2010: Pharmaceutical foams: are they the answer to the dilemma of topical nanoparticles?. Nanomedicine: Nanotechnology Biology and Medicine 6(2): 227-236
Moya, Y.; Bernal, F.; Rojas, E.; Barthel, E. 2012: Pharmaceutical follow up of antirretroviral treatment in outpatients. Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de Infectologia 29(4): 412-419
Morikawa, T.; Muraoka, O.; Yoshikawa, M. 2010: Pharmaceutical food science: search for anti-obese constituents from medicinal foods-anti-hyperlipidemic saponin constituents from the flowers of Bellis perennis. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 130(5): 673-678
Aldea Lindenau, A. 1947: Pharmaceutical forms of penicillin. Revista de Quimica E Farmacia 5(49): 14-19
Buettner, K.M.; Snoeberger, R.C.; Batista, V.S.; Valentine, A.M. 2011: Pharmaceutical formulation affects titanocene transferrin interactions. Dalton Transactions 40(37): 9580-9588
Phillips, P.J.; Smith, S.G.; Kolpin, D.W.; Zaugg, S.D.; Buxton, H.T.; Furlong, E.T.; Esposito, K.; Stinson, B. 2010: Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environmental Science and Technology 44(13): 4910-4916
Cecchi, C.; Canonico, P.L. 2012: Pharmaceutical formulations and adherence to pharmacological treatment in psychiatry: the example of oral disintegrating tablet of olanzapine. Rivista di Psichiatria 47(1): 30-39
Qureshi, Z.P.; Sartor, O.; Xirasagar, S.; Liu, Y.; Bennett, C.L. 2011: Pharmaceutical fraud and abuse in the United States, 1996-2010. Archives of Internal Medicine 171(16): 1503-1506
Hack, E.I. 2007: Pharmaceutical global marketing practices: increased scrutiny ahead?. Food and Drug Law Journal 62(2): 343-348
Schmeer, M.; Schleef, M. 2014: Pharmaceutical grade large-scale plasmid DNA manufacturing process. Methods in Molecular Biology 1143: 219-240
Romain, S.J. 2013: Pharmaceutical health care and Inuit language communications in Nunavut, Canada. International Journal of Circumpolar Health 72
Spitz, J.; Wickham, M. 2012: Pharmaceutical high profits: the value of R&D, or oligopolistic rents?. American Journal of Economics and Sociology 71(1): 1-36
Fabbiani, F.P.A.; Buth, G.; Levendis, D.C.; Cruz-Cabeza, A.J. 2014: Pharmaceutical hydrates under ambient conditions from high-pressure seeds: a case study of GABA monohydrate. Chemical Communications 50(15): 1817-1819
Easter, J.L.; Steiner, R.R. 2014: Pharmaceutical identifier confirmation via DART-TOF. Forensic Science International 240: 9-20
Milroy, L.-G.; Brunsveld, L. 2013: Pharmaceutical implications of helix length control in helix-mediated protein-protein interactions. Future Medicinal Chemistry 5(18): 2175-2183
Savjani, J.K.; Gajjar, A.K. 2011: Pharmaceutical importance and synthetic strategies for imidazolidine-2-thione and imidazole-2-thione derivatives. Pakistan Journal of Biological Sciences: Pjbs 14(24): 1076-1089
Maggio, R.én.M.; Calvo, N.L.; Vignaduzzo, S.E.; Kaufman, T.S. 2014: Pharmaceutical impurities and degradation products: uses and applications of NMR techniques. Journal of Pharmaceutical and Biomedical Analysis 101: 102-122
Zeitouni, S.; Ford, B.S.; Harris, S.M.; Whitney, M.J.; Gregory, C.A.; Prockop, D.J. 2008: Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs). Bmc Biotechnology 8: 75
Delabarre, F. 2013: Pharmaceutical industry and clinical practice: complementation and evolution. Bulletin du Cancer 100(12): 1231-1232
Hashmi, A.; Singh, G.K. 2010: Pharmaceutical industry and continuing medical education. Indian Journal of Dermatology Venereology and Leprology 76(5): 581-582
Das, A. 2011: Pharmaceutical industry and the market: the case of Prozac and other antidepressants. Asian Journal of Psychiatry 4(1): 14-18
Ljungberg, S. 1948: Pharmaceutical industry and trade in medicinal products in France. Farmacevtisk Revy 47(42): 651-657
Barouni, M.; Ghaderi, H.; Banouei, A. 2012: Pharmaceutical industry and trade liberalization using computable general equilibrium model. Iranian Journal of Public Health 41(12): 66-75
Monasterio, E.; Gleeson, D. 2014: Pharmaceutical industry behaviour and the Trans Pacific Partnership Agreement. New Zealand Medical Journal 127(1389): 6-12
Gunnarsson, L.; Kristiansson, E.; Rutgersson, C.; Sturve, J.; Fick, J.; Förlin, L.; Larsson, D.G.J. 2009: Pharmaceutical industry effluent diluted 1:500 affects global gene expression, cytochrome P450 1A activity, and plasma phosphate in fish. Environmental Toxicology and Chemistry 28(12): 2639-2647
Brody, H. 2009: Pharmaceutical industry financial support for medical education: benefit, or undue influence?. Journal of Law Medicine and Ethics: a Journal of the American Society of Law Medicine and Ethics 37(3): 451-460; 396
Robertson, J.; Walkom, E.; Moynihan, R.; Bero, L.; Henry, D. 2010: Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme. International Journal of Pharmacy Practice 18(2): 88-92
Kutaini, D.; Davila, C. 2010: Pharmaceutical industry in Syria. Journal of Medicine and Life 3(3): 348-350
Mulberg, A.E. 2008: Pharmaceutical industry in pediatric drug development: partners and collaborators with academia and the FDA. Journal of Pediatric Gastroenterology and Nutrition 47(5): 711-713
Sufrin, C.B.; Ross, J.S. 2008: Pharmaceutical industry marketing: understanding its impact on women's health. Obstetrical and Gynecological Survey 63(9): 585-596
Nicholson, S.; Peterson, J.; Yektashenas, B. 2012: Pharmaceutical industry perspective on risk evaluation and mitigation strategies: manufacturer take heed. Expert Opinion on Drug Safety 11(2): 299-314
Frier, E.M.; Wilson, J.A. 2014: Pharmaceutical industry regulation: does the UK take the easy way out?. British Journal of Hospital Medicine 75(5): 246-247
Ghali, W.; Kendall, C.; Palepu, A. 2010: Pharmaceutical industry representation on CIHR's governing council. Open Medicine: a Peer-Reviewed Independent Open-Access Journal 4(1): E26-E27
MacKay, P. 2008: Pharmaceutical industry spending. New Zealand Medical Journal 121(1277): 94
Loertscher, L.L.; Halvorsen, A.J.; Beasley, B.W.; Holmboe, E.S.; Kolars, J.C.; McDonald, F.S. 2010: Pharmaceutical industry support and residency education: a survey of internal medicine program directors. Archives of Internal Medicine 170(4): 356-362
Kerridge, I. 2011: Pharmaceutical industry support for continuing medical education: is it time to disengage?. Journal of Paediatrics and Child Health 47(10): 690-692
Gunn, W.G.; Krause, U.; Lee, N.; Gregory, C.A. 2011: Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model. Blood 117(5): 1641-1651
Robertson, S. 2018: Clinical Studies for the Sake of Negative Data: the Proof Is in the Pudding. Clinical and Translational Science 11(6): 535-536
Lichtenberg, F.R.; Duflos, G. 2008: Pharmaceutical innovation and the longevity of Australians: a first look. Advances in Health Economics and Health Services Research 19: 95-117
Munos, B.H. 2013: Pharmaceutical innovation gets a little help from new friends. Science Translational Medicine 5(168): 168ed1
Greig, D.M. 1933: Clinical Studies in the Pathology of Bone. No. I.-A Fractured Vertebra. Edinburgh Medical Journal 40(8): 365-368
Karampli, E.; Souliotis, K.; Polyzos, N.; Kyriopoulos, J.; Chatzaki, E. 2014: Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to Greece. Hippokratia 18(2): 100-106
Bullinger, M.; Gringeri, A.; von Mackensen, S. 2008: Quality of life of young patients with haemophilia in Europe. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51(6): 637-645
Reed, K. 2008: Pharmaceutical interaction with medical students: to be or not to be. Iowa Medicine: Journal of the Iowa Medical Society 98(6): 27
Ganesan, P.; Wildsoet, C.F. 2010: Pharmaceutical intervention for myopia control. Expert Review of Ophthalmology 5(6): 759-787
Zhou, H.; Peng, Z.-b.; Yu, H.-j. 2007: Pharmaceutical intervention for pandemic influenza. Zhonghua Liu Xing Bing Xue Za Zhi 28(10): 1041-1043
Morante, M.; Matoses-Chirivella, C.; Rodríguez-Lucena, F.J.; Del Moral, J.M.; Ruiz-García, M.; Navarro-Ruiz, A. 2014: Pharmaceutical intervention in duration of antimicrobial treatment at hospital ambit. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 27(3): 159-169
Sánchez-Gili, M.; Toro-Chico, P.; Pérez-Encinas, M.; Gómez-Pedrero, A.M.; Portolés-Pérez, J.M. 2011: Pharmaceutical intervention on the therapeutic adherence in patients with chronic renal disease. Revista de Calidad Asistencial: Organo de la Sociedad Espanola de Calidad Asistencial 26(3): 146-151
Sánchez Ulayar, A.; Gallardo López, S.; Pons Llobet, N.; Murgadella Sancho, A.; Campins Bernadàs, L.; Merino Méndez, R. 2012: Pharmaceutical intervention upon hospital discharge to strengthen understanding and adherence to pharmacological treatment. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 36(3): 118-123
Sevilla Sánchez, D.; Placeres Alsina, M.M.; Miana Mena, M.T.; López Suñé, E.; Codina Jané, C.; Ribas Sala, J. 2010: Pharmaceutical intervention with parenteral nutrition. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 34(1): 9-15
Ishihara, M.; Iihara, H.; Okayasu, S.; Yasuda, K.; Matsuura, K.; Suzui, M.; Itoh, Y. 2010: Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 18(12): 1531-1538
Hackett, M.L.; Yang, M.; Anderson, C.S.; Horrocks, J.A.; House, A. 2010: Pharmaceutical interventions for emotionalism after stroke. Cochrane Database of Systematic Reviews 2: Cd003690
Postma, M.J.; Milne, G.; Nelson, E.A.S.; Pyenson, B.; Basili, M.; Coker, R.; Oxford, J.; Garrison, L.P. 2010: Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts. Expert Review of AntI-Infective Therapy 8(12): 1431-1439
Caveney, E.; Caveney, B.J.; Somaratne, R.; Turner, J.R.; Gourgiotis, L. 2011: Pharmaceutical interventions for obesity: a public health perspective. Diabetes Obesity and Metabolism 13(6): 490-497
Fischell, T.A. 2008: Pharmaceutical interventions for the management of no-reflow. Journal of Invasive Cardiology 20(7): 374-379
Llop-Talaverón, J.; Gracia-García, B.; Machí-Ribes, J.J.; Perayre-Badia, M.; Badia-Tahull, M.B.; Jódar-Masanes, R. 2008: Pharmaceutical interventions in metabolic and nutritional follow-up of surgical patients receiving parenteral nutrition. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 32(4): 216-225
Arrabal-Durán, P.; Durán-García, M.E.; Ribed-Sánchez, A.; Hidalgo-Collazos, P.; Sanjurjo-Sáez, M.ía. 2014: Pharmaceutical interventions in prescriptions for patients admitted with chronic renal failure. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 34(6): 710-715
Pottegård, A.; Hallas, J.; Søndergaard, J. 2011: Pharmaceutical interventions on prescription problems in a Danish pharmacy setting. International Journal of Clinical Pharmacy 33(6): 1019-1027
Venkateswarlu, V.; Kokate, C.K.; Peddanna, G.; Veeresham, C.; Rambhau, D. 1990: Pharmaceutical investigations on salacia macrosperma-1. Ancient Science of Life 9(4): 215-219
Chen, C. 2012: Pharmaceutical kinetics and toxicological effects of nanosystems and nanomaterials for biomedical applications. Current Drug Metabolism 13(8): 1033-1034
Lemmens, T. 2013: Pharmaceutical knowledge governance: a human rights perspective. Journal of Law Medicine and Ethics: a Journal of the American Society of Law Medicine and Ethics 41(1): 163-184
Dixon, R.M. 1983: Pharmaceutical legal restrictions. Canadian Veterinary Journal 24(9): 298
Worthen, D.B. 2006: Pharmaceutical legislation: an historical perspective. International Journal of Pharmaceutical Compounding 10: 20-28